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Abstract 
The organisation of a multitude of cellular niche components, their communication 
via many signalling pathways and their response to physical factors, protects and 
regulates haematopoietic stem cell (HSC) fate in adult bone marrow. Whilst the 
contribution of osteoblasts, endothelial cells and perivascular cells have been 
examined, the role of a second stem cell population in the bone marrow; 
mesenchymal stem cells, is not well understood due to the lack of distinctive 
markers to identify them in vivo. There is therefore a requirement to determine a 
characteristic that allows their prospective isolation. Under certain conditions, 
stromal cells and osteoblasts in the bone marrow express IL-7. The use of a novel 
IL7-Cre BAC transgenic mouse line has allowed more accurate IL-7 protein detection 
in situ and demonstrated IL-7 reporter expression in mesenchymal lineage cells in 
endosteal and vascular HSC niche locations. These cells were further characterised 
in this study in order to determine if IL-7 or nestin, an intermediate filament 
associated with a wide range of stem cell populations, is expressed by and could 
identify bone marrow derived MSCs.  
 
YFP positive cells were analysed in sections of IL-7Cre Rosa26-eYFP mice. 
Interestingly, it was only a proportion of mesenchymal cells that expressed YFP, 
supporting the theory that subsets of MSCs exist and therefore, that they may have 
different roles in numerous bone marrow niches. IL-7 was not observed to have any 
effect on the proliferation or differentiation of human MSCs. Generation of MSC 
clones supported the suggestion that in vitro cultures of MSCs are a heterogeneous 
population and they displayed a wide range of IL-7 and nestin mRNA expression 
levels.  
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1. Introduction 
 
1.1 Mesenchymal stem cells  
The recapitulation of bone and bone marrow formation was demonstrated in the 
late 1960s by transplanting bone marrow fragments to heterotopic anatomical sites 
in mice (Reviewed by Tavassoli & Crosby, 1968). However, it is Friedenstein who is 
acknowledged with the discovery of bone marrow mesenchymal stem cells (MSCs) 
as his group demonstrated over a series of refined experiments that the osteogenic 
potential was confined to a small subset of bone marrow cells distinct from 
haematopoietic cells (Friedenstein et al, 1970). These cells were observed to adhere 
to tissue culture plastic with a fibroblastic morphology and could give rise to 
discrete colonies of cells when plated at clonogenic concentrations, subsequently 
termed colony-forming unit-fibroblasts (CFU-Fs). Additionally, single cells could be 
transplanted in vivo and demonstrated self renewal and skeletal differentiation 
capacity. Fulfilling the criteria for stem cells, the CFU-Fs were consequently named 
osteogenic stem cells and later stromal stem cells. Some years later the term 
mesenchymal stem cell was popularised for these stem cells ex vivo and remains, if 
a little controversially, in use today.  
 
1.1.1 Nomenclature 
Discrepancies exist around the term ‘mesenchymal stem cell’ that was originally 
conceived in 1991 by Caplan and given to multipotent bone marrow precursors 
(Caplan, 1991). The inclusion of the term “stem cell” suggests that alongside a 
multipotent ability to generate cells of bone, fat and cartilage (Figure 1.1), a single 
MSC may be transplanted and self renew appropriately to give rise to bone 
structure with accompanied host haematopoiesis. As many authors had used the 
term MSC to describe plastic-adherent cells that were multipotent in vitro but had 
not necessarily demonstrated in vivo self renewal capacity, the International 
Society for Cellular Therapy (ISCT) released a statement in 2005 to encourage the 
use of the term ‘multipotent mesenchymal stromal cell’ for these cells, reserving 
the ‘mesenchymal stem cell’ label for those that accomplished in vivo self renewal 
Chapter 1. Introduction 
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(Horwitz et al, 2005). They recognised that the acronym MSC was widely accepted 
and sought to keep this for either population, as will be adopted in this report. 
However, this particular point has been disputed as causing more confusion in the 
field and therefore some designate different acronyms to try to acknowledge the 
‘stemness’ of the cells they are reporting. As the identification and characterisation 
of MSCs in all their guises continues, this nomenclature is likely to shift further in 
the future and the most important points will concern the standardisation of their 
isolation and the accurate descriptions of their functionality and various 
subpopulations both in vivo and in vitro.  
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Figure 1.1 Lineage potential of mesenchymal stem cells  
Mesenchymal stem cells are able to proliferate, self-renew and differentiate to give rise to 
cells of the bone, fat and cartilage. Evidence has also been reported to suggest their ability 
to differentiate into other lineages such as neural cells or liver cells although this remains 
controversial. 
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1.2 Developmental origin of MSCs 
To date, a limited amount is known about the developmental origins of MSCs. MSCs 
have been isolated from numerous connective tissues in adult mammalian systems 
with a variation in their functional properties. The definition of their progenitor 
population may explain some of the current inconsistencies and allow directed 
differentiation of pluripotent stem cells and analysis for expanding MSC populations 
for therapeutic use.  
Currently, bone marrow MSCs are predicted to arise from specific progenitors as 
skeletal tissue is derived from distinct embryonic regions. Neuroectodermal 
progenitors generate the craniofacial bones and cartilage, the limb skeleton 
originates from lateral plate mesodermal cells and axial skeleton develops from 
paraxial mesoderm (somites) (Olsen et al, 2000).  
 
1.2.1 Mesoderm 
Colony forming assays directing the differentiation of mouse embryonic stem cells 
(mESC) resulted in the identification of the haemangioblast, a bipotent precursor of 
haematopoietic and endothelial progeny (Choi, 1998). The haemangioblast was 
subsequently demonstrated in mouse embryos as a subpopulation of mesoderm 
prominently detected in the posterior primitive streak (Huber et al, 2004).  
Previous derivation of MSCs from human ESCs (hESCs) with comparable potential to 
those isolated from adult bone marrow has been reported (Trivedi & Hematti, 
2008) but the precursor population that gives rise to the MSCs remains poorly 
defined. Recent progress has been made in the designation of a 
mesenchymoangioblast as a direct MSC precursor with endothelial and 
mesenchymal potential. hESCs were subcultured with OP-9 (bone marrow-derived 
mouse stromal cell line) cells and directed towards a mesodermal specification. 
These hESCs were then plated in semi-solid media in the presence of fibroblast 
growth factor 2 (FGF2) and absence of serum. After a 2 day initial co-culture, this 
generated colonies that could be identified as mesenchymal (MS) by the surface 
marker pattern of CD140a+CD90+CD56+CD166+CD31−CD43−CD45− CD146+. When 
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cells were initially co-cultured for 3 days, they formed more dispersed cell colonies 
(blast) that expressed haematopoietic commitment transcripts, as measured by 
RT-PCR. Both of these colony types were transient and could not be produced from 
hESCs co-cultured for more than 3 days before the colony assay or in the presence 
of serum  (Vodyanik et al, 2010). The precursor for each colony was further 
specified as expressing apelin receptor (APLNR). APLNR was upregulated during 
co-culture mesodermal differentiation. Undetectable levels of APLNR were 
associated with undifferentiated hESCs that then increased to approximately 20% 
and 70% APLNR positive cells on days 2 and 3 of co-culture with OP-9 cells, 
respectively. Transcript analysis of APLNR+ cells reported the absence of neural 
crest associated genes, in contrast to the presence of but no particular enrichment 
for, mesodermal genes. The treatment of co-culture cells with the Wnt agonist 
Dkk-1 or inhibitors of TGF-β signalling, both known to interrupt pathways mediating 
mesodermal differentiation, individually obliterated APLNR+ expression. The 
authors therefore suggest that APLNR+ cells represent a subpopulation of the 
mesoderm and further investigation will hopefully identify a unique marker for 
these cells (Vodyanik et al, 2010).  
 
1.2.2 Neural crest 
The neural crest is a mass of cells that arises at the neural fold during vertebrate 
development. Neural crest-derived stem cells (NCSCs) are able to differentiate to 
provide cells that constitute most of the peripheral nervous system (PNS) including 
neurons, glial cells and myofibroblasts. NCSCs also differentiate to chondrocytes, 
adipocytes and osteocytes that generate the bone structure and connective tissues 
in the head and neck. These tissues in the main body are widely attributed to cells 
of mesodermal origin and the differentiation of MSCs. The generation of transgenic 
mice have provided useful tools to investigate specific neural crest-derived cells. 
Protein zero (P0) or Wnt1 promoter or enhancer-driven Cre recombinase activity 
indelibly marks neural crest cells with a reporter transgene such as GFP (Danielian 
et al, 1998; Yamauchi et al, 1999). P0 is a cell adhesion molecule primarily 
associated with myelin sheaths in the PNS and at a transcript level has been 
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reported in neural crest cells after delamination from the neuroepithelium (Filbin et 
al, 1990) whilst Wnt1 expression is restricted to the neural plate and dorsal neural 
tube (Echelard et al, 1994). These transient expression windows make P0 and Wnt1 
ideal candidates to demarcate cells of the neural crest. Additionally, Sox10 has been 
used in a similar way, as its expression is identified in the neural crest in the 
developing embryo in humans and rodents (Bondurand et al, 1998; Kuhlbrodt et al, 
1998). Evidence suggests that these cells migrate to the developing thymus and 
differentiate into the cells associated with vasculature, indicating the contribution 
of neural crest derived mesenchymal cells to organs outside of the nervous system 
(Foster et al, 2008).  
 
Emerging evidence suggests that NCSCs migrate to the adult bone marrow and 
contribute to the functional MSC population. GFP+ cells were isolated from the 
bone marrow of adult Wnt1-Cre and P0-Cre/GFP transgenic mice and were able to 
self renew in sphere culture and differentiate into neural lineages (Nagoshi et al, 
2008). Additionally, GFP+ NCSCs were detected in the aorta-gonad-mesonephros 
(AGM) region, circulating blood and foetal liver as well as adult bone marrow, 
suggesting the NCSCs migrate to the bone marrow from the neural crest through 
the blood (Nagoshi et al, 2008). They also appeared in each tissue location to 
coincide with the concurrent arrival of haematopoietic stem cells (HSCs). As the 
stromal network of the niche is a supportive collaboration that is resident before 
the entrance of HSCs in order to guide and maintain the HSCs, this suggests that the 
NCSCs have intrinsic spatial and temporal roles on HSCs development. The NCSCs 
seem to retain the neuronal potential presumably gained at the site of generation 
in the neural crest, although it remains to be seen whether this is required for 
maintenance of sympathetic nerves in the bone marrow or whether it is a 
redundant pathway that can be reinstated in isolated cells in vitro.  
 
Identification of NCSCs in bone marrow is hampered by the intrinsic problem of a 
unique characterisation marker for MSCs. P75 has been used to isolate rodent 
NCSCs from the sciatic nerve (Morrison et al, 1999) and although this marker had 
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been determined in multipotent cells obtained from tissue explants, in vivo BrdU 
incorporation experiments demonstrated the self renewal capabilities of these cells 
(Morrison et al, 1999). More recent advances utilise the Wnt1-Cre transgenic 
mouse model allowing neural crest-derived cells to be determined and examined in 
tissues outside the central nervous system (CNS).  NCSCs have been located in the 
adult murine cornea (Yoshida et al, 2006), heart (Tomita et al, 2005) and gut 
(Kruger et al, 2002), indicating their migration and retention throughout adult life. 
Comparison between the adult and foetal NCSCs reported a reduced efficiency and 
more restricted multipotency in adult stem cells from the cornea (Yoshida et al, 
2006) and gut  (Bixby et al, 2002) (Kruger et al, 2002) prompting the requirement 
for classification and further understanding of this cell population. 
 
Neuroepithelium cells have also been proposed as a common progenitor for bone 
marrow MSCs. Sox1+ neuroepithelial cells differentiate into MSCs as detected in 
embryonic stem cell culture and Sox1-Cre/GFP transgenic embryo analysis 
(Takashima et al, 2007). Further investigation reported that somitic PDGFRα+ cells 
present in E9.5 embryos could not give rise to MSCs in vitro but could differentiate 
into adipocytes, suggesting that the first MSC progenitors in this murine model are 
from a neuroepithelium source and not from the mesoderm. Further analysis 
concluded that Sox1+ progeny could not account for all of the MSCs present in 
neonates and suggests that they only represent an initial wave of MSC supply which 
is supplemented from as yet undescribed sources (Takashima et al, 2007).  
 
Another study using transgenic mice with neural crest specific GFP expression 
(P0-Cre/Floxed-eGFP) found that GFP positive and negative MSCs isolated from 
adult bone marrow were comparable in their ability to differentiate down 
tri-lineage mesenchymal pathways and into neuronal cell types under appropriate 
instruction (Morikawa et al, 2009b). MSCs were sorted as populations with the 
phenotype PDGFRα+Sca-1+CD45−TER119−,  as alterations to this pattern led to lack 
of a fully differentiating or CFU-F forming potential (Morikawa et al, 2009b). Bone 
marrow-derived NCSC and MSC clones could be differentiated into osteocytes and 
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chondrocytes but NCSCs required pre-treatment with Wnt1 before successful 
adipogenic differentiation, which was not necessary for MSCs (Wislet-Gendebien et 
al, 2012). MSCs were only seen to differentiate into Tuj-1-expressing cells when 
cultured in contact with cerebellar granule neurons whereas NCSCs spontaneously 
differentiated into neural lineage cells in normal or induction media (Wislet-
Gendebien et al, 2012).  Taken together, these studies support the theory that bone 
marrow MSCs are comprised of cells from at least two origins: neural crest and 
mesodermal. However, the confinement of neural differentiation potential to MSCs 
derived from the neural crest is still disputed. 
 
HSCs have also controversially been proposed as the origin of bone marrow 
fibroblasts and their precursors (Ebihara et al, 2006). Further investigations will be 
important to determine the full potential of each of these cells to generate MSCs 
and any physiological differences in MSCs that arise from different developmental 
origins.  
 
1.2.3 Surface markers of MSCs 
Identifying tissue resident MSCs will naturally facilitate the isolation of their 
precursors. MSCs represent a rare population inhabiting a complex bone marrow 
environment. Their characterisation is further hampered by the lack of a unique 
identifying cell surface marker. Currently, isolated and cultured MSCs are 
commonly distinguished in vitro by a panel of cell surface markers. In 2006 the 
International Society for Cellular Therapy (ISCT) produced a specification of markers 
that should determine plastic-adherent MSCs in vitro (Dominici et al, 2006). This 
included expression of CD105, CD90, and CD73. MSCs should also be negative for a 
vast array of markers; haematopoietic markers CD45 and CD34, monocytic markers 
CD14 and CD11b, B cell markers CD79a and CD19 and HLA class II. They must also 
be able to differentiate in vitro into osteoblasts, adipocytes and chondrocytes as 
part of the minimum suggested criteria.  Despite these attempts to standardise the 
cell populations used to study MSC biology, issues remain surrounding alterations in 
expression that may occur due to in vitro culture before analysis. For example, 
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CD44, routinely used to characterise MSCs (Herrera et al, 2007; Sun et al, 2003) has 
been reported to be acquired in culture in murine and human populations as 
prospectively isolated MSCs were found to be CD44- (Qian et al, 2012).  
Isolation from multiple tissue sources and the determination of multipotentiality 
in vitro contributes to the reported differences in MSC characterisation and the 
difficulty in confidently isolating a single cell type. It has been suggested that the 
heterogeneous properties of in vitro MSCs are not consistent with those in the 
in vivo environment. Cultures of MSCs can appear homogeneous for the expression 
of a range of cellular markers but have functional heterogeneity as demonstrated 
by clonal line production of Stro-1+ VCAM-1+ MSCs (Gronthos et al, 2003). Isolation 
of the monoclonal antibody Stro-1 led to recognition of a cell surface antigen on 
bone marrow cells that were capable of CFU-F generation and classic tri-lineage 
differentiation in vitro (Simmons & Torok-Storb, 1991). Although Stro-1 enriched 
the MSC population, the antibody also cross-reacts with glycophorin-A-positive 
nucleated red cells and B-lymphocytes, which meant contaminating cells prevented 
a homogeneous culture. This was partly overcome by using the combination of 
Stro-1 with vascular cell adhesion molecule-1 (VCAM-1/CD106), which generated a 
purer population but still showed varying clonogenic potential (Gronthos et al, 
2003).  
 
CD146 expression was detected in human bone marrow-derived subendothelial 
cells that were able to transfer ectopic bone and bone marrow when transplanted 
into irradiated mice hosts suggesting its use for prospectively isolating stromal 
progenitors in vivo (Sacchetti et al, 2007). In human bone marrow sections, CD146 
labelling was restricted to adventitial reticular cells (ARCs) that were observed lining 
sinusoidal vessels with extended cellular processes. This localisation was supported 
by evidence that CD146 is upregulated in normoxic conditions but down regulated 
in hypoxia (Tormin et al, 2011). CD271 has been used to prospectively isolate bone 
marrow MSCs (Jones et al, 2002). CD271 is also known as p75NTR (a low affinity 
neurotrophin receptor), which is expressed on NCSCs that are capable of neuronal 
and mesenchymal differentiation (Lee et al, 2007; Stemple & Anderson, 1992). As is 
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common with other prospective markers, there is some cross reaction with other 
cell types. In this case, CD271 has been reported at low levels on erythroid cells that 
can be removed from the MSC culture by selecting CD45 negative cells (Cuthbert et 
al, 2012). CD271 had been used in conjunction with CD146 to identify 
subpopulations of MSCs. Similar CFU-F ability and morphological appearance was 
observed when cultured in vitro between CD271+/CD45−/CD146−/low and 
CD271+/CD45−/CD146+ cells (Tormin et al, 2011). Additional markers CD105, CD90, 
and Stro-1, as well as PDGFR-β were expressed by each population. Interestingly, 
immunodetection in human bone marrow sections determined the 
CD271+/CD45−/CD146−/low population as  bone lining cells whilst 
CD271+/CD45−/CD146+ cells were associated with the sinusoids as previously 
reported for CD146+ cells (Tormin et al, 2011). Isolated CD146+ cells have also been 
reported to support in vitro haematopoiesis in long term cultures through the 
expression of adhesion molecules and cytokines (Sorrentino et al, 2008). 
 
Murine MSCs are comparatively more difficult to culture in vitro due to a high level 
of haematopoietic cells contaminating the culture and the strict growth conditions 
that are required. Some surface markers detected on human MSCs cannot be 
conferred to mouse MSCs and additionally, the markers on mouse MSCs can vary 
between different mouse strains, adding an extra level of complexity when using 
these models to study MSCs. For example, Stro-1, mentioned above as an 
important human MSC marker, has no comparable antigen in mice. Another human 
marker, CD90 is also inconsistently reported with negative, (Anjos-Afonso et al, 
2004) heterogeneous (Morikawa et al, 2009a) and positive (Chan et al, 2009) 
expression associated with MSCs despite using the same mouse strain (C57BL/6). 
This may be due to the inability to accurately define MSCs generally and therefore 
the identification of true MSCs or progenitors using CD90 as a marker in vitro. 
Therefore, slightly different candidates are considered in mice alongside those 
markers determined on human MSCs and whilst not completely compatible, the 
use of murine models can provide a useful understanding of the physiology of 
MSCs.  
Chapter 1. Introduction 
25 
 
In murine studies, prospectively isolated PDGFRα+Sca-1+CD45-TER119- were 
identified in a perivascular region in adult mouse bone marrow with mesenchymal 
differentiation potential when transplanted into immunodeficient recipients 
(Morikawa et al, 2009a). The highest expression levels of HSC maintenance genes 
angiopoietin-1 (Ang-1) were detected in PDGFRα+Sca-1+ cells, with abundant 
CXCL12 expression detected in PDGFRα+Sca-1− cells (Morikawa et al, 2009a). 
Nestin+CD45-CD31- cells investigated in the bone marrow of Nes-GFP transgenic 
mice, in which cells express GFP under regulatory elements of the nestin promoter 
(Mignone et al, 2004), have also been shown to contain the MSC capacity of the 
bone marrow. Nes-GFP+ cells were able to self renew in vivo and differentiated 
down mesenchymal lineages that were incorporated into bone and cartilage tissue, 
as analysed by lineage tracing studies (Mendez-Ferrer et al, 2010).  
 
Despite progress to characterise the MSCs, the use of a multiple set of markers is 
problematic, as other cell types express individual markers, each marker may not 
have continuous roles throughout the life of MSCs and there are clear differences 
between expression of the markers used in mouse and human studies that requires 
a cautionary approach. Therefore, identifying a unique marker would be a very 
powerful tool to isolate specific MSC populations in order to provide consistent 
results and potential sources for therapeutic use. 
 
1.3 The stem cell niche concept 
Whilst MSCs can be isolated by their ability to adhere to plastic and studied in vitro, 
the restrictions of studying representative behaviour and not just culture artefact, 
requires that MSCs be identified in vivo. Confidently identifying MSCs begins with 
considering where they reside in the bone marrow.  
The concept of the stem cell niche was proposed in 1978 to describe an 
environment that would accommodate and regulate the action of stem cells by 
maintaining the properties of self renewal and multipotent differentiation 
(Schofield, 1978). This idea was corroborated by the existence of stem cell niches in 
Drosophila, which demonstrated regulation of germ line stem cells by the stromal 
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cells in the ovary and asymmetric division (Xie & Spradling, 2000). This explained 
the apparent immortality of the HSCs despite the replenishment of mature bone 
marrow cells that had intrigued Schofield and colleagues. Further work has 
continued to examine the regulation of stem cell fate by its immediate environment 
as the cellular components and their interactions are still unclear.  
 
1.3.1 Bone marrow microenvironment 
Bone is a complex, specialised tissue that provides the body with mechanical 
support, protection of internal organs and a resource for ions such as calcium and 
phosphate. Skeletal bones have an outer layer of compact bone surrounding an 
inner trabecular bone. Bone matrix is continually replaced and remodelled, 
controlled by osteoblastic and osteoclastic action and is therefore a dynamic and 
organised structure. The bone marrow is contained within the bone cavities and 
encompasses a vast network of blood vessels supplying access and nutrients to 
undifferentiated and mature haematopoietic and stromal cells.    
 
In mammalian bone marrow, two stem cell populations, HSCs and MSCs are 
evident. Their respective niches are intertwined and much niche investigation has 
been modelled using HSCs as it is a well characterised stem cell population with 
defined transplantation end point assays. In this way, most of the proposed niche 
components are presumed to be in close contact with the HSCs. Multipotent, 
long-term HSCs (LT-HSCs) are able to expand the stem cell pool for the life time of 
an organism to maintain and replace the haematopoietic system. By the process of 
asymmetric division these cells also give rise to differentiated short-term HSCs 
(ST-HSCs) or lineage restricted cells known as multipotent progenitors (MPPs) that 
proliferate and differentiate to produce the mature cells of the blood. HSCs have 
been identified in perivascular, endosteal and stromal compartments in the bone 
marrow (Kiel et al, 2005). In the continually remodelled bone marrow environment, 
it remains to be seen how much these niches overlap and the extent to which they 
might themselves be remodelled in the process of regulating HSC and MSC fate.  
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Figure 1.2 The bone marrow microenvironment 
The bone marrow environment comprises multiple cellular components and a complicated cross-talk to regulate HSC fate. 
Stromal cells are an important element of the HSC niche in vascular and endosteal locations and interact with osteoblasts and osteoclasts at the 
endosteum. Osteoblasts are implicated in retaining HSCs in the bone marrow. Expression of nestin, leptin receptor, CD146 and CXCL12 have all been 
described as potentially distinct markers of MSCs in the bone marrow HSC niche. Abbreviations: HSC; Haematopoietic stem cell, Ca2+; calcium, O2; oxygen, 
CAR cell; CXCL12 abundant reticular cell, MSC; mesenchymal stromal cell. 
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1.3.2 Perivascular niche 
HSCs are closely associated with vascular tissue throughout their development. 
Haematopoietic cells are first detected in the extra-embryonic tissue of the yolk sac 
and then migrate to the foetal liver and bone marrow, a highly vascularised tissue 
(Moore & Metcalf, 1970). HSCs are also present at extramedullary sites such as the 
liver in adult tissues. Lineage–Sca-1+c-kit+ (LSK, markers used to define HSC lineage) 
cells isolated from adult mouse liver could competently reconstitute irradiated mice 
(Taniguchi et al, 1996). Additionally, HSCs are detected in the adult peripheral blood 
during homeostasis (Goodman & Hodgson, 1962) and in response to chemokines 
that can mobilise HSCs within minutes of administration (Laterveer et al, 1995). It is 
a logical explanation that HSCs residing in contact to bone marrow sinusoids would 
be able to monitor exogenous signals in the blood and respond effectively to 
haematopoietic requirement. Taken together, these findings support the location of 
HSCs in a perivascular location (Figure 1.2). 
 
The SLAM (signalling lymphocytic activation molecule) family contains 10-11 cell 
surface receptors that are involved in lymphocyte activation (Engel et al, 2003). 
SLAM-family members CD150, CD244 and CD48 were used to identify HSCs by 
immunohistochemistry on tissue sections and a vascular niche was identified in the 
bone marrow (Kiel et al, 2005). There is some debate whether the endosteal and 
perivascular niches that have been recognised are true niches that maintain the 
self-renewal properties of HSCs. Perhaps the perivascular niche is just a holding pen 
for the HSCs that are primed to differentiate and provide a multitude of mature 
cells for systemic dispersal and the endosteal niche is where the most immature 
HSCs reside. Further detailed analysis is therefore required to understand the role 
of the niche on HSC behaviour.  
 
1.3.3 Endosteal niche 
The endosteum is the margin between bone and bone marrow and as such is the 
site of bone turnover. It is populated by a range of osteoblastic cells at different 
stages of differentiation that contribute to bone formation. The co-operation 
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between the processes of bone remodelling and haematopoiesis and the 
relationships between the cells that are involved are gradually being uncovered 
(Figure 1.2). Since the HSC niche proposal, there has been an accumulation of 
evidence to demonstrate that HSCs are located in close proximity to the endosteum 
(Lord et al, 1975) and that HSCs in this region possess the highest proliferative and 
haematopoietic potential (Haylock et al, 2007). This has been facilitated by the 
development of techniques such as intravital microscopy and multiphoton 
microscopy to analyse HSCs in situ. Transplanted LSK CD150+ CD48- cells could be 
viewed by two-photon microscopy in live, irradiated mouse calvarial bones. The 
cells homed to within 20 µm of the endosteum while more committed progenitors 
and HPCs (LSK Flt3+ CD34+) were observed to home to a position further from the 
endosteum. This homing to a greater distance from the endosteum was also the 
case for HSCs in non-irradiated mice, suggesting that the endosteal niche is a 
preferred site for HSCs but that they must be depleted before lodgement of HSCs 
can occur and that different niches exist for cells that are more mature (Lo Celso et 
al, 2009). 
 
1.3.4 HSC mobilisation to and from the niche 
The processes of homing and mobilisation are key to understanding what first 
attracts HSCs to their niche in the bone marrow and what subsequently stimulates 
their mobilisation out again. Just before birth, HSCs migrate from foetal liver to the 
bone marrow and are able to re-enter the peripheral circulation during homeostasis 
or in response to demands for blood cells (Christensen et al, 2004; Massberg et al, 
2007; Wright et al, 2001). CXCL12, (also known as stromal cell–derived factor-1, 
SDF-1) is an essential chemoattractant of HSCs that express its receptor CXCR4. The 
CXCL12/CXCR4 axis is an important signalling mechanism in the process of HSC 
homing to the niche and their subsequent retention. Deletion of either gene leads 
to depletion of HSCs in the bone marrow (Sugiyama et al, 2006; Tzeng et al, 2011). 
Therefore, a thorough understanding of the process and the identification of niche 
cells that express CXCL12 will provide improved strategies to aid the mobilisation of 
HSCs into peripheral blood for harvest and subsequent therapeutic use. 
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Whilst the mechanism of HSC direction into the peripheral blood in homeostasis is 
largely unknown, it has been proposed that it is initiated by circadian oscillations of 
CXCL12 in the bone marrow that result in the rhythmic release of HSCs into the 
bloodstream, in mice at least (Mendez-Ferrer et al, 2008). Mice deficient for CXCL12 
die perinatally due to extreme defects in haematopoietic and central nervous 
systems (Baune et al, 2011). This is due to the disruption of the homing and 
engraftment of HSCs to the bone marrow from the liver. Furthermore, elevated 
levels of plasma CXCL12 mobilised HSCs into circulation in severe combined 
immunodeficient (SCID) mice, an activity that can be exploited to improve the 
harvesting of HSCs for therapy (Hattori et al, 2001). In clinical trials, an antagonist of 
CXCR4, Plerixafor (AMD3100), mobilised HSCs and their progenitors to the 
peripheral blood (Fruehauf et al, 2009).  
 
Granulocyte-colony-stimulating factor (G-CSF) has been traditionally used to 
mobilise HSCs but not all patients respond satisfactorily. G-CSF functions to induce 
the degradation of SDF-1 in the bone marrow and indirectly causes the 
upregulation of CXCR4 (Petit et al, 2002). A synergistic response is seen when the 
two chemokines are used in combination to stimulate HSCs to enter the circulation 
and AMD3100 can be used as an alternative stimulant where G-CSF fails (Uy et al, 
2008; Watt & Forde, 2008); an attractive benefit resulting from increased 
understanding of the roles of niche components. Entering and exiting the stem cell 
niche is a tightly controlled process which is adaptive to changes detected in the 
microenvironment. 
 
1.3.5 Cellular candidates of the HSC niche 
Whilst the cellular components of the niche may depend on the physical location in 
the bone marrow, a common theme is the skeletal progenitors that are reported at 
each site. Cells implicated in the HSC niches include osteoblasts, CXCL12-abundant 
reticular (CAR) cells and MSCs (Figure 1.2).  
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1.3.5.1 HSCs regulate their own niche 
Mature cells derived from HSCs such as osteoclasts and macrophages (described 
below) have been implicated in regulating the stem cell niche and therefore 
indirectly influencing the fate of HSCs. Evidence also exists to support the theory 
that HSCs are able to regulate the niche directly. Using an in vitro co-culture system 
with HSCs and mesenchymal cells, steady state HSCs were observed to direct 
osteoblastic differentiation of bone marrow stromal cells and this osteogenesis was 
increased in conditions where the HSCs were derived from acutely stressed mice. 
The HSCs mediated the response through secretion of bone morphogenic protein 
(BMP)-2 and BMP-6, as detected by cDNA screening and RT-PCR (Jung et al, 2008).  
  
1.3.5.2 Osteoclasts 
Bone forming osteoblasts and bone resorbing osteoclast numbers and function are 
tightly regulated in order to maintain the structural integrity of bone. Osteoblasts 
are responsible for initiating the maturation of osteoclasts with the production of 
receptor activator of NF-κB ligand (RANKL). The haematopoietic origin of 
osteoclasts is indicated by the ability of RANKL to initiate their generation from the 
differentiation of macrophage progenitors (CFU-M) (Miyamoto et al, 2001). 
Following RANKL activation in mice, osteoclasts promote the release of 
haematopoietic progenitors into circulation (Kollet et al, 2006). However, 
osteoclasts have been shown to be non-essential for this role as their targeted 
depletion in mouse models had no effect on G-CSF induced HSC mobilisation 
(Miyamoto et al, 2011).  In fact, another action of osteoclasts suggests the reverse 
of this role as during bone resorption, calcium is released from the bone into the 
endosteal region, which has a reported role in HSC retention (Adams et al, 2006) .  
 
1.3.5.3 Macrophages 
Macrophages and monocytes are implicated in the retention of HSCs within their 
niche. Endosteal macrophages or ‘osteomacs’ have a reported osteoblast 
supportive role and their depletion results in the mobilisation of HSCs and was 
concomitantly associated with a reduction in endosteal osteoblast numbers and a 
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significant reduction of CXCL12, stem cell factor (SCF also known as kit ligand), and 
Ang-1 mRNA levels at the endosteum (Winkler et al, 2010). This is similar to the 
effects observed by G-CSF administration. F4/80+ macrophages in mice and CD68+ 
macrophages in human bone sections are both observed at the endosteal surface 
(Chang et al, 2008). Addition of bone marrow macrophages to osteoblast 
differentiation cultures in vitro increases mineralisation, indicating their role in 
regulating osteoblast function and the consequential niche adaptation (Chang et al, 
2008). In order to more specifically identify the macrophage cells responsible for 
HSC retention, CD169+ macrophages have been investigated. Specific depletion of 
CD169+ macrophages resulted in HSC mobilisation to the peripheral blood (Chow et 
al, 2011). Similar to the effects of ‘osteomac’ depletion (Winkler et al, 2010), the 
depletion of CD169+ macrophages was also associated with almost a 50% reduction 
in CXCL12 mRNA detected in total bone marrow (Chow et al, 2011). In this instance, 
the reduction was attributed to the nestin+ stromal cells, as CD169+ macrophages 
themselves do not produce CXCL12. CXCL12 associates with its receptor CXCR4 
which is expressed on HSCs and functions to attract and retain HSCs in the niche 
(Lapidot & Petit, 2002). The subsequent loss of CXCL12 therefore explains the exit 
of HSCs into the circulation and reinforces the control of CXCL12 in the stem cell 
niche. 
 
1.3.5.4 MSCs 
MSCs have been reported to be an essential component in initiating the formation 
of the niche. CD45-Tie2-α+CD105+Thy1.1- cells isolated from foetal mouse bones 
produced bone with bone marrow when transplanted under the kidney capsule, 
through a transitional stage of cartilage formation known as endochondral 
ossification (Chan et al, 2009). Only bone was derived from cells with a similar 
phenotype isolated from foetal calvarial tissue and CD105+Thy1+ progenitors from 
foetal bone, indicating that the mechanism of endochondral ossification is essential 
for HSC niche formation and that it is orchestrated by specific MSC populations. 
 Stromal cells expressing GFP under the control of nestin regulatory elements were 
observed in the murine bone marrow (Mendez-Ferrer et al, 2010). Differentiation 
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studies attributed tri-lineage potential only to nestin+ stromal cells that could also 
contribute to osteochondral lineages when transplanted in vivo. Thus, nestin+ 
stromal cells were proposed to be MSCs. These nestin+ MSCs were located in the 
central marrow and at the endosteum near to HSCs and in contact with adrenergic 
nerve fibres of the sympathetic nervous system (SNS) which are known to regulate 
the mobilisation of HSCs (Katayama et al, 2006). Depletion of nestin+ MSCs led to a 
reduction in HSC number and decreased their ability to home to the bone marrow 
when transplanted into irradiated mice. These studies indicate that MSCs 
contribute to the homing of HSCs to the niche and their retention and maintenance 
once in the bone marrow.  
 
1.3.5.5 Osteoblasts 
The differentiated progeny of MSCs are also widely regarded as niche components. 
The location of the endosteal niche suggests the involvement of osteoblastic cells in 
the regulation of HSC fate. Osteoblasts line the bone margin and secrete 
unmineralised matrix in the process of bone formation and control osteoclast 
activation (Mackie, 2003). in vitro, osteoblasts have been shown to maintain the 
immature phenotype of HSCs and support limited expansion of progenitors 
(Taichman et al, 1996). This supports the notion that osteoblasts are capable of 
promoting in vivo stem cell survival and self renewal. Osteoblasts secrete a number 
of haematopoietic cytokines including G-CSF, M-CSF, IL-1, IL-6 (Taichman & 
Emerson, 1994), IL-7 (Weitzmann et al, 2000) and CXCL12 (Ponomaryov et al, 2000) 
that have a significant role in the retention and maintenance of HSCs.  
 
Two reports reinforced these initial in vitro findings by identifying osteoblasts as a 
key component in HSC regulation in mouse models. In the first of the 
simultaneously released articles, an increase in osteoblast numbers in response to 
stimulation by parathyroid hormone (PTH) was associated with an increase in the 
number of HSCs, which do not themselves express the receptor for PTH (Calvi et al, 
2003). In the second study, depletion of BMP receptor 1A in haematopoietic cells 
and stromal cells resulted in the expansion of the HSC population and an increase in 
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osteoblast numbers (Zhang et al, 2003). Mice deficient in BMPR1A had abnormal 
bone formation and a 2-fold increase in functional LT-HSCs, whilst the number of 
progenitor cells remains the same as controls, indicating the increase in stem cells 
was not caused by an obstruction to differentiation (Zhang et al, 2003) 
Furthermore, N-cadherin expressing, spindle shaped osteoblasts were increased in 
number in the deficient mice and were closely associated with HSCs. Also using a 
mechanism involving N-cadherin, osteoblasts expressing Ang-1 attach to tyrosine 
kinase receptor (Tie2) positive HSCs, regulating the quiescent state of the stem cells 
(Arai et al, 2004). However, other work disputes the importance of the expression 
of N-cadherin in the niche as its deletion in mouse models does not alter the size of 
the HSC population or haematopoiesis and others are unable to detect any 
N-cadherin+ HSCs (Kiel et al, 2008). Méndez-Ferrer et al report that N-cadherin 
positive osteoblastic cells are distinct from nestin+ MSCs (Mendez-Ferrer et al, 
2010). However, others have shown low nestin staining in some osteoblasts lining 
the trabeculae and these were proposed to be an immature osteoblastic cell type 
(Calvi et al, 2012). Osteoblast deficiency also leads to a reduced number of HSCs 
and their progenitors in the bone marrow and increased haematopoiesis at 
extramedullary sites. This could be reversed with the reappearance of osteoblasts, 
accompanied with local sites of haematopoiesis (Visnjic et al, 2004). 
 
The roles of osteoblasts in HSC survival and proliferation has also been 
demonstrated in human studies in which CD34+ cells derived from cord blood were 
co-cultured with osteoblasts from trabecular bone. Co-cultures were able to 
promote survival and expansion of an increased number of haematopoietic 
precursors compared to controls. After 14 days of co-culture with osteoblasts, the 
CD34+CD38- cells were examined by flow cytometry. It was noted that 
haematopoietic cell expression of markers for monocyte/macrophage 
differentiation (CD14 and CD163) were increased and the number of cells positive 
for erythroid commitment was reduced, indicating a role for osteoblasts in the 
differentiation decision of haematopoietic cells (Salati et al, 2013).  
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Although significant niche function has been attributed to osteoblasts, they are not 
thought to be essential for all HSC niches as functional HSCs can be found in 
extramedullary sites such as spleen and liver that do not contain osteoblasts 
(O'Malley, 2007). Clearly, there are some inconsistencies and questions remaining 
about the identity and role of osteoblasts in the HSC niche. 
 
1.3.5.6 Adipocytes 
Adipocytes have been shown to maintain HSCs in a quiescent state and have an 
overall negative impact on haematopoiesis with reduced HSCs and progenitors 
isolated from the more fatty marrow of tail vertebrae (Naveiras et al, 2009). 
A-ZIP/F1 ‘fatless’ mice cannot produce adipocytes as they express a 
dominant-negative form of the C/EBP under the adipocytic fatty-acid-binding 
protein 4 (Fabp4) promoter (Moitra et al, 1998). Using these mice confirmed that 
adipocytes were the negative regulators of haematopoiesis, as the process was 
restored in tail vertebrae in these mice. There was no difference in the number of 
HSCs isolated from the tail vertebrae compared to the thoracic vertebrae and 
furthermore, when irradiated, marrow engraftment was enhanced in these fatless 
mice compared to wild-types (Naveiras et al, 2009).  
 
1.3.5.7 Endothelial cells 
Endothelial cells line the blood vessels in the bone marrow and are well placed to 
interact with HSCs when they enter the bone marrow during development and 
when they enter peripheral blood during homeostasis and in response to stress. In 
vitro, endothelial cells effectively support HSCs (Li et al, 2004). Selective deletion of 
sinusoidal endothelial cells was achieved by administration of neutralising 
antibodies of vascular endothelial cadherin (VE-cadherin) into myelosuppressed 
mice.  The subsequent disruption to the vascular niche inhibited thrombopoiesis 
(Avecilla et al, 2004), indicating the important role for endothelial cells in 
haematopoiesis.  
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Haematopoiesis has been promoted in vitro by bone marrow endothelial cells that 
express G-CSF, granulocyte-macrophage-CSF (GM-CSF), SCF and interleukin 6 (IL-6) 
(Rafii et al, 1997). in vivo studies utilised the expression of SLAM markers to 
distinguish HSCs in histological sections of spleen and bone marrow. These 
observed HSCs were in contact with sinusoidal endothelium (Kiel et al, 2005). 
Human subendothelial cells derived from haematopoietic marrow were able to 
generate bone and marrow when subcutaneously transplanted into 
immunocompromised mice, unlike cells from trabecular bone or periosteal cells 
which only formed bone and skin fibroblasts which failed to generate bone or 
marrow. CD146 expression was not detected in any of the cell types apart from the 
subendothelial cells and was therefore used to characterise these cells (Sacchetti et 
al, 2007). CD146 was expressed at a higher level in human umbilical cord 
perivascular cells which have a higher proliferative potential and similar 
differentiation ability than bone marrow MSCs (Baksh et al, 2007) thus confirming 
the ability of CD146 to be used as a putative stem cell marker.  
 
SCF is a recognised mediator of HSC maintenance, which is proposed to be 
expressed by a variety of cells including endothelial cells and osteoblasts. However, 
in a series of depletion experiments, HSC number and function was not perturbed 
when SCF was specifically depleted from osteoblasts or nestin+ cells. In contrast, 
using Cre-mediated deletion of SCF in perivascular cells under the control of the 
Leptin receptor and by Tie2 in endothelial cells, HSC activity was affected (Ding et 
al, 2012). Despite nestin+ cells reportedly having high mRNA levels of SCF (Mendez-
Ferrer et al, 2010), its deletion in these cells did not alter HSC numbers in the bone 
marrow, although the spleen population was reduced; nestin+ cells were also found 
in distinct vascular locations to those expressing GFP under the control of SCF. This 
could perhaps be explained by the subsequent analysis of nestin expression in 
different mouse models using different transgenes that showed some variation. In 
particular Nestin-GFP expression was reported around larger blood vessels whilst 
nestin Cre expression was associated with perisinusoidal stromal cells that 
resembled the SCF-GFP expression pattern (Ding et al, 2012).  
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Another important mechanism of endothelial control in the niche is through the IL-
6 family receptor subunit gp130. Tie-2 Cre; gp130fl/fl mice showed defects in the 
bone marrow including hypocellularity and expanded sinusoidal spaces in the 
vascular niche. These abnormalities could not be rescued by a HSC transplant from 
wild type mice. In fact, HSC number and function was normal in Tie-2 Cre; gp130fl/fl 
mice and could themselves reconstitute irradiated hosts, indicating that the 
intrinsic factor within the HSC niche was endothelial cells (Yao et al, 2005). 
 
1.3.5.8 CXCL12 abundant reticular cells (CARs) 
Cells expressing GFP under the control of the CXCL12 promoter were identified as 
the main source of CXCL12 in the bone marrow and were thus termed CXCL12 
abundant reticular (CAR) cells (Sugiyama et al, 2006). They are distributed 
throughout the bone marrow and were in contact with CD150+CD48−CD41− cells in 
endosteal and vascular niches as well as in the central marrow. CAR cell depletion 
leads to a reduction in HSC number and cell cycling, suggesting their role in 
controlling population size and proliferation (Sugiyama et al, 2006). These niche 
functions were also attributed to CAR cells in another study after their short term 
ablation in a mouse model. As well as being more quiescent, HSCs in CAR cell 
depleted mice had an increase in genes involved in myeloid differentiation. 
CXCL12-GFP cells were analysed by flow cytometry and the population was 
relatively homogeneous for expression of VCAM-1, CD44, CD51 (αv integrin), 
PDGFRα and PDGFRβ. These cells could also differentiate into osteoblastic and 
adipocytic cells in vivo (Omatsu et al, 2010).  
 
Nestin+ MSCs share many features with CAR cells such as their perivascular location, 
morphology and expression of CXCL12, SCF and VCAM-1. The extent to which these 
two populations overlap has yet to be defined. It has been suggested that nestin+ 
MSCs may represent a more primitive niche cell as increased CFU-F activity and a 
greater differentiation potential is attributed to them (Ehninger & Trumpp, 2011). 
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The intercalation of the physical environment and the processes of haematopoiesis 
and bone remodelling is a complicated system that centres around two stem cell 
populations. HSCs and MSCs share the same anatomical space and are intrinsically 
linked to support and regulate each other’s function as well as that of the niche.  
MSCs and their progeny are commonly implicated in maintaining HSC self-renewal 
and proliferation and have close interactions with committed HSC progenitors to 
provide an effective niche in the dynamic tissue of bone marrow. Therefore, further 
study is required to fully dissect the contribution of each cell to the niche and their 
relationship to each other.  
 
1.3.6 Non-cellular components of the HSC niche. 
1.3.6.1 Osteopontin 
Osteopontin is secreted by a number of different cells in the bone marrow but most 
prominently by osteoblasts and at the endosteal surface. HSCs express CD44 and 
integrin α4 both known to interact with osteopontin (Schmits et al, 1997; Scott et 
al, 2003). Osteopontin-deficient mice have increased numbers of HSCs indicating 
that it is a negative regulator of the stem cell pool size. This response is attenuated 
in wild type mice by osteoblast activation by PTH (Nilsson et al, 2005; Stier et al, 
2005). Furthermore, altered expression of Jagged-1 and Ang-1 in the absence of 
osteopontin suggests that it may regulate other niche components. 
 
1.3.6.2 Calcium 
Calcium (Ca2+) ion levels at sites of bone resorption have been shown to reach 
40 mM, a concentration much higher than the physiological level in serum (Silver et 
al, 1988). HSCs were found to express the G-protein coupled calcium receptor (CaR) 
and mice deficient in the receptor were unable to engraft to the endosteum, 
suggesting an important role for the calcium ion and its detection by HSCs to home 
to the niche (Adams et al, 2006). 
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1.3.6.3 Oxygen gradient 
The lack of oxygen in some areas of bone marrow has been implicated in the 
regulation of haematopoiesis. Evidence suggests that HSCs are hypoxic and exist in 
sites of low oxygen concentration (Takubo et al, 2010). Mice injected with Hoechst 
dye 33342 (Ho) before cells were collected from the bone marrow provided cells 
with varying amounts of dye which were sorted using FACS analysis and 
transplanted into lethally irradiated mice. Those cells with the lowest Ho 
fluorescence (more likely to be furthest away from blood supply therefore least 
perfused) were able to repopulate the mice with fewer cells than those from high 
dye staining and contained 90-200 fold more HSCs, indicating that HSCs were more 
highly concentrated at the least perfused sites in bone marrow. These cells were 
also shown to have the highest staining of pimonidazole, a chemical marker of 
hypoxia (Parmar et al, 2007). These results agree with those of Ceradini et al who 
found areas of pimonidazole stained bone marrow were co-localised with the 
CXCL12 expression (Ceradini, Kulkarni et al. 2004). 
 
1.4 The role of nestin in the HSC niche 
As described above (section 1.3.5.4), nestin has been recently described in the field 
of niche biology after an unexpected finding that it is expressed by a subset of 
murine mesenchymal stem cells (Mendez-Ferrer et al, 2010). This section will focus 
on the current understanding of nestin expression and its potential as a marker of 
progenitor cells. 
  
1.4.1  Nestin structure and transcriptional regulation 
Intermediate filaments contribute to the cytoskeleton in combination with 
microtubules and microfilaments. Six sub-types of intermediate filament have been 
classified as determined by their structural properties. Nestin is a type V1 
intermediate filament originally identified in rat neuroepithelial stem cells and 
previously known as Rat.401 (Cattaneo & McKay, 1990). Nestin is a 240 kDa protein 
comprised of an α-helical central rod with a short N-terminus and an unusually long 
C terminus which contains actin and microtubule binding domains to allow 
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interaction with other intermediate filaments. Nestin, unlike other intermediate 
filaments, is unable to self polymerise and consequently integrates into the 
cytoskeleton network via polymerisation with type III filaments such as desmin and 
vimentin.  
 
The cellular distribution of nestin appears to be cell-type and cell cycle-stage 
specific. As well as a distinct cytoplasmic network of filaments, nestin expression in 
the cell nucleus has been reported in two cell lines derived from glioblastomas. 
Immunofluorescence and TEM confirmed its nuclear presence and as nestin 
depolymerised in mitotic cells, the protein was detected as a diffuse cytoplasmic 
staining (Veselska et al, 2006). Nuclear localisation of nestin is also reported in 
human neuroblastoma cells where it was reported to interact with DNA (Thomas et 
al, 2004).  
 
Transcriptional control of nestin is cell-specific with enhancer elements in the 
second intron of the nestin gene regulating its expression in the CNS but less 
strongly associated with control on the PNS and the first intron controls the 
expression in muscle cells (Zimmerman et al, 1994). The first intron is also reported 
to control nestin expression in tumour epithelium (Aihara et al, 2004). 
 
1.4.2 Nestin in the central nervous system  
Nestin is now accepted as a marker of neural stem cells in embryonic development 
and in the adult brain. Nestin expression can be first detected in the mouse embryo 
at E7 in neuroectoderm and is highly expressed during early neurogenesis 
(Kawaguchi et al, 2001). In the adult brain, nestin expression is restricted to distinct 
regions of neurogenesis such as the subventricular zone (Kawaguchi et al, 2001). 
Nestin knockout strategies result in murine embryo lethality. This is in contrast to 
knockout models of other intermediate filaments that show little or no change to 
their phenotype (Colucci-Guyon et al, 1994; Milner et al, 1996). Knockout mice 
were generated using homologous recombination to remove exon 1 of the nestin 
gene and the resulting embryos were examined to establish the critical point of 
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nestin expression (Park et al, 2010). The lack of nestin expression was confirmed 
with RT-PCR, western blotting and immunofluorescence of forebrain sections of 
E11.5 embryos that showed no positive cells in the nes-/- animals. Embryonic stages 
of the mice were examined to determine the point of lethality for the knockout 
mice. By stage E8.5 and beyond, the nes-/- embryos were smaller than littermates 
and after E8.5 some of the embryos removed did not have a heartbeat suggesting 
they may have already died by this point. Despite a 50% reduction in nestin mRNA 
in nestin+/- embryos, these mice survived and were comparable to wild type 
littermates throughout their development. A severely defective neural tube was 
associated with nes-/- embryos although other than this and their small size, no 
other major organ defect was detected. NSCs within the neural tube were reduced 
in number in nes-/- embryos and although they had a similar proliferation status to 
those in E11.5 littermates, there was increased apoptosis of cells in the neural tube 
as early as E9 specifically in the NSC fraction. Microarray analysis carried out on 
nes-/- NSCs from E11.5 embryos found minimal changes in the gene expression. 
Only 16 genes had more than a 2-fold change in expression, indicating that nestin is 
unlikely to have a role in the regulation of gene expression in NSCs. Nestin was 
found to co-localise with vimentin in wild type NSCs and the polymerisation of 
vimentin was normal in nestin knockout mice but nestin was not able to polymerise 
in vimentin-/- embryos (Park et al, 2010). No defect in NSCs from vimentin knockout 
mice was observed as might be expected from studies of normal development in 
these mice (Colucci-Guyon et al, 1994). Therefore, the role of nestin in the 
self-renewal and survival of NSCs does not depend on its incorporation into the 
intermediate filament network. 
 
1.4.3 Nestin as a marker of stem cells 
Nestin expression measured in embryoid bodies (EBs) cultured in vitro showed 
abundant protein expression that localised to the periphery of the ectodermal rim 
of cells at day 2 of culture. After 5 days, nestin expression in spindle shaped cells at 
the edges of the colonies indicated nestin in migratory, proliferating cells. Upon 
differentiation, EBs showed an initial, transient co-expression of nestin with lineage 
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specific intermediate filaments such as glial fibrillary acidic protein (GFAP) in 
neurons and desmin in mesodermal cells. Continued differentiation resulted in the 
loss of nestin altogether (Wiese et al, 2004). These observations are consistent with 
the theory that nestin is a marker for stem cells and progenitors and is not 
expressed on terminally differentiated cells. 
As well as the recognised population of nestin+ neural stem cells discussed above, 
an increasing number of reports are identifying regions outside the CNS that 
contain nestin positive cells including: developing cardiomyocytes (Kachinsky et al, 
1995), dental follicles, pancreas, eyes, skin (Wang et al, 2006) and skeletal muscle . 
Its expression is frequently attributed to stem and progenitor cells with functional 
roles in stem cell fate rather than solely a characteristic stem cell marker.  
 
1.4.4 Nestin expression in MSCs 
Controversy remains about the extent of differentiation potential of bone marrow 
derived MSCs. Mesenchymal lineages of osteogenic, adipogenic and chondrogenic 
cells are accepted pathways for MSCs to follow, with more limited studies to 
support the probability of bone marrow MSCs to generate progeny of muscle 
(Ferrari et al, 1998), neuronal (Tropel et al, 2006) and hepatocytic classification.  
 
Evidence has been presented to suggest neuronal capabilities of MSCs and that this 
differentiation strategy was confined to nestin+ cells isolated from rat bone 
marrow.  Initial attempts at characterising nestin-positive and negative MSCs using 
microarray data found approximately 400 genes to be significantly different 
between the two populations with nestin positive cells expressing higher levels of 
stem cell and neural cell related genes and lower levels of epithelial, 
haematopoietic and mesenchymal fate genes (Wislet-Gendebien et al, 2012). 
However, they failed to satisfactorily determine if nestin expression identified 
separate stem cell populations from the bone marrow or simply reflected cells of 
the same population at various stages of differentiation (Wislet-Gendebien et al, 
2012). Using a Wnt1-Cre/R26R transgenic mouse model, NCSCs and MSCs were 
isolated from the adult bone marrow and clonal populations of each were 
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compared.  An increase in nestin expression from 20% to 90% of cells within each 
clone was observed in MSCs that were serum starved but no difference was 
detected in NCSCs which all expressed nestin (Wislet-Gendebien et al, 2012). This 
indicates that nestin is distinctively regulated in different cell types. Additionally, 
50% of in vitro cultured mMSCs expressed nestin, which increased to 90% after 
bFGF treatment, indicating the neural potential of a large proportion of MSCs.  
Neurofilament (NF-L) and beta III tubulin (β3-tub) were also upregulated in treated 
mMSCs although GFAP and other mature neural markers were not, indicating an 
inability to progress beyond an immature neural cell fate. However, these 
differentiated neural cells were functional, as established by calcium signalling in 
response to glutamate treatment (Wislet-Gendebien et al, 2012).  
 
Nestin expression was heterogeneous in examined murine clones generated 
in vitro. Clonally generated murine mMSCs were all positive for nestin, which was 
maintained or increased after bFGF treatment. Three out of the 17 clones tested 
had tri-lineage potential and showed high expression of nestin that was maintained 
upon bFGF treatment. However, expression of neural marker β-tub was only limited 
after treatment and reported as low expression in one clone. Other MSCs with 
restricted differentiation potential were able to upregulate neural specific markers 
with greater ease, suggesting that mesenchymal cells that are perhaps already 
committed are more susceptible to the treatment and neuronal differentiation than 
stem cells (Tropel et al, 2006).  
 
Nestin expression in bone marrow MSCs has been reported by some to depend on 
in vitro factors. Serum removal and extended cell passaging is required for nestin 
expression in culture. Nestin is inhibited when the cells are plated at high densities 
(Wautier et al, 2007).  Thrombin has been suggested as the factor present in serum 
that inhibits nestin expression, as individually it has been reported to decrease the 
level of nestin expressed in MSCs in a dose dependent manner (Wautier et al, 
2007). Thrombin has wide ranging roles in inflammation and tissue remodelling and 
is implicated in brain development with an increase of thrombin resulting in the 
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contraction of processes on neural cells and thereby altering their actin 
cytoskeleton (Reviewed by Grand et al, 1996).   
 
1.4.5 Nestin in the HSC niche 
Studies using transgenic mouse models have identified nestin+ stromal cells to be 
MSCs with a key role in the HSC niche (Mendez-Ferrer et al, 2010). 
Analysis of bone marrow sections of nestin-GFP transgenic mice located GFP+ cells 
closely associated with HSCs. 80% of HSCs were within 5 cell diameters of a GFP+ 
cell. Real time PCR identified a high level of expression of genes important for HSC 
maintenance: IL-7, SCF, Ang1 and VCAM-1.  
In vivo depletion of nestin+ cells using inducible tamoxifen/diphtheria toxin mice led 
to a reduction in the number of HSCs in the bone marrow, giving a clear indication 
that nestin positive cells are important for the maintenance of HSCs in the bone 
marrow (Mendez-Ferrer et al, 2010). Further analysis of the nestin+ MSC population 
found them to be involved in attracting and retaining HSCs in vivo. When purified 
HSCs were transplanted into irradiated hosts, they localised to nestin positive cells. 
Conversely, when nestin positive MSCs were depleted, the ability of HSCs to home 
to the bone marrow was almost completely ablated.  
Depletion of SCF in nestin-positive cells specifically using a Nes-Cre mediated 
removal of SCF resulted in a decreased number of HSCs in the spleen, although 
bone marrow HSCs were unaffected (Ding et al, 2012). This indicates that HSCs in 
the bone marrow do not require SCF from nestin+ cells or that it can be sourced 
elsewhere in its absence and that nestin+ cells may have an intrinsic role in HSC 
niche function in the spleen through the action of SCF. 
 
1.4.6 The role of nestin-positive cells in tissue repair 
Nestin+ cells have been reported at sites of injury and remodelling, highlighting 
their stem cell attributes in the ability to proliferate and contribute mature cells in 
response to stress. One such tissue that has received a lot of attention is the 
infarcted heart. In normal rat heart tissue, nestin-positive stem cells have been 
isolated and could be induced to a neuronal or glial phenotype and to form cellular 
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spheres in culture in a similar fashion to NSCs (El-Helou et al, 2008). They are a 
resident cardiac cell population and express cardiac progenitor transcription 
factors. Nestin has also been detected in human and murine heart tissue (Beguin et 
al, 2011) (Tomita et al, 2005). Initially, cardiac nestin+ cells were proposed to 
originate from the bone marrow, however, when irradiated rats were transplanted 
with GFP–labelled bone marrow cells and subsequently subjected to an induced 
myocardial infarction, only 20% of the nestin positive cells in the region also 
co-expressed GFP. (El-Helou et al, 2005). Therefore, the numbers could not account 
for all of the nestin-expressing cells detected in the heart. It remains to be seen 
whether the cells were nestin positive in the bone marrow and were attracted to 
the site of destruction or whether the expression of nestin was induced in the 
damage environment once in situ. The bone marrow population may represent a 
subset of cells required to regenerate the damaged tissue and the resident cells be 
a reservoir of stem cells. In the infarcted heart, resident nestin positive cells have 
been observed to migrate to the sites of damage and contribute to the repair of 
cardiac tissue by sympathetic innervation and angiogenesis (El-Helou et al, 2008). 
Nestin mRNA is increased following myocardial infarction (Scobioala et al, 2008). 
Nestin protein is reported in endothelial cells of the new blood vessels of the 
recovering heart and may represent a marker of the neovascularisation (Beguin et 
al, 2009) (El-Helou et al, 2008) (Reviewed by Calderone, 2012).  
 
Reactive astrocytes are a key modulator of lesion repair in the brain and proliferate 
and upregulate GFAP in response to damage. Quiescent astrocytes in healthy tissue 
do not express nestin, however, these cells were found to re-express nestin after 
lesions were performed. Using a transgenic mouse with lacZ expression under the 
control of the same regulatory elements reported to promote nestin expression in 
the developing CNS, a close relationship between the adult astrocytes and 
neuro-progenitor is implied.  Immunohistochemical staining confirmed that lacZ 
cells expressed nestin and GFAP, suggesting the astrocytic phenotype but not all of 
the GFAP+ astrocytes expressed nestin (Lin et al, 1995). So, rather than astrocytes 
reverting to a more immature phenotype, the reactive astrocytes were proposed to 
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originate from a pool of stem cell precursors, as lacZ+ cells were found near to the 
lesion site and also in a subependymal region known to contain a stem cell pool in 
the adult brain (Morshead et al, 1994).  
 
1.4.7 Nestin expression in tumours 
The initiation of tumours is thought to arise from cancer stem cells that function 
similarly to stem cells in their ability to self renew and produce large numbers of 
differentiated progeny. Their existence was demonstrated in acute myeloid 
leukaemia (Bonnet & Dick, 1997) and has since been recognised in a range of solid 
tumours. Concomitant with its expression amongst tissue stem cells, nestin is being 
recognised as a characteristic marker of tumour stem cells. Indeed, nestin 
expression is seen in many tumours, especially those derived from the CNS such as 
astrocytomas and gliomas, reflecting the original identification of nestin in the 
neural tissues. Tumours from other origins known to express nestin include cervical 
carcinomas (Aihara et al, 2004) and malignant melanomas (Florenes et al, 1994). An 
examination of prostate cancers and matched bone marrow metastases found 
nestin+ cells confined to the epithelial cells (Eaton et al, 2010) suggesting a potential 
role in tumour vascularisation, which is consistent with the nestin expression 
detected in epithelial cells in the infarcted rat heart (El-Helou et al, 2008). Each 
prostate cancer sample was from established metastatic disease, therefore early 
onset upregulation of nestin for initiation of the primary tumour may not have been 
possible to detect in these samples. Appearance of cancer stem cells may be due to 
the mis-regulation and mutation of normal stem cells or the acquisition of the self 
renewal property in progenitor cells. Aberrant nestin expression may contribute to 
the transformation of these cells or be a subsequent consequence of the 
transformation which has yet to be addressed. Certainly, nestin expression is 
strongly correlated to the malignant grade of tumours as seen in angiosarcomas 
and gastrointestinal stromal tumours (Yang et al, 2008) where stronger nestin 
expression was detected by immunohistochemistry in human tumour samples.  
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Nestin expression within tumours has been specifically associated with proliferative 
endothelial cells (Sugawara et al, 2002). Almost 80% of 82 tumours from a range of 
sources examined by another group were found to contain nestin-positive 
intra-tumour epithelium (Aihara et al, 2004). Tumour epithelium is characterised by 
neovascularisation, therefore nestin may play a role in tumour progression by 
enabling angiogenesis for tumour growth. Normal uterine epithelium contained 
nestin positive cells confirming its association with cells involved in angiogenesis 
(Aihara et al, 2004). Although the function of increased nestin expression is still to 
be fully determined, it is clearly implicated in the roles of tumour initiation, 
metastatic progression and migration of cells in some tumours. Therefore, further 
research into the regulation of nestin expression on stem cells should help clarify 
and identify targets for disease intervention and conversely, the study of ectopic 
nestin expression in tumours may help identify roles in normal stem cell function.  
 
1.5 IL-7 
Interleukin-7 (IL-7) was originally identified in the late 1980s as a factor to promote 
murine B cell precursors in a long term culture system (Namen et al, 1988). Now 
IL-7 is recognised as a member of the type 1 cytokine family that is expressed by 
non-haematopoietic stromal cells in a range of organs including: lymph nodes, 
thymus, skin, liver and bone marrow. IL-7 plays critical roles in lymphopoiesis and T 
cell development. Murine T and B cell numbers are dramatically increased on 
injection of IL-7 (Morrissey et al, 1991). In contrast, injection of a neutralising IL-7 
antibody results in the inhibition of B cell development in the bone marrow 
(Grabstein et al, 1993). These cell types are resident in the bone marrow, therefore 
alteration by and consumption of IL-7 impacts the niches they inhabit.  
 
1.5.1 IL-7 signalling 
1.5.1.1 IL-7R 
The IL-7 receptor is composed of two subunits; the IL-7R alpha chain (IL-7Rα or 
CD127) and the common chain (γc). This common chain, as the name suggests, is 
shared by several other cytokines including: IL-2 (Takeshita et al, 1992), IL-4, IL-9 
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(Russell et al, 1994), IL-15 (Giri et al, 1994) and IL-21 (Habib et al, 2002). IL-7Rα is a 
member of the type I cytokine receptor family, which are characterised by a 
structural composition containing two fibronectin-like domains, four conserved 
cysteine residues and a WS motif in their extracellular domain. Both receptor 
components are expressed on the cell surface independently and become 
dimerised upon ligand binding. Thymic stromal lymphopoietin (TSLP) shares 
structural homology with murine IL-7 and is capable of similar pre B cell supportive 
functions (Sims et al, 2000). TSLP signals through IL-7Rα, which dimerises with a 
TSLP receptor that shows some resemblance to the γc subunit (Park et al, 2000). 
 
IL-7Rα is expressed by a wide range of haematopoietic cells including natural killer 
cells, dendritic cells, lymphoid precursors, developing B cells and mature T cells as 
well as bone marrow macrophages. IL-7Rα has also been detected in endothelial 
cells, bone marrow stromal cells as well as numerous cancer cell types.  
 
In lymphoid stromal cells, the expression of IL-7 mRNA is not affected by fluctuating 
levels of IL-7 or lymphocyte cell number (Fry & Mackall, 2005). However, the 
surface expression of IL-7Rα is altered depending on the differentiation status of 
the cells (Mazzucchelli & Durum, 2007). IL-7Rα is not expressed on HSCs but is 
acquired during lymphopoiesis and is consequently expressed by common 
lymphoid progenitors (Reviewed by Bhandoola & Sambandam, 2006). IL-7Rα is 
initially required to promote cell survival and proliferation but then is 
downregulated on B cells at the small pre-B2 cell stage in order to allow 
differentiation to continue. Expression of IL-7Rα is comparable between mouse and 
human systems (Mazzucchelli & Durum, 2007).  
 
In respect of T cell development, small variations occur between mouse and human 
systems with an earlier downregulation of  IL-7Rα in human cells at the pre-T1 cell 
stage, which in mice still express the receptor. Once T cells mature, they express 
either CD4 or CD8 and are known as single positive T cells. Murine immature single 
positive T cells do not express the IL-7 receptor although it is unclear if their 
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immediate precursor does whilst in both human and mouse mature single positive 
T cells, IL-7Rα is re-expressed. The expression of IL-7Rα on mature T cells is further 
regulated depending on environmental factors and cytokine availability. The 
regulation of IL-7 is speculated to be via its rate of consumption. IL-7 levels are 
thought to be at a level sufficient to maintain the resident T cell population with 
cells using only the IL-7 they require for homeostasis, thereby allowing each cell to 
harness the available IL-7.  In response to IL-7 exposure, mature T cells 
downregulate IL-7Rα. This would support the view that after receiving adequate 
IL-7 signal for survival, the receptor is downregulated thereby preventing its own 
consumption of IL-7 and subsequently IL-7 is made available to other, 
non-stimulated T cells (Mazzucchelli & Durum, 2007). This theory has yet to be 
confirmed and will require some technical advancement of the detection of IL-7 
protein which is currently too low to be detected accurately in mouse tissue.  
IL-7R signalling is essential in T cell survival which is mediated by upregulation of 
the expression of pro-survival proteins Bcl2 (B cell lymphoma-2) and MCL1 (Myeloid 
cell leukaemia sequence 1). Withdrawal of IL-7 consequently leads to T cell death 
(Khaled & Durum, 2002).  
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Figure 1.3 IL-7 signalling 
IL-7 binding to its receptor IL-7Rα and common chain co-receptor initiates a signalling 
cascade through JAK and STAT proteins that results in the upregulation of pro-survival 
genes Bcl-2 and Mcl-1. 
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1.5.1.2 JAK-STAT pathways 
IL-7 is known to signal through the heterodimerisation of the α and γ chains of its 
receptor resulting in a cascade of phosphorylation events orchestrated by janus 
kinases (JAKs) and signal transducers and activators of transcription (STATs). Upon 
IL-7 binding, JAK3, which is already associated with the γc, is activated to 
phosphorylate both the γc receptor and JAK1 which subsequently phosphorylates 
the α chain (Figure 1.3) (Khaled & Durum, 2002).  
 
JAK3 is an essential transducer of cytokine signals. JAK3 and γc knockout mice show 
similar defects in lymphoid development and mutations in the human JAK3 gene 
also result in a disease almost identical to XSCID (X-linked recessive severe 
combined immune deficiency) (Nosaka et al, 1995). Lack of different JAK-STAT 
signalling components leads to similar phenotypes between mice and humans, 
suggesting their functions are highly conserved (Leonard, 2001).  
 
STAT5a and b are two isoforms of STAT5 that become phosphorylated and may 
form homo or heterodimers which then translocate to the nucleus to bind DNA and 
induce gene activation. IL-7 induces STAT5 phosphorylation which is then altered 
during T cell development and correlates with thymocyte survival. STAT5a and b 
deficiencies in mice display different phenotypes (Teglund et al, 1998). A combined 
deficiency in STAT5a and b does not result in the inhibition of T cell development, 
suggesting other downstream components may be able to compensate for the STAT 
deficiency, although the exact signalling mechanism is yet unknown. 
 
Cytokine signalling is negatively regulated by the protein family of suppressors of 
cytokine signalling (SOCS). These proteins can bind to JAKS, competitively bind STAT 
proteins or target proteins for degradation to inhibit the cytokine signalling 
pathway (Starr & Hilton, 1998). Eight SOCS proteins have been reported and SOCS1 
is responsible for the inhibition of IL-7. IL-7 induces SOCS1 expression in B cells in a 
negative feed-back regulation of its own signalling (Corfe et al, 2011). SOCS1 
deficient mice die perinatally due to extreme inflammation (Marine et al, 1999).  
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IL-7 has also been reported to initiate signalling mechanisms in cells that do not 
express IL-7R as it can associate with Flt3 and c-kit (Cosenza et al, 2002), although 
this remains controversial. 
 
1.5.2 Mouse models of IL-7 
Recently, a number of bacterial artificial chromosome (BAC) transgenic mice have 
been generated in order to study the in vivo expression of IL-7 (Reviewed by Kim et 
al, 2011). Detection of IL-7 protein is difficult using traditional immunodetection 
methods and relatively little is known about its promoter. The BAC reporter 
strategy provides an advantageous solution to locate IL-7 reporter expressing cells 
in vivo that can be further characterised to understand the role of IL-7 regulation in 
these cells and tissues. 
 
1.5.2.1 BAC transgenesis 
Transgenesis introduces exogenous DNA sequences or transgenes into the genome 
of an organism. BAC transgenes are employed to report spatial and temporal 
expression of endogenous genes at the physiological level. BACs are derived from 
single-copy functional fertility plasmid (F factor) of Escherichia coli (Shizuya et al, 
1992). Replication of the F factor is tightly controlled and is only present in the cell 
as one or two copies, restricting recombination of DNA fragments and the DNA 
appears stable. Large genomic fragments can be cloned into these vectors, which 
made them a useful tool in the construction of DNA libraries allowing their 
subsequent sequencing. The ability to modify the BAC construct further improved 
its usefulness and cell-specific expression of reporters was possible by manipulation 
of the reporter gene by homologous recombination within bacteria (Yang et al, 
1997). As demonstrated in Drosophila studies, enhancers and promoters may lie 
some distance away from the gene of interest (Dillon & Grosveld, 1993; Kennison, 
1993) therefore, the faithful expression of transgenes to the endogenous gene 
expression is likely to be dependent on the incorporation of these areas in the 
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relatively large (300 kb) segments of DNA that are used to avoid integration site 
induced varied expression.  
 
1.5.2.2 IL-7 reporter BAC mice 
The IL-7 BAC transgenic mice insert a reporter gene into the IL-7 locus immediately 
after the ATG start codon of exon-1 (Figure 1.4).  
The first IL-7 reporter mouse used yellow fluorescent protein (YFP) cDNA in the BAC 
construct and demonstrated identification of YFP+ thymic epithelial cells TECs in the 
foetal thymus that persisted into adult tissues (Alves et al, 2009). They were either 
cortical or medullary and negative for epithelial or fibroblast markers. Cortical and 
medullary TECs are believed to have a common progenitor, which was postulated 
to be the distinct subsets of cells expressing YFP for each cell type. The TECs were 
also located in a specialised region of the adult thymus and were noted to have 
high expression of factors important for T cell development such as CXCL12 and 
CCL25 (Alves et al, 2009). This first report of an IL-7 BAC transgenic mouse only 
detected reporter expression in the thymus despite indications that IL-7 is 
expressed in other organs demonstrating a limitation in the detection of IL-7 using 
this method. To investigate this disparity, mRNA levels between cells known to 
express IL-7 and YFP+ cells were compared. When compared against the levels of 
IL-7 transcript in fibroblastic reticular cells from the lymph node which did not 
express the reporter but are a known source of IL-7, the level of IL-7 in YFP positive 
TECs was found to be much higher. Thus they suggest a critical threshold limit for 
the expression of the YFP reporter that is only reached in cells with the highest 
expression of IL-7 transcript (Alves et al, 2009) and explains the lack of detection of 
YFP in peripheral tissues. A low level of IL-7 transcript was found in YFP negative 
TECs indicating heterogeneity within the cell type.  
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Figure 1.4 BAC constructs used to generate transgenic mice 
Four independent groups have generated 5 different IL-7 BAC transgenic mice by inserting 
a transgene into the IL-7 locus.  
Diagram modified from Kim et al (Kim et al, 2011). 
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Repass et al devised two models that used either human CD25 or Cre recombinase 
as a reporter of IL-7 (Repass et al, 2009).  Both transgenes were inserted into 
position one of the IL-7 exon 1 and were composed of the whole 43kb IL-7 locus as 
well as 96kb of the 5’ and 17kb of the 3’ flanking sequences in order to include as 
many regulatory elements as possible. The IL-7.hCD25 transgene could then be 
detected by anti human CD25 antibodies. hCD25 staining was detected in E13.5 
foetal thymus but not in those from non-transgenic mice. In foetal thymus cell 
suspensions, hCD25 was not detected on haematopoietic cells but was detected in 
almost a third of the stromal population. Of the non-haematopoietic cells that were 
isolated, only the hCD25-positive cells expressed hCD25 mRNA. Additionally, IL-7 
mRNA was detected only in these cells and not in hCD25 negative cells. To confirm 
transgene expression was faithful to that of endogenous IL-7 expression, hCD25 
expression was measured by flow cytometry. Lymph nodes, liver, small intestine, 
thymus and brains of adult mice were analysed for hCD25 and IL-7 expression by 
qPCR. In adult tissues that were analysed, IL-7 mRNA was a similar level in hCD25 
positive cells to that of endogenous IL-7 detected in non-transgenic mice and with 
the exception of liver tissue, displayed a uniform level of expression of transgene 
and endogenous IL-7. Expression was highest in the thymus and lymph nodes and 
IL-7 in bone marrow was not reported. 
 
Expression of Cre from the transgenic mice was detected by crossing the mice with 
either Rosa26R or R26YFP reporter mice (Repass et al, 2009). This generated mice 
in which the stop cassette is removed by Cre recombinase and subsequent 
expression of lacZ or eYFP. These were then detected by whole mount staining with 
X-gal or anti-YFP antibodies in thymus, lymph nodes, liver and small intestine but 
not in the kidney. Bone marrow and skin tissue were also mentioned to contain 
reporter expression. Lymph node, thymus and spleen tissue from YFP mice were 
further characterised by flow cytometry and demonstrated that YFP positive cells 
were confined to CD45 negative cells in the lymph node and thymus but entirely 
absent from the spleen. Each mouse therefore presented IL-7 reporter expression 
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that was in line with previous reports of endogenous IL-7, which used in-situ 
hybridisation to detect IL-7 in E13.5 thymus (Zamisch et al, 2005), and reported IL-7 
expression in the stromal fraction of lymphoid cells (Repass et al, 2009).  
 
The Durum group generated a fluorescent reporter strain of mice which replaced 
exon 1 in this instance with an enhanced cyan fluorescence protein (eCFP) in the 
BAC clone (Mazzucchelli et al, 2009). The weak level of eCFP expression was 
overcome by staining with anti-eCFP and an appropriate fluorescent secondary 
antibody. Multi-photon microscopy also enabled visualisation of IL-7 reporter 
expression without the need for additional antibody staining. eCFP positive cells 
were not detected in the gut, lungs, skin, brain or blood platelets, which reiterates 
the limitation of the direct YFP reporter mice that they may also only be useful in 
detecting cells with the highest levels of IL-7 mRNA. ECFP-positive cells were 
detected in the thymus and were negative for markers of fibroblastic and 
endothelial cells and further to the characterisation reported by Alves et al; 
dendritic cells and myeloid cells were eCFP negative.  
 
Bone marrow stromal cells that were eCFP positive displayed an epithelial cell 
morphology. CFSE-labelled memory T cells were intravenously injected into the 
reporter mice and homing could be monitored using intravital microscopy of the 
skull. Numerous T cells were detected close to IL-7 reporter cells and preferentially 
interacted with eCFP positive cells. In order to further examine the potential of IL-7 
in this relationship the group generated a mouse that expressed the reporter but 
lacked IL-7 and repeated the T cell experiment. In this case, the number of T cells 
that was detected 24 hours later in the skull bone marrow was not reduced but in 
fact slightly higher than in control mice, so the role of IL-7 as a chemoattractant was 
ruled out. As memory T cells express CXCR4, they may be recruited to the bone 
marrow by cells expressing CXCL12. Therefore, the CXCR4 agonist AMD3100 was 
injected into the IL-7 reporter mice but this did not prevent the T cells entering the 
bone marrow and so CXCL12 was also eliminated as the potential attractant to the 
IL-7 producing cells (Mazzucchelli et al, 2009).  
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An alternative BAC transgenic mouse uses four genes under the control of the IL-7 
promoter to simultaneously express enhanced green fluorescent protein (G), Cre 
recombinase (C), the human diphtheria toxin receptor (D) and click beetle green 
luciferase 99 (L) (Shalapour et al, 2010). The mice were therefore termed IL-7GCDL. 
Luciferin was injected into the mice and whole organs were examined for 
bioluminescence. This was most highly detected in the thymus, skin and intestine 
whereas low levels were detected in the lung, heart, kidney and liver and no 
increase from background levels could be detected in the spleen. IL-7 mRNA levels 
corresponded well with the amount of bioluminescence detected apart from in the 
lymph nodes where relatively high levels of IL-7 mRNA compared to low detected 
levels of bioluminescence attributed to their small size. Although the highest levels 
of bioluminescence detected were in the colon of the transgenic mice, eGFP 
reporter could not be detected and so a further mouse was generated by crossing 
the strain with an RA/EG mouse that expressed eGFP after Cre recombinase 
activity. In this way, eGFP could be detected in the intestinal epithelial cells in the 
gut (Shalapour et al, 2010).  
 
There are some inconsistencies between the studies generally accepted to be due 
to the differences in the generation of each mouse model. Together, the data builds 
an extensive picture of the cells that express IL-7 that were previously inaccessible. 
Three out of the five mice generated reported IL-7 expression in the bone marrow 
where it has established roles in B cell lymphopoiesis. 
 
1.5.3 IL-7 in bone marrow 
A negative impact on bone has been attributed to the actions of IL-7. IL-7 is known 
to be expressed by stromal cells in the bone marrow but the precise identification 
of these cells and their functional role are still to be described adequately 
(Mazzucchelli et al, 2009). It has been reported that IL-7 KO mice have increased 
bone mass due to a lack of IL-7 stimulated T cell activation (Weitzmann et al, 2000). 
This activation would ordinarily lead to T cell secretion of RANKL and M-CSF and 
subsequent activation of osteoclasts to initiate bone resorption (Figure 1.5). 
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Therefore, the absence of IL-7 in the bone marrow disrupts the regulation of bone 
remodelling, resulting in higher bone mass. However, it was noted that the RANKL 
pathway was not the only one responsible for increased osteoclastogenesis as 
osteoprotegerin (OPG), which inhibits RANKL, did not reduce all osteoclast 
formation (Weitzmann et al, 2000). RANKL deficient mice have no osteoclasts or 
lymph nodes and display defective B lymphocyte development, indicating the 
critical role it plays in osteoclast differentiation (Dougall et al, 1999). 
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Figure 1.5 IL-7 interactions in bone 
IL-7 is expressed by stromal cells and osteoblasts in the bone marrow and consequently 
initiates T-cell expression of RANKL and M-CSF that activate osteoclast maturation and 
activity. Stromal cells also express OPG, which is a soluble decoy receptor for RANKL and 
acts to antagonise OC activation. IL-7 negatively regulates OPG in order to increase OC 
maturation. IL-7 also suppresses bone formation by osteoblasts and therefore has a 
negative impact on bone. 
Abbreviations: OPG; osteoprotegerin, RANKL; receptor activator of NF-κB ligand, M-CSF; 
macrophage colony stimulating factor, OC; osteoclast. 
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Gene inactivation of both IL-7 and IL-7R in mouse knockout models results in 
reduced size of both the thymus and spleen. When the bone marrow of these 
animals is examined, B lymphopoiesis is found to be perturbed. The overall number 
of B lymphocytes is greatly reduced compared to wild type mice and is a block to 
differentiation at the pro-B cell stage. Pre-pro B cells are unaffected but the number 
of pro-B cells reduced by a third and almost no cells transitioning from pro-B to 
pre-B cells were detected.  
 
In mice that overexpress IL-7 under the control of a major histocompatibility 
complex (MHC) class II promoter, B cell development is greatly affected with no 
effect reported on T cell development (Fry & Mackall, 2002). The numbers of pro, 
pre and immature B cells are increased and myeloid cell numbers are extremely 
low. At 4-6 weeks, femur diameter is increased in the mice accompanied by a larger 
bone marrow cavity and focal osteolysis.  
 
Direct administration of IL-7 into healthy mice results in B lymphopoiesis induction 
accompanied by bone loss (Miyaura et al, 1997). The mice examined in this study 
were females and an increased number of tartrate resistant acid phosphatase 
(TRAP)-positive osteoclasts were observed that contributed to the loss of 
mineralised cancellous bone to the extent seen in mice with oestrogen deficiency 
(induced by ovariectomy). Bone loss was not observed in organ cultures of murine 
foetal long bones (Onoe et al, 1996) and so the resulting reduction in bone loss 
determined by radiological and histological analysis in vivo suggests that the 
alterations in B lymphopoiesis modify the microenvironment to stimulate bone 
resorption. Additionally, bone marrow derived B220+ B cell precursors have been 
stimulated in vitro to generate osteoclasts themselves and may serve as a 
progenitor population (Manabe et al, 2001). However, despite an increase in B220+ 
cells upon administration of IL-7, no increase in RANKL or bone loss was detected in 
T cell deficient nude mice (Toraldo et al, 2003). This suggests that the bone loss is T 
cell mediated and describes a clear relationship between IL-7, T cells and 
osteoclasts in the balance of bone remodelling. 
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IL-7 has been shown to be up-regulated in ovariectomised mice which have an 
oestrogen deficiency. This oestrogen deficiency leads to bone loss that can be 
prevented with IL-7 neutralisation. IL-7 was shown to promote osteoclastogenesis 
and suppress osteoblastic activity such that the result was an ‘uncoupling’ of the 
two processes as the balance is tipped, leading to the loss of bone. IL-7 blocked new 
bone formation of in vitro calvarial cultures that were stimulated with BMP-2 and 
in vivo intraperitoneal IL-7 administration (Weitzmann et al, 2002). Altogether, IL-7 
has an overall negative impact on bone and clearly interacts with and is expressed 
by mesenchymal lineage cells. 
 
1.5.4 IL-7 in arthritis 
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by 
inflammation and degradation of the bone joints which causes pain and stiffness in 
patients that can be debilitating. There is an increasing body of evidence to suggest 
the involvement of IL-7 in the activity and progression of this disease (Reviewed by 
Churchman & Ponchel, 2008). In human studies of RA, serum levels of IL-7 have 
been detected and measured that vary widely depending on the method of 
detection employed. In four separate studies, serum IL-7 concentrations have been 
reported at ranges between 1.5 – 3.8 pg/ml in one study and at the other end of 
the scale at 300 pg/ml. Serum levels were also measured in healthy controls and 
these were also found to differ between the reports. In a review of the studies, 
ELISAs from 5 different origins showed comparable levels of IL-7 in healthy controls 
of 13 ± 5 pg/ml with the exception of one which showed the lowest range of IL-7 
mentioned above. The reported levels were found to be below the lower detection 
limit (3 pg/ml) of the ELISA. IL-7 detection from sources other than serum is also 
inconsistent. Whilst some report elevated levels of IL-7 in synovial fluid, others 
observe a reduction, although in general, studies agree that IL-7 levels are higher in 
rheumatoid arthritis compared to osteoarthritis. The increases in synovial fluid IL-7 
measured in 44 RA patients was not correlated with age or sex and was not 
significantly different between groups that had rheumatoid factor present disease 
or not (van Roon et al, 2005). However, it has been shown that IL-7 is up-regulated 
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in human osteoarthritis chondrocytes as well as in normal chondrocytes with age 
(Long et al, 2008). 
A small sample of human articular chondrocytes samples found IL-7 mRNA 
expression by RT-PCR in 2/6 osteoarthritis patients and in 2/3 RA patients. They also 
found that 1/5 normal infant chondrocyte samples expressed IL-7 whereas all 
balb/c mouse chondrocyte samples produced cytokine profiles including IL-7 
(Tanabe et al, 1996). Another report published two years later found IL-7 mRNA to 
be exclusively detected in RA patients and absent from osteoarthritis and normal 
cartilage (Leistad et al, 1998). 
  
As an auto-immune disease, antibodies such as rheumatoid factor and anti 
citrullinated peptides antibodies (ACPA) have been used to diagnose RA but show 
lack of specificity in the earliest stages of the disease. When examined as a 
potential biomarker for early onset RA, the median expression of serum IL-7 was 
found to be similar in 250 patient samples compared to 80 healthy controls. 
However, the lowest levels were detected in the samples from patients who were 
considered to have very early inflammatory arthritis symptoms. 108 patients 
progressed to RA and again the range of IL-7 serum levels measured was distributed 
at the lower end of the scale. Low IL-7 serum level (<10 pg/ml) predicted structural 
damage at follow-up in patients after two years but overall the sensitivity of IL-7 in 
predicting disease progression was lower than that of the currently used antibodies 
(Goeb et al, 2012). Low serum levels of IL-7 in RA patients were associated with 
lower IL-7 expression from bone marrow stromal cells cultured in vitro compared to 
healthy controls (Ponchel et al, 2005) suggesting a systemic defect in IL-7 
regulation. However, peripheral blood mononuclear cells had the same proliferative 
response to IL-7 in RA and healthy patient samples indicating that the signalling 
pathway is still intact in these cells (Ponchel et al, 2005). 
 
Lymphocytes extracted from the synovial fluid in RA patients proliferated at a 
greater rate at higher doses of IL-7 than those extracted from peripheral blood. 
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Culturing CD4+ T cells from these sources in vitro with the addition of IL-7 led to 
their activation as MHC class II and CD25 were upregulated (van Roon et al, 2005).   
In contrast to the low circulating levels of IL-7, it is reported to be high in arthritic 
joints. Immunodetection of IL-7 has been reported in human RA synovial tissue. 
This was reported to be co-localised with CD68 which is a glycoprotein expressed by 
macrophages, monocytes, activated T cells and fibroblasts. CD68 may be used as a 
measure of arthritis disease status and therefore the co-localisation of IL-7 may 
suggest a similar role. CD68+ macrophage numbers are increased at the synovium 
of RA patients compared to controls and are reduced upon disease remission 
following successful treatment with a variety of disease modifying anti-rheumatic 
drugs (DMARDs) (Haringman et al, 2005). Macrophages and epithelial cells were 
also confirmed to be associated with extracellular IL-7 and collagen IV (Timmer et 
al, 2007). Samples from patients in clinical remission showed single sporadic IL-7 
positive cells detected by immunohistology compared to an extensive area of IL-7 
expression in a sample from active disease. These results correlated with the 
detection of high IL-7 mRNA levels from synovial fibroblasts cultured from patients 
with the highest inflammation scores measured at arthroscopy (Churchman & 
Ponchel, 2008). Low IL-7 serum levels return to normal levels in disease remission 
and the high levels of IL-7 observed at tissue sites also reverses in clinical remission. 
This may be due to the sequestering of IL-7 at the sites of inflammation and 
consequently, a reduced amount of free IL-7 in the circulation.  
 
Approximately one quarter of patients with RA have an organised structure in the 
affected joint synovium which resembles that in the lymph node and are 
consequently referred to as ectopic lymphoid structures (Takemura et al, 2001). 
Infiltrated B and T cells are arranged in distinct areas and the presence of a network 
of follicular dendritic cells within the B cell areas leads to the formation of germinal 
centres (Takemura et al, 2001). Other patients have more diffuse infiltrations of 
cells or singular B or T cell type accumulations. These structures are common to a 
number of other chronic inflammatory conditions including chronic hepatitis 
(Mosnier et al, 1993), multiple sclerosis (Serafini et al, 2004) and Crohn’s disease 
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(Kaiserling, 2001). Analysis of IL-7 within these lymphoid structures showed that 
IL-7 was secreted and positioned around the structure, possibly to promote the 
survival of T cells and subsequent B cell activation. In diffuse or aggregated cell 
infiltrations into synovial tissues, IL-7 detection was exclusively cellular. In RA 
synovial tissues with lymphoid areas, gene expression analysis of microarray data 
showed an upregulation in the JAK/STAT pathway and in particular each component 
of the IL-7R, compared to tissue that did not contain lymphoid structures (Timmer 
et al, 2007). Collectively this suggests a role for IL-7 in the organisation and 
maintenance of the lymphoid structures presented in RA in a similar manner to the 
IL-7 signalling mechanism in lymphoid tissue inducer cells that initiate lymph node 
development. 
 
Evidence to suggest that IL-7 may be responsible for cartilage destruction in 
osteoarthritis disease has been presented. S100A4 is a calcium binding protein and 
has been found at elevated levels in both rheumatoid and osteoarthritis. On 
addition to chondrocytes cultures it promotes the chondrocyte hypertrophy and 
the expression of matrix metalloproteinase 13 (MMP-13). Ankle articular 
chondrocytes stimulated with 10 ng/ml IL-7 showed an increased expression in 
S100A4. This secretion appeared to be moderated by the JAK/STAT pathway as 
inhibition of JAK3, which was measured by immunoblotting and seen to be 
phosphorylated upon addition of IL-7, blocked the secretion of S100A4. 
 
Arthritis is a progressive, debilitating disease characterised by damaged cartilage 
and bone around the joints. IL-7 involvement in human arthritis is contradictory, 
which indicates a requirement for standardised protocols to identify IL-7 and 
further study to identify the roles of IL-7 in the bone marrow cells involved in the 
arthritic process. 
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1.6 Thesis aims 
MSCs are a rare population in the bone marrow that hold huge potential due to 
their ability to differentiate into skeletal lineages and therefore generate and 
maintain bone, fat and cartilage. As their developmental origin and functional 
contributions to the HSC niche are explored, it is becoming apparent that subsets of 
MSCs exist alongside each other in the bone marrow. Being able to accurately 
distinguish these subsets will be critical to understand not only MSC expansion and 
behaviour but also the factors that regulate HSC fate. However, to date, there is no 
agreement or demonstration of a marker to successfully isolate bone marrow 
MSCs. A number of potential candidates of unique markers have been proposed, 
among which, nestin is increasingly associated with stem cells and progenitor cells 
in a wide range of tissues and work continues to decipher its functional significance 
in the context of stem cell behaviour and potential.  
 
IL-7 has essential roles in T and B cell development and has a negative impact on 
bone. The identity of IL-7 expressing stromal cells in bone marrow is currently 
unclear although significant advances have been made with the generation of 
transgenic mouse lines that allow the visualisation of IL-7 expressing cells. Detailed 
analysis and characterisation of the cells that express IL-7 may provide new insights 
into the processes of haematopoiesis and bone remodelling.  
 
The aim of this study is to address the potential of nestin and IL-7 expression as 
markers of bone marrow derived MSCs and further examine the role of IL-7 
expressing stromal cells in the bone marrow in the context of the stem cell niche, 
with the following objectives:  
 
1. To examine the fate of murine IL-7 expressing cells in the bone marrow of 
IL-7CreRosa26-eYFP transgenic mice. 
2. To develop a 3D in vitro model to assess IL-7 and nestin in the HSC niche. 
3. To investigate the expression of IL-7 and nestin in primary human MSCs. 
4. To investigate the role of IL-7 in MSC proliferation and differentiation. 
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2 Methods 
 
2.1 Cell Culture 
All cells were incubated at 37°C with 5% CO2 in an atmosphere with 95% humidity 
unless otherwise stated. All plasticware was purchased from Corning and all 
reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless stated 
otherwise. 
 
2.1.1 Isolation of primary mesenchymal stromal cells (MSCs) 
Primary human mesenchymal stromal cells (MSCs) were extracted from femoral 
heads and knees obtained from Harrogate District Hospital and Clifton Treatment 
Centre, York, following informed consent and ethics approval from the University of 
York and NHS. Donors were anonymous and samples were identified with the prefix 
FH or K to denote donor site origin, followed by a unique number. 
 
2.1.2 Isolation of cells from femoral heads  
Bone marrow was removed from the femoral head using sterile instruments and 
collected into Dulbecco’s Modified Eagle’s Medium (DMEM, GIBCO, Life 
Technologies, Paiseley, UK) containing 100 ug/ml penicillin and 100 U/ml 
streptomycin (1% P/S). The fragments were minced with scissors and the 
supernatant removed once the large bone fragments had settled. The mincing 
process was repeated 3 times followed by vortexing the bone fragments for 1 
minute and collecting the supernatant. The supernatant was centrifuged at 450 g 
for 5 minutes. The cell pellet was re-suspended in 16 ml DMEM and filtered through 
a 70 µm strainer into a fresh tube. This was then gently layered onto 12 ml 
Ficoll-Paque Plus (Amersham, GE Healthcare) in a falcon tube and centrifuged at 
350 g for 30 minutes. The mononuclear fraction of cells could then be removed 
from above the Ficoll layer and washed in buffer A (phosphate buffered solution 
[PBS] containing 1% bovine serum albumin [BSA] and 5 mM 
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 ethylenediaminetetracetic acid [EDTA, GIBCO]). Cells were seeded in DMEM 
containing 15% foetal bovine serum (FBS, batch tested for MSC growth) and 1% P/S 
into a 75cm2 flask and cells allowed to adhere for 5 days. 
  
2.1.3 Isolation of cells from knee bones 
Knee bones were broken into pieces using sterile instruments, placed into a 10 cm 
petri dish and covered with DMEM containing 15% FBS and 1% P/S. Bone fragments 
were removed 5-7 days after seeding and the media changed to remove 
non-adherent cells and debris. 
Adherent cells were termed passage 0 (P0) and once established, MSCs from both 
sources were maintained in DMEM containing 10% FBS and 1% P/S with media 
changes every 3-4 days. At 70% confluency the medium was removed, cells washed 
with PBS and harvested with 0.05% trypsin/0.02% EDTA. Cells were first seeded at a 
density of 1000 cells/cm2 (P1) and thereafter at a 1:3 ratio. 
 
2.1.4 Isolation and culture of primary murine stromal cells  
IL-7cre Rosa26-eYFP mice were bred under specific pathogen free conditions in the 
Biological Services Facility at the University of York.  All work was in accordance 
with ethical approvals from the University of York and Home Office Licence 60/4169 
to Mark Coles.  IL-7cre Rosa26-eYFP mice were schedule-1 killed and different long 
and flat bones were harvested by Priyanka Narang, Amy Sawtell and Anne Thuery. 
The rear femora and tibiae leg bones were scraped clean, the proximal and distal 
ends removed and PBS containing 2% FBS was flushed through using a 25 gauge (25 
G) needle and syringe to collect the bone marrow. Separately, the bones were 
minced with scissors and washed in PBS containing 2% FBS to collect the cells. 
Settled bone fragments were incubated for 40 minutes at 37°C with gentle agitation 
in serum-free medium containing a collagenase cocktail to release the cells from 
the bone (Liberase TL, 1:40; Roche, Sussex, UK). DMEM containing 10% FBS was 
then added and the bones vortexed. The supernatant was removed to a fresh tube 
and centrifuged at 450g for 5 minutes to pellet the cells. All cells were washed and 
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filtered through a 70 µm cell strainer and maintained in DMEM with 10% FBS. After 
4 days, non-adherent cells were removed and the medium changed every 3 days. 
  
2.1.5 Primary cultures 
Human adipose derived stem cells (ADSCs) were purchased from Invitrogen 
(Carlsbad, Ca, USA) and cultured in MesenPRO medium (Invitrogen) supplemented 
with 10% FBS.   
Human T cells were isolated from peripheral blood cones (Blood Transfusion 
Service) by Dr Bridget Glaysher using the T cell purification kit RosetteSep 
(STEMCELL Technologies, Grenoble, France) which separates T cells using antibody 
mediate red cell resetting and a density gradient centrifugation.   
Embryonic day 12.5 liver in murine foetal development is considered highly 
enriched for stem and progenitor cells and therefore the isolated cells have 
consequently been termed mouse haematopoietic progenitor cells (HPCs).  
Additionally, very few, if any mature myeloid or lymphocyte lineage cells are found 
at this stage in development.  Mouse HPCs were isolated by Dr Mark Coles from day 
12.5 embryos by removal of the foetal liver.  Briefly, day 12.5 embryos were 
isolated from timed pregnancies and the foetal liver isolated by micro-dissection 
and placed in 10% DMEM.  The foetal livers were teased apart through passage in a 
19.5 gauge needle and finally filtered through a 70 uM mesh cell strainer.  The cells 
were centrifuged and either frozen in 10% DMSO/FCS or used fresh in the spheroid 
and culture systems. 
 
2.1.6 Culture of cell lines 
The multipotent, murine mesenchymal cell line C3H10T1/2 (ATCC) and the human 
embryonal carcinoma stem cell line NTERA2/D1 were cultured in DMEM with 10% 
FBS.   AFT024, a temperature sensitive mouse stromal cell line was maintained in 
DMEM with 10% FBS, 50 µM 2-mercaptoethanol and 1% P/S at 33°C.  Mouse 
stromal cell line OP-9 was cultured in Minimum Essential Medium Eagle Alpha 
Modification (α-MEM, GIBCO) containing 20% FBS, 1% P/S, 1% L-glutamine and 1% 
non-essential amino acids (NEAA).  Media was changed for each cell line every 3-4 
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days and cells passaged by trypsinisation at a ratio of 1:6 upon reaching 90% 
confluency. 
 
2.1.7 Mycoplasma testing 
All cells were subject to regular testing for mycoplasma. Cells were seeded into 24 
well plates and allowed to adhere. Cells were washed with PBS and fixed for 5 
minutes in methanol. Cells were washed with PBS and then incubated with 200 µl 
DAPI (1 µg/ml) for 5 minutes at room temperature. The DAPI was removed and the 
cells washed and viewed under UV light. Clear, defined nuclear staining was 
indicative of a negative result.  
 
2.2 Colony forming unit assays 
2.2.1 Colony forming unit – fibroblast (CFU-F) assay 
To obtain clonal lines of MSCs from single cells, 10 cells/cm2 were seeded out into 6 
cm petri dishes and allowed to grow for 10-14 days with media changes every 3-4 
days. MSCs of passages 0-7 were initiated, with passage 3 and 4 yielding enough 
clones to further analyse for donors FH408 and K6, respectively. DMEM with 20% 
HyClone FBS (GE Healthcare) and 1% P/S was used. Discrete colonies typically 
containing 200-300 cells were isolated using cloning cylinders sealed around each 
colony with sterile vacuum grease and harvested by trypsinisation. Cells were 
seeded into 48 well plates and transferred to larger vessels as the cell numbers 
increased.   
 
2.2.2 Colony forming cell (CFC) assay  
In order to quantify the potential of HPCs, cells were seeded into a semisolid 
medium (complete MethoCult; StemCell Technologies) containing cytokines and 
growth factors (rmSCF, rmIL-3, rhIL-6, rhEpo) to facilitate the proliferation and 
differentiation of progenitor cells into colonies of cells of the haematopoietic 
lineage such as granulocytes, erythroid cells and monocytes. HPCs were washed in 
Iscove's Modified Dulbecco's Media (IMDM) with 2% FBS, counted and adjusted to 
10x the final concentration required (5 x 104 cells). 0.3 ml of cell suspension was 
Chapter 2. Methods 
 
70 
 
added to 3 ml of MethoCult media and vortexed to allow thorough mixing before 
seeding 1.1 ml into 35 mm dishes. Triplicate dishes were incubated in a humidified 
chamber at 37°C for 9 days and resulting colonies were identified according to 
descriptions and images provided with the MethoCult.  
 
2.3 Spheroid culture 
2.3.1 Spheroid media 
A semi-solid media was prepared for the culture of cells in 3D spheroids as follows; 
6 g methyl-cellulose was autoclaved and then stirred for 20 minutes to dissolve in 
150 ml DMEM which had been pre-heated to 60°C. A further 100 ml media was 
added and stirred for 2-3 hours at 4°C. The mixture was finally centrifuged at 3600 g 
for 2 hours at room temperature to provide a stock solution of methyl-cellulose. 
The stock was diluted 1:7 in DMEM containing 10% FBS and 1% P/S and mixed 
thoroughly to provide a working solution of spheroid media. 
 
2.3.2 Spheroid formation 
Cell suspensions were seeded into non-adherent, U-bottomed 96 well plates in 
200 µl spheroid media. Cells aggregated spontaneously over 24 hours to form a 
spheroid structure. Half media changes were carried out every 3-4 days. 
 
2.3.3 Enzyme digestion of spheroids 
To produce a single cell suspension from the 3D mesenchymal – haematopoietic 
cell spheroids they were enzymatically digested. Spheroids were collected into a 1.5 
ml eppendorf and allowed to settle. Media was removed and the spheroids washed 
twice with PBS. Spheroids were re-suspended in 100 µl PBS and 5 µl Liberase TL 
(Roche, Sussex, UK) (2.5 mg/ml stock) added. Tubes were incubated with gentle 
agitation at 37°C for 20 minutes to disaggregate the spheroids. 1 ml DMEM 
containing 10% FBS was added and the sample then passed several times through a 
25G needle to remove any clumps. 
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2.3.4 Fluorescent labelling of cells 
In order to visualise the arrangement of cells within spheroids, cells were labelled 
with fluorescent probes; CellTracker green or red (Molecular probes, Invitrogen). 
Media was aspirated from monolayer cultures and replaced with 5 µl of 10 mM 
stock CellTracker probe diluted in 10 ml of serum-free media. Cells were incubated 
for 45 minutes at 37°C followed by a further 30 minutes in normal medium 
containing serum. Cells were then washed with PBS to remove any excess probe 
and replenished with normal media until further use.  
 
2.3.5 LIVE/DEAD cell viability assay 
To allow the analysis of viability of cells within spheroids, a LIVE/DEAD assay 
(Invitrogen) was used and the manufacturer’s protocol was followed. Medium was 
removed from around the spheroid and replaced with 100 µl PBS containing 8 µM 
each of calcein-AM and ethidium homodimer-1 (EthD-1) as supplied. After 
incubating for 40 minutes in the dark at 37°C the spheroids were washed with PBS 
and fixed in 4% paraformaldehyde (PFA) for 15 minutes before imaging on a 
LSM510 confocal microscope (Carl Zeiss). Viable cells are able to convert 
calcein-AM to calcein by intracellular esterase activity and appeared fluorescently 
green whereas EthD-1 passes into cells with damaged plasma membranes and 
binds nucleic acids, resulting in an increase of a red fluorescence. 
 
2.4 Cell proliferation  
Cell proliferation of MSCs was determined using the colourimetric assay Cell 
Counting Kit-8 (CCK-8, Dojindo, Kumamoto, Japan). Cellular dehydrogenase activity 
reduces the tetrazolium salt WST-8 to give a soluble yellow coloured formazan 
product. The amount of formazan produced is directly proportional to the number 
of living cells. MSCs were seeded at 2 x 104 cells/cm2 into 96 well plates. At days: 0, 
3, 5 and 7, 100 µl of fresh medium was added to each well and inoculated with 10 
µl CCK-8 reagent. The plate was incubated at 37°C for 100 minutes and the 
absorbance read at 450 nm on a plate reader (Dynex Technologies MRX II).  
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2.5 Cell differentiation 
All differentiation reagents were obtained from Sigma-Aldrich unless stated 
otherwise. 
 
2.5.1 Osteogenic differentiation 
For monolayers, cells were seeded at 2 x 104 cells/cm2 and allowed to adhere 
overnight. These adhered cells were designated day 0. Medium was replaced on 
day 0 with DMEM containing osteogenic factors: 5 mM β-glycerophosphate, 10 nM 
dexamethasone and 50 µg/ml L-ascorbic acid-2-phosphate. Cells were cultured up 
to 21 days and the medium was replaced every 3 days throughout. 
 
2.5.1.1 Alkaline phosphatase and von Kossa staining 
To visually determine alkaline phosphatase enzyme activity as a marker of 
osteogenic differentiation, the cells were washed twice in PBS and then stained for 
2 minutes in a solution containing 1 mg/ml Fast red TR and 0.2 mg/ml napthol 
AS-MX phosphate dissolved in 1% N,N-dimethylformamide diluted in 0.1M Tris 
buffer at pH 9.2. von Kossa staining was subsequently used to visualise 
mineralisation. Cells were washed twice and fixed for 5 minutes in 4% PFA and then 
washed once in PBS and again in dH2O. 1% silver nitrate solution was added to the 
cells and incubated for 60 minutes under strong light. After 3 washes in dH2O, 2.5% 
sodium thiosulphate was added for 5 minutes before two final washes in dH2O. 
Staining was visualised using a DM IRB light microscope (Carl Zeiss). 
 
2.5.1.2 Alizarin Red staining 
Cells were washed 3 times in PBS and fixed in 4% PFA for 20 minutes at room 
temperature. The cells were then washed 3 times in PBS and stained with 40 mM 
alizarin red at pH 4.2 for 20 minutes at room temperature. Thorough washing with 
PBS and then tap water whilst the plates were gently shaken removed residual stain 
and the cells were air dried before imaging on a stereo microscope (Stereo lumar, 
Carl Zeiss). Red staining indicated the presence of calcium after osteogenic 
differentiation. Differentiation was quantified by eluting alizarin red stain with 
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100 µl 10% w/v cetylpyridium chloride in sodium phosphate buffer (pH 7). 
Monolayers were incubated for 25 minutes with gentle agitation to release the 
stain. 96 well plates were then read at 570 nm (Dynex Technologies MRX II). 
 
2.5.2 Adipogenic differentiation 
Cells were seeded at 2 x 104 cells/cm2 and allowed to adhere overnight. These 
adhered cells were designated day 0. Medium was replaced on day 0 with DMEM 
containing adipogenic factors: 500 µM 3-isobutyl-1-methylxanthine (IBMX), 1 µg/ml 
insulin, 1 µM dexamethasone, and 100 µM indomethacin. Cells were cultured up to 
21 days and the medium was replaced every 3 days.  
 
2.5.2.1 Oil Red O stain 
A working solution of Oil Red O stain was prepared by first making a 0.5% stock 
solution of Oil Red O in 99% isopropanol. The stock was diluted with dH2O to a 0.3% 
working dilution, left overnight and filtered before use to remove any solid residue. 
Cells were washed once in PBS and fixed for 5 minutes in 4% PFA and then washed 
in dH2O. Cells were then left in 60% isopropanol for 5 minutes followed by a 10 
minute incubation in 0.3% Oil Red O working solution. Cells were then washed once 
in 60% isopropanol to remove excess stain and 3 times in dH2O before counter 
staining for 2 minutes in haematoxylin. Staining was visualised using a DM IRB light 
microscope (Carl Zeiss). In order to quantify the amount of Oil Red O staining on 
monolayers in 96 well plates, the haematoxylin stain was omitted and after cells 
were washed in dH2O, the stain was released from the cells by the addition of 50 µl 
100% isopropanol and incubation for 15 minutes at room temperature. The 
absorbance of Oil Red O in solution was then measured at 450 nm on a microplate 
reader (Dynex Technologies MRX II). 
 
2.5.3 Chondrogenic differentiation 
Cells were seeded at 2 x 105 cells into a universal in 500 µl of media. These cells 
formed pellets overnight and 24 hours after seeding the media was changed to 
serum-free DMEM containing chondrogenic factors: 100 nM dexamethasone, 
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50 µg/ml L-ascorbic acid-2-phosphate, 40 µg/ml L-proline, 1% ITS+1 supplement and 
20 ng/ml TGF-β3 (Peprotech). Control pellets were cultured in identical media with 
the omission of TGF-β3. 
 
2.5.3.1 Alcian blue staining 
The presence of sulphated glycosaminoglycans (GAGs) was detected by alcian blue 
staining to indicate chondrogenic differentiation. Slides were fixed in ice cold 
acetone for 10 minutes; monolayers in 96 well plates were fixed for 5 minutes with 
4% PFA. The fixative was removed and the sample washed twice with dH2O before 
incubation with 1% alcian blue (ph<1) for 30 minutes. Excess stain was removed 
with a 10 second wash in 1% acetic acid followed by rinsing in dH2O. The sample 
was then covered with 10% glycerol and imaged on a DM IRB light microscope or 
stereo microscope (Carl Zeiss). 
 
2.5.3.2 Collagen II staining 
Using the Vectastain ABC kit (Vector Laboratories), the manufacturer’s protocol was 
followed. Briefly, the sections were incubated in freshly prepared 10 mM sodium 
phosphate buffer for 2 minutes followed by 20 minutes in normal serum (provided 
in kit) in buffer. The serum was then removed and the slides were incubated 
overnight at 4°C in primary antibody (rabbit polyclonal anti-collagen II, Abcam, 
ab53047) diluted 1:200. The following day, the sections were washed 3 x 5 minutes 
in buffer and incubated with biotinylated secondary antibody (supplied) for 30 
minutes at room temperature. Meanwhile, the Vectastain ABC reagent was 
prepared by adding equal drops of reagents A and B into buffer and mixing. Once 
the secondary antibody was removed, the slides were washed with buffer for a 
further 3 x 5 minute washes and incubated for 30 minutes with ABC reagent. This 
was removed and the slides washed before a final incubation in peroxidase 
substrate, NovaRED for 10 minutes until the colour developed. The sections were 
rinsed with tap water. The samples were then covered with 10% glycerol and 
imaged on a DM IRB light microscope (Carl Zeiss). 
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2.5.4 Spheroid differentiation 
Spheroids were seeded at 4 x 104 cells per well in 96 well plates and then treated 
the same as the monolayer cultures but with spheroid media. 10 µm sections of 
cryo-preserved spheroids were taken before von Kossa and Oil Red O staining were 
carried out on slides. 
  
2.6 Histology and immunofluorescence 
2.6.1 Monolayers 
13 mm glass coverslips were sterilised in 100% IMS, allowed to dry and placed 
individually into each well of a 24 well plate. Cells were seeded at 1 x 104 per well 
and allowed to adhere overnight.  Staining was carried out in the plate and then the 
coverslips were removed and mounted with Vectashield (Vector Laboratories) onto 
glass slides and sealed with nail polish. 
 
2.6.2 Vibratome sections 
IL-7cre Rosa26-eYFP embryos were mounted in 8% agarose and set at 4°C. The 
embryo was cut into 250 µm thick longitudinal sections collected into PBS using a 
Vibratome (Leica Microsystems). 
 
2.6.3 Tissue sample freezing and cryosectioning 
Mouse bones from IL-7cre Rosa26-eYFP mice for immunohistochemistry were fixed 
in 4% PFA overnight. After fixation, bones were placed in 30% sucrose solution for 
15 minutes at room temperature followed by 15% sucrose overnight at 4°C. Bones 
were then coated with 10% PVA and frozen in cooled isopropanol on dry ice.  They 
were then fully mounted in 10% PVA and stored at -80°C. 
 
Spheroids were embedded in OCT (Tissue-Tek, Sakura Finetek) and frozen by 
immersion in liquid nitrogen and stored at -80°C before sectioning. All samples 
were acclimatised to the chamber temperature (-30°C) of the cryostat (Bright 
Instrument Co.) before 10 µm sections were taken. Sections were collected onto 
Superfrost glass slides (Menzel-Gläser) and stored at -20°C until use. 
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2.6.4 Cytospin preparations 
200 µl of cell suspension at a concentration of 1 x 105 cells/ml was added to the 
cytospin chamber (Cytospin 3, Shandon Scientific) and centrifuged for 5 minutes at 
850 rpm with LO acceleration onto Superfrost slides. Slides were kept at -20°C until 
use. 
 
2.6.5 Haematoxylin and Eosin (H&E) staining  
Sections were fixed in 4% PFA for 5 minutes followed by 2 washes in dH2O. Sections 
were incubated in Mayer’s haematoxylin for 15 minutes and washed thoroughly 
with tap water. Unspecific staining was removed by addition of acid alcohol (0.25% 
hydrochloric acid in 50% ethanol) for 10 seconds followed by washing in dH2O. 
Sections were then incubated in Scott’s tap water for 5 minutes and washed well 
with tap water. One percent eosin was added for 5 minutes followed by thorough 
washing in tap water and then dehydration in 70% IMS for 2 minutes and then 
100% IMS for a further  2 minutes. Sections were then cleared in xylene for 2 
minutes and mounted in DPX mountant. Morphology was observed using a DM LA 
light microscope (Carl Zeiss). 
 
2.6.6 Immuofluorescent staining 
Samples were initially fixed in 4% PFA for 5 minutes at room temperature followed 
by 2 washes in PBS. To detect nestin, an intracellular protein, samples were 
permeabilised at this point with a 10 minute incubation in 0.25% Triton X-100 in 
PBS (PBS-T). Samples were then washed in PBS for 5 minutes several times. All 
samples were then blocked for 30 minutes in PBS containing 10% animal serum of 
the same species that the secondary antibody was raised in. Primary antibodies 
(Table 2.1) were added at the appropriate dilution in PBS and incubated in a 
humidified chamber overnight at 4°C. The primary antibody was washed off the 
next day with 3 x 5 minute PBS washes. If required, samples were incubated for 45 
minutes at room temperature with a conjugated secondary antibody. The washing 
steps were repeated.  Samples were counter-stained with DAPI for 5 minutes. 
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Negative controls were carried out by replacing the primary antibody with the 
appropriate immunoglobulin G (IgG). Samples were mounted with Vectashield 
(Vector Laboratories) and imaged using a LSM710 invert confocal microscope (Carl 
Zeiss). In order to quantify YFP expressing cells, 3 random areas of interest per 
region (central bone marrow, endosteum etc) were counted. Cells were counted 
manually and expressed as a percentage of total nucleated cell number which were 
counted using DAPI stain. n = 5 mice. 
 
Target Clone Conjugate Dilution Supplier 
Rat anti mouse 
Nestin 
polyclonal purified 1:800 abcam 
GFP polyclonal Alexa Fluor 488 1:500 Invitrogen 
Rabbit anti 
mouse CD169 
MOMA-1 purified 1:50 AbDserotec 
VCAM-1 429 APC 1:200 Invitrogen 
Rat polyclonal Alexa Fluor 647 1:500 Invitrogen 
Rabbit polyclonal Cy3 1:800 Sigma-Aldrich 
Table 2.1 Antibodies for immunofluorescent staining 
Primary antibodies used on mouse tissue were either directly conjugated or detected with 
an appropriate secondary antibody that detected the species that the primary was raised 
in.  
 
2.6.7 Ki67 staining 
Proliferation was analysed by Ki67 immunofluorescent staining. Primary Ki67 
antibody was used diluted at 1:250 (ab15580, Abcam) whilst the secondary; Alexa 
Fluor 488 goat anti-rabbit was used at 1:5000 (A11008, Sigma-Aldrich). Cells were 
counter stained for 5 minutes in DAPI (1 µg/ml). 
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2.6.8 F4/80 staining 
The presence of mature macrophages was determined using marker F4/80 using 
immunofluorescence described in section 2.6.6 with some modification.  The 
antibody was Alexa Fluor 647 conjugated (clone BM8, ebioscience) and used at a 
concentration of 1:200 for 45 minutes at room temperature rather than overnight. 
Slides were mounted in Prolong gold (Invitrogen) and imaged using a LSM510 invert 
confocal microscope (Carl Zeiss). 
 
2.6.9 Whole mount staining 
For embryo sections taken on the Vibratome (section 2.6.2), immunostaining was 
extended. Sections were blocked in 10% rabbit serum for 1 hour at room 
temperature followed by antibody staining with Alexa Fluor 647 conjugated 
anti-GFP and Cy3 labelled anti-SMA (each 1:1000; Invitrogen) in 400 µl volume in a 
24 well plate. The sections were incubated for 72 hours at 4°C followed by 24 hours 
of washing in PBS, replacing the PBS 3 times throughout the day. Sections were 
then fixed for 20 minutes at room temperature in 4% PFA followed by several PBS 
washes. Whole mounts were transferred to glass pots and covered in progressively 
stronger methanol solutions (25, 50, 75, and 100%) for 15 minutes each at room 
temperature. A final 100% methanol incubation for 1 hour completed their 
dehydration. A 50:50 solution of methanol: BABB (benzyl alcohol: benzyl benzoate; 
Sigma-Aldrich) was added for 15 minutes and then replaced with BABB for a further 
2 hours to clear the sections. Sections were mounted in BABB in thick metal slides 
sealed between glass coverslips and viewed with a LSM510 confocal microscope 
(Carl Zeiss). 
 
2.7 Flow cytometry 
2.7.1 Flow cytometric analysis of human MSC surface antigen expression. 
Isolated MSCs from human donors were analysed to confirm the expression of a 
panel of stromal cell surface markers commonly used to describe MSCs. Antibodies 
were previously titrated for optimal dilution for use by flow cytometry.  Media was 
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removed from cultured MSCs which were then washed twice with PBS and 
harvested using FACS buffer (buffer A, see section 2.1.2) at 37°C. Cells were 
collected by centrifugation at 450 rpm for 5 minutes and the supernatant removed. 
Approximately 5 x 104 cells for each marker were resuspended in separate 
eppendorf tubes in 100 µl FACS buffer containing the appropriate dilution of 
primary antibody (Table 2.2) and incubated on ice for 30 minutes. Cells were then 
washed twice with 1 ml FACS buffer and centrifuged at 450 rpm for 5 minutes. Cells 
incubated with purified primary antibodies were incubated further for 20 minutes 
on ice in the dark with the appropriate dilution of secondary antibody followed by 2 
FACS buffer washes. All samples were then re-suspended in 400 µl FACS buffer and 
kept on ice before processing on a cyAn flow cytometer and analysed using Summit 
software (v4.3; Beckman Coulter). 1 x 104 events per sample were collected. 
 
Target Clone Conjugate Dilution Supplier 
CD45 HI30 FITC 1:100 Caltag labs 
CD166 3A6 PE 1:50 BD Pharmingen 
CD44 G44-26 FITC 1:10 BD Pharmingen 
CD90 ebio5E10 PE-Cy5 1:100 eBioscience 
CD105 SN7 APC 1:100 eBioscience 
CD29 MAR4 Purified 1:100 BD Pharmingen 
CD73 AD2 Purified 1:100 BD Pharmingen 
CD34 AC136 FITC 1:50 Miltenyi Biotec 
Goat anti-
mouse 
polyclonal Alexa Fluor 488 1:200 Invitrogen 
Table 2.2 Antibodies for human MSC flow cytometry 
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2.7.2 Flow cytometric analysis of murine stromal cell surface antigen expression. 
Following the protocol in section 2.7.1, stromal cells isolated from murine bones 
were analysed for cell surface markers in Table 2.3. Cells were analysed fresh or 
from cultured cells. 
 
Target Clone Conjugate Dilution Supplier 
F4/80 BM8 647 1:200 ebioscience 
Ter-119 TER-119 PE 1:100 ebioscience 
CD73 eBioTY/11.8 PE 1:100 ebioscience 
CD90.2 30-H12 APC 1:100 ebioscience 
CD45 30-F11 Biotin 1:200 ebioscience 
CD127 (IL7Rα) A7R34 PE 1:50 ebioscience 
CD54 (ICAM-1) YN1/1.7.4 PE 1:1000 ebioscience 
CD106 (VCAM-1) 429 647 1:1000 ebioscience 
CD105 MJ7/18 PE 1:100 ebioscience 
Hamster anti 
mouse Gp38 
eBio8.1.1 purified 1:800 ebioscience 
Streptavidin Not 
applicable 
Pacific blue 1:400 Invitrogen 
Goat anti 
hamster 
Polyclonal 647 1:500 Invitrogen 
Table 2.3 Antibodies for mouse MSC flow cytometry 
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2.7.3 MACs depletion of cells 
Freshly harvested murine bone marrow cells were first depleted for CD45 cells by 
Magnetic affinity cell sorting (MACS) flow cytometry. Briefly, red cells were lysed in 
ACK buffer (0.15M, ammonium chloride [BDH lab supplies], 1 mM sodium hydrogen 
carbonate [Fisher], 0.1 mM EDTA [GIBCO] in dH20); remaining cells were blocked for 
10 minutes with Fc block (1:1000) and incubated with primary biotin conjugated 
CD45 antibody (1:200). After 2 PBS washes, cells were incubated with anti-biotin 
MACS microbeads (20 µl per 107 cells) before magnetic separation through a MACS 
column. The depleted cell fraction was then labelled for analysis.  
 
2.7.4 Identification of HSCs 
An antibody lineage cocktail (lin), c-kit and sca-1 (Table 2.4) were used to identify 
HSCs within the population of HPCs by flow cytometry (see section 2.7). 
 
Target Clone Conjugate Dilution Supplier 
c-kit 2B8 PE 1:100 ebioscience 
Sca-1 D7 APC 1:100 ebioscience 
lineage markers: 
(CD3, CD45R, 
CD11b, Ter-119, 
Gr-1) 
 
145-2C11, 
RA3-6B2, 
M1/70, TER-
119, RB6-8C5 
Biotin 1:200 ebioscience 
Streptavidin Not 
applicable 
Pacific blue 1:400 Invitrogen 
Table 2.4 Antibodies to detect HSCs by flow cytometry 
 
2.7.5 Cell sorting by flow cytometry 
To purify the YFP expressing stromal cells from murine line IL-7cre Rosa26-eYFP, 
cells were sorted and collected on a MoFlo sorter (Beckman Coulter). Isolated cells 
from bone marrow and bone digests were incubated in 1 ml ACK buffer to lyse any 
red blood cells. Cells were then washed in buffer A (see section 2.1.2) and filtered 
through a 70 µm cell strainer. Cells were incubated with APC conjugated CD45 at 
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1:1000 dilution for 20 minutes on ice. Cells were washed twice in buffer A and 
re-suspended at a concentration of 1 x 107 cells/ml. Only cells that were CD45 
negative were collected to remove haematopoietic cells from the sort  and YFP 
positive and negative cells were then collected separately into tubes of 
DMEM + 20% FBS. Tubes of collected cells were centrifuged for 20 minutes at 450 
rpm. 
 
2.7.6 IL-7 binding assay  
Binding of biotinylated recombinant IL-7 to human MSCs was detected using a 
Fluorokine kit (R&D systems) following manufacturers’ guidelines. Briefly, cells were 
removed from adherent culture with buffer A, centrifuged at 500g for 5 minutes 
followed by 2 x PBS washes and re-suspension in PBS at a final concentration of 4 x 
106 cells/ml. Cells were incubated with 10 µl biotinylated IL-7, a negative control 
protein (soybean trypsin inhibitor), both provided in the kit, or no protein for 45 
minutes at 4°C. In a separate tube, 10 µl biotinylated IL-7 was incubated with 20 µl 
of an anti-IL7 blocking antibody to confirm specificity of the test. Cells were then 
stained with avidin-FITC for 30 minutes at 4°C in the dark, washed in the RDF1 
buffer (a buffered saline and protein solution) provided and analysed by flow 
cytometry. 
 
2.8 Gene expression analysis 
All reagents were from Invitrogen unless stated otherwise. 
 
2.8.1 RNA extraction 
RNA was extracted from cells using TRIzol reagent following the manufacturer’s 
protocol. For adherent cell cultures, 500 µl TRIzol reagent was added directly to a 
25cm2 cell culture flask to lyse the cells. For cells cultured in 3D, the spheroids were 
first digested as described in section 2.3.3 and centrifuged at 450 g for 5 minutes to 
pellet the cells. 500 µl TRIzol reagent was added to lyse the cells and then passed 
through a pipette several times. All samples were then incubated at room 
temperature for 5 minutes and treated in the same way. 200 µl chloroform (Sigma-
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Aldrich) per 1 ml of TRIzol was added, vortexed for 15 seconds and incubated at 
room temperature for 5 minutes. Samples were then centrifuged at 12000 g for 20 
minutes at 4°C. The RNA contained in the upper aqueous phase was removed to a 
fresh tube and precipitated using 500 µl of 100% isopropanol per 1 ml of TRIzol 
initially used. Samples were incubated at 4°C for 30 minutes and then centrifuged 
at 12000 g for 15 minutes at 4°C to pellet the RNA. The isopropanol was removed 
and the RNA washed with 1 ml 75% ethanol and centrifuged at 12000 g for 5 
minutes. The supernatant was removed and the pellet allowed to air dry before 
being re-suspended in 12 µl of nuclease free H20.  RNA concentration was 
measured on a NanoDrop spectrophotometer (Thermo Scientific). 
 
2.8.2 cDNA synthesis 
First strand cDNA was synthesised from isolated mRNA using Superscript II reverse 
transcriptase. Briefly, reactions were carried out in duplicate for each sample with 1 
µl oligo dt, 1 µg RNA and 1 µl 10 mM dNTPs  (ATP, TTP, GTP, CTP) made up to 12 µl 
total reaction volume with nuclease free water. Samples were incubated at 65°C for 
5 minutes followed by 2 minutes chilled on ice.  Seven microlitres of a reaction mix 
containing 1st strand buffer, 0.1M DTT and nuclease free water was added to each 
sample and incubated for 2 minutes at 42°C.  One microlitre of Superscript II was 
then added to half the samples and 1 µl nuclease-free water was added to the 
duplicates to act as a no reverse transcriptase control (no RT control). Primer 
extension occurred during a 1 hour incubation at 42°C followed by 15 minutes at 
72°C to inactivate the reverse transcriptase. cDNA was diluted 1:2 after synthesis 
with nuclease-free water and stored at -20°C until subsequent PCR amplification. 
  
2.8.3 Reverse transcriptase polymerase chain reaction (RT-PCR) 
PCR amplification of specific genes of interest was carried out using 2.5 µl cDNA 
template in a 25 µl total volume reaction containing the following components: 
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Component Amount (µl) 
Template cDNA 2.5 
10 x PCR buffer  2.5 
50 mM MgCl2 0.75 
10 mM dNTPs  0.5 
Forward primer (10 µM) 0.5 
Reverse primer (10 µM) 0.5 
Taq DNA polymerase  0.25 
Nuclease-free water 17.5 
Table 2.5 Standard PCR reaction components 
 
PCR amplification for GAPDH was carried out for each sample of cDNA produced to 
confirm successful synthesis. A water control was run for each gene within a PCR. 
Primers (Table 2.6) were designed using the NCBI Primer BLAST program, produced 
by Sigma-Aldrich and optimised using human T cell RNA. 
 
Gene Forward Primer Reverse Primer Product 
size 
m/h 
GAPDH 
GGTGAAGGTCGGWGTCAACGG GGTCATGAGYCCTTCCACGAT 514 
h IL2Rγ CCTGCTGGGAGTGGGGCTGA CCCGTGGGTCCTGGAGCTGA 359 
h JAK1 ATGGCGTCTGTGTCCGCGAC ACTGGCCTGCACCGGCTTTC 478 
h STAT5B TCAGTGGATCCCGCACGCACA TGGCCAACTTCCAGGCTTCACG 379 
h JAK3 TCCGGGAGGCGCAGACACTT ATAGCGGCACAGCTCCACGC 437 
Table 2.6 PCR primers 
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Samples were run on a DNA thermocycler (G-Storm) with the following conditions: 
 
Step   Process Temperature °C Time 
I Initial denaturation 94 3 minutes 
II Denaturation 94 10 seconds 
 Annealing 58 (GAPDH) or 62 20 seconds 
 Extension 72 1 minute 
III Repeat step II   30 times 
IV Final elongation 72 5 minutes 
V Hold 12 - 
Table 2.7 PCR conditions 
 
 
2.8.4 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to verify the expected size of the PCR 
products. 1.5% agarose gels were made with TAE buffer (Tris, EDTA, acetic acid) 
with the addition of 5 µl SYBR safe to allow visualisation of the gel under UV light. 
The samples were run at 120v for approximately 45 minutes alongside a molecular 
weight marker (Hyperladder IV; Bioline). Images were acquired using an 
AlphaImager 2000 gel documentation system (Protein Simple). 
 
2.8.5 Quantitative real time polymerase chain reaction (qRT-PCR) 
Quantitative real time polymerase chain reaction (qRT-PCR) was used to measure 
the relative expression of genes of interest and was carried out in triplicate in a 96 
well plate for each sample using reactions containing the components in Table 2.8. 
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Component Amount (µl) 
Template cDNA 5  
Sybr green PCR master mix (Applied Biosystems) 12.5 
Forward primer (10 µM) 1 
Reverse primer (10 µM) 1 
Nuclease free water 5.5 
Table 2.8 Standard qRT-PCR components 
 
Plates were covered with an adhesive lid and centrifuged at 3600 rpm for 1 minute 
50 seconds before processing on an ABI7300 Prism System Detection System 
(Applied Biosystems) with the following cycle conditions: 
 
Step   Temperature (°C) Time 
I 50 2 minutes 
II 95 10 minutes 
III 95 15 seconds 
 60 1 minute 
IV Repeat step III 40 times 
Table 2.9 qRT-PCR conditions   
 
Results were analysed with the ABI7000 prism software based on the change in 
cycle threshold (ΔΔct) method. Target genes were normalised to the housekeeping 
gene and reported as relative expression as compared to the appropriate day 0 
control. Controls were conducted for each primer set using nuclease free water and 
no reverse transcriptase template controls were run for the housekeeping gene. 
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Gene Forward Primer Reverse Primer 
h RPS27A TGGATGAGAATGGCAAAATTAGTC CACCCCAGCACCACATTCA 
m HPRT CATCTTCTCAAAATTCGAGTGA TGGGAGTAGACAAGGTACAAC 
h IL-7 AGCCACGCCGTAGTGTGTGC TCCGCGGAGTTGCCGAGTCT 
m IL-7 CCTGTGACAGCCTTTCTGAAGA AGGATAGGGAGCCTCAGACATAGG 
h Nestin CCTGTGACAGCCTTTCTGAAGA AGGATAGGGAGCCTCAGACATAGG 
h IL-7Rα CCTGCTTAGCCTTGGGACTACA GGGTTCAATGTCAGGATTCCA 
m IL-7Rα CCCACAGAGAAAACTACGACCAA ACTCGCTCCAGAAGCCTTTG 
h FABP4 TGTGCAGAAATGGGATGGAAA CGCATTCCACCACCAGTTT 
h PPARg GGCTTCATGACAAGGGAGTTTC AACTCAAACTTGGGCTCCATAAAG 
h Runx2 AGTGATTTAGGGCGCATTCCT GGAGGGCCGTGGGTTCT 
h ALP GGGAACGAGGTCACCTCCAT TGGTCACAATGCCCACAGAT 
h Sox 9 TTCCGCGACGTGGACAT TCAAACTCGTTGACATCGAAGGT 
h Collagen II TTGCCTATCTGGACGAAGCA CGTCATTGGAGCCCTGGAT 
h IL-6 CCGGGAACGAAAGAGAAGCT GCGCTTGTGGAGAAGGAGTT 
Table 2.10 qRT-PCR primers 
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2.8.6 Primer optimisation 
Primers were designed using ABI Primer Express software (Applied Biosystems) and 
are shown in Table 2.10. Newly designed primers were tested for equal qRT-PCR 
efficiency compared to the housekeeping gene by analysing 10 fold serial dilutions 
of cDNA by absolute quantification. In this example, cDNA from primary human T 
cells was used as the control sample to measure the efficiency of IL-7Ra primers. 
Reactions were carried out in triplicate and processed with the same conditions as 
for relative quantification (Table 2.9) with the addition of a dissociation step after 
step IV of 15 seconds at 95°C, 20 seconds at 60°C and a further 15 seconds at 95°C. 
Plots were generated using the ABI software of the threshold cycle (Ct) value 
against the log of the cDNA concentration (Figure 2.1 A). For primers to be 
acceptable for use and indicate equal efficiency the slope of the standard curve 
should be similar (Figure 2.1 C) and there must also only be a single peak in the 
dissociation curve (Figure 2.1 B). IL-7R was compared to the housekeeping gene 
ribosomal protein S27a (RPS27a).  
 
2.9 Statistics 
Data are expressed as mean ± SD. After testing for normal distribution 
(Kolmogorov-Smirnov normality test), control and treated or differentiated groups 
were compared using an independent samples t-test (for data with equal variance 
measured by a Levene’s test). Statistically significant results were considered to 
have a p value < 0.05 and were annotated on graphs according to the following 
rule; p ≤ 0.05 not significant (ns), p < 0.05 *, p < 0.01 **, p < 0.001 ***. 
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Figure 2.1 Optimisation of qRT-PCR primers 
IL-7Rα primers were optimised using T cell RNA. Plots were generated of Ct values of serial 
dilutions of cDNA (A).  No product was observed when RT was replaced with H20 (no RT 
control).  A single dissociation curve indicates a specific PCR product from all samples (B) 
and a standard curve produced from ct values and the log of DNA dilutions shows the same 
slope between the target of interest and the housekeeping gene (C). 
 
 
A 
C 
B 
IL7Rα 
RPS27A 
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3 Fate tracing of IL-7 expressing cells in the mouse 
bone marrow microenvironment 
 
3.1 Introduction 
 
IL-7 is a cytokine originally identified for its ability to stimulate B lymphopoiesis 
(Namen et al, 1988). Additionally, IL-7 is known to have an essential role in T cell 
survival and proliferation (Morrissey et al, 1991). These two fundamental roles of 
IL-7 are the best understood, although the detailed mechanisms of their regulation 
are still being investigated.  
 
Investigations into the involvement of IL-7 in the murine system are hampered by 
the low levels of protein and transcript expression of endogenous IL-7 and the 
consequential lack of success of its detection by traditional methods such as 
immunohistochemistry (Mazzucchelli et al, 2009). To overcome this problem, 
several bacterial artificial chromosome (BAC) transgenic mice have been developed 
in which reporter genes were inserted into the IL-7 locus. Depending on the 
construct used, IL-7 reporter expression can then be assessed directly by 
fluorescent microscopy, using antibody staining or further crossing with reporter 
mice of Cre recombinase activity (Reviewed by Kim et al, 2011).  
 
The Cre/lox system has been widely employed to manipulate gene expression in a 
tissue or temporal specific manner. Originally identified in bacteriophage, the 
recombination mediates circularisation and DNA replication during bacterial 
division. Cre recombinase is an enzyme that catalyses recombination between two 
loxP sites (locus of X-over of P1). These are specific 34-base pair (bp) sequences 
consisting of an 8-bp core sequence, where recombination takes place, and is 
flanked by two 13-bp inverted repeats. The recombination excises the DNA 
sequence between the loxP sites and can be used to produce gene deletions, or in 
combination with fluorescent proteins, to track Cre activity, as in the case of IL-7Cre 
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rosa26-eYFP mice. LoxP sites and the cre gene are not found in mice and are 
therefore introduced to produce the transgenic strains (Sauer, 1998). Detection of  
Cre mediated IL-7 reporter is located in the thymus, lymph nodes, bone marrow, 
liver and small intestines of IL-7Cre rosa26-eYFP mice (Repass et al, 2009).   
 
IL-7 is known to be expressed by stromal cells in the bone marrow but the precise 
identification of these cells and their functional role are still to be described 
adequately. Overall, IL-7 has a negative impact on bone as knockout studies in mice 
report an increased bone mass due to a lack of IL-7 stimulated T cell activation and 
subsequent increased osteoclast number (Roland et al, 2011).  Oestrogen is a 
critical regulator of bone mass and is involved in promoting survival of osteoblasts 
(Gohel et al, 1999) and suppressing osteoclast activity (Manolagas, 2000). 
Oestrogen deficiency leads to accelerated bone loss or osteoporosis. In order to 
provide effective treatment strategies for osteoporosis the mechanisms of this 
osteoclastogenesis must be understood. Ovariectomy induces oestrogen deficiency 
which is accompanied by bone loss. Interestingly, IL-7 production is increased in 
these mice and enhances the production of osteoclast precursors in vitro (Sato et 
al, 2007).  Neutralisation of IL-7 in vivo prevented the ovariectomy induced bone 
loss by inhibiting osteoclastogenesis and stimulating bone formation, suggesting 
that IL-7 plays a role in the balance between bone formation and resorption in 
these conditions (Weitzmann et al, 2002). Together, these data suggest that IL-7 
production is interlinked with the bone remodelling process and by extension, with 
haematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs).  
 
3.2 Aims 
In this chapter IL-7Cre Rosa26-eYFP BAC transgenic mice were used to determine 
the localisation of YFP positive cells in bone and bone marrow. Briefly, the activity 
of Cre recombinase under the control of IL-7 regulatory elements in IL-7Cre 
Rosa26-eYFP BAC transgenic mice leads to the genetic marking, by YFP expression, 
of cells that are either currently expressing IL-7, have previously expressed IL-7 or 
have been derived from a precursor that at one point expressed IL-7. These cells 
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were isolated and further characterised in order to gain a better understanding of 
the stromal cells that express IL-7.  
 
3.3 Results 
3.3.1 Localisation of YFP expressing cells 
In order to define the location of YFP expressing cells from IL-7Cre Rosa26-eYFP 
mice, frozen sections of bones were immunostained with an anti-GFP antibody in 
order to amplify the YFP signal and counter stained with DAPI (see section 2.1.7). 
Serial image sections were acquired using confocal microscopy and are presented 
as a stacked projection of roughly 30-40 µm tissue.   
 
YFP expressing cells were found throughout the central bone marrow (Figure 3.1) 
and represented approximately 4% of the total bone marrow cell population (Table 
3.1). In some cases the YFP+ cells were arranged in distinct patterns and associated 
with vessels within the bone marrow (Figure 3.2, B). 
  
Additionally, YFP expressing cells were located in areas of cartilage such as articular 
chondrocytes at joint surfaces and hypertrophic chondrocytes in the growth plate 
of the bones that were identified by their characteristic appearance and location 
(Figure 3.1 A and B). YFP+ cells were also present at the joint interface in the 
cartilaginous triangular meniscus extending into the synovium (Figure 3.1 B).  
YFP expressing cells were also found closely associated with the bone. YFP+ cells 
were found lining the bone at the junction with the bone marrow or endosteum, 
and particularly around trabeculae. A proportion of the osteocytes within the bone 
were YFP+ (Figure 3.1 D). YFP expressing cells were also detected at the periosteum 
and in skeletal muscle attached to the bones (Figures 3.1 and 3.2 D). 
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Figure 3.1  Detection of YFP expressing cells in the adult mouse femur 
Representative images of 10 µm sections of snap frozen femur show YFP expressing cells 
(green) at the growth plate (A), joint (B), bone marrow (C) and endosteum (D). Slides were 
counter stained with DAPI (blue). bm, bone marrow.  
  
YFP only DAPI and YFP 
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Figure 3.2 Detection of YFP expressing cells in the adult mouse tibia 
Representative images of 10 µm sections of snap frozen tibia show YFP expressing cells 
(green) are  located around trabeculae (A) and vessels (v, B), are osteocytes contained 
within bone (C), are at the endosteum (D) are articular chondrocytes (E) and hypertrophic 
chondrocytes (F, arrows). YFP is not expressed in all cells in which it is present. Circles in C 
and F indicate YFP negative osteocytes and chondrocytes, respectively.  
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Figure 3.3 Detection of YFP expressing cells in the adult mouse sternum 
Representative images of 10 µm sections of snap frozen sternum show YFP expressing cells 
(green) in regions of bone marrow and cartilage (A-D). Slides were counter stained with 
DAPI (blue). bm, bone marrow. 
 
DAPI and YFP YFP only 
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Figure 3.4 Detection of YFP expressing cells in the adult mouse calvaria 
Representative images of 10 µm sections of snap frozen calvaria show YFP expressing cells 
(green) in the bone marrow and periosteum (dotted lines, A-C). Slides were counter stained 
with DAPI (blue). bm, bone marrow. 
 
 
 
YFP only DAPI and YFP 
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HSCs have been reported to be located at the endosteum. If YFP expression 
demarcates cells involved in the HSC niche we might expect their occurrence to 
increase within this area. The proportion of approximately 4% of YFP+ cells 
increased slightly to between 5% and 6% in the long bones in the 20 µm endosteal 
region next to the bone, compared to the total area of the bone marrow. 
Additionally, the cells in this area appeared morphologically different as they were 
much more elongated than those found in the central marrow and therefore, the 
endosteum appeared a defined location for the presence of these cells (Figure 3.2, 
D). 
 
Each of the cell types found to express YFP; stromal cells, chondrocytes and 
osteocytes arise from the differentiation of MSCs. As YFP expression is inherited, 
reporter expression allows a level of lineage analysis and indicates the possibility of 
an IL-7 expressing MSC progenitor that gave rise to these mature cells. The location 
of some of the remaining YFP expressing cells suggests that they may be also be 
differentiated cells of mesenchymal lineage, such as those lining the endosteum 
which could potentially be osteoprogenitors and osteoblasts. Interestingly, YFP was 
not universally expressed within each cell type identified and therefore if an IL-7 
expressing MSC existed, it is likely to only represent a subset of the MSC population 
that differentiate and contribute to the skeletal lineages. Chondrocytes and 
osteocytes were identified by their location and histological appearance and 
approximately 60% of articular chondrocytes and 10% of osteocytes were YFP+ in 
femoral sections (Table 3.1). Other cell types such as stromal cells contained in the 
central marrow could not be identified without further staining but it is probable 
that there were also YFP- cells in this fraction.  
 
As bones may develop by the processes of either endochondral or 
intramembranous ossification, the long bones and the sternum were harvested to 
represent these processes respectively to assess any difference in YFP appearance. 
The features of YFP expression and localisation within each bone were common to 
all adult femurs, tibiae (Figure 3.2) and sterna (Figure 3.3) analysed as YFP was 
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detected in chondrocytes, osteocytes and in marrow cells. Slight differences in the 
proportion of each cell type that were YFP+ was exhibited in bones from different 
sources. Hypertrophic chondrocytes in the sternum were more frequently YFP+ than 
in long bones. 30% of hypertrophic chondrocytes in the sternum were YFP+ 
compared to only 14% in the femur and 4% in the tibia were YFP+. Calvarial bones 
of the skull were also analysed as an example of bones that form by 
intramembranous ossification. Calvarial bones displayed a similar proportion of 
YFP+ cells in the bone marrow but the distinction of the endosteal region was 
difficult as the thin width of the tissue meant this also overlapped with the central 
marrow (Figure 3.4). 
 
Cell/Tissue Femur Tibia Sternum Calvaria 
Central marrow 
 
3.9 3.9 5.2 3.4 
Endosteal region 5.4 6.0 8.5 2.2 
Articular chondrocyte 60.0 54.0 11.1 nd 
Hypertrophic chondrocyte 13.8 3.6 31.0 6.9 
Osteocyte 9.5 22.9 nd 7.6 
Table 3.1 Distribution of YFP positive cells in bone  
Slides were manually scored for the number of YFP+ cells per section as a percentage of 
total nucleated cells as stained by DAPI. nd, not determined. 4-7 sections were scored, n=3 
mice. Sections were demarcated into appropriate regions of interest including marrow, 
chondrocytes or bone and therefore, in excess of 1000 cells may be counted, in the case of 
bone marrow, or as few as 50 osteophytes in regions of bone. 
 
In order to determine the presence of YFP+ cells in embryonic tissue, three E17.5 
embryos were examined. YFP expression was not as widespread as in the adult 
tissues.  Whole mount staining of 250 µm vibratome sections detected a small 
number of YFP+ cells in the foot tissue (Figure 3.5). These cells were clustered 
together and showed an elongated, stromal like morphology. No YFP positive cells 
were detected in the sterna of the embryos (Figure 3.5, B). 
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Figure 3.5 YFP expressing cells in embryonic tissue 
Representative images of whole mount staining of 250 µm vibratome sections of E17.5 legs 
(A-C) and sterna (D). YFP expressing cells (turquoise, arrows) were detected in the toes and 
feet. Slides were stained with α-SMA (red) for visualisation. Dotted lines show tissue edge. 
B 
C 
D 
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3.3.2 Localisation of YFP+ cells with other niche cells   
Femoral sections were further analysed for the presence of CD169 and CD146 in 
order to assess the relationship of YFP+ cells with other cells that have been 
proposed as key niche components.  
 
Bone marrow macrophages identified by CD169 expression are reported to have a 
key role in retaining HSCs in their niche by acting specifically on nestin+ MSCs (Chow 
et al, 2011; Tormin et al, 2011). Lymph nodes were used as a staining control and 
CD169+ cells could be clearly detected in the periphery of the nodes (Figure 3.6 A). 
CD169+ cells were found throughout the bone marrow of IL-7 mice (Figure 3.6 B and 
C) in a distribution consistent with that reported in the literature. CD169+ cells were 
not detected at the growth plate or joint areas of the long bones (Figure 3.6 D). In 
sternal sections, CD169+ cells were also distributed throughout the bone marrow 
and not at the cartilaginous regions (Figure 3.7). CD169+ cells were often in close 
proximity to YFP+ cells due to this frequency and localisation. However, no 
co-localisation with YFP was observed. 
 
It is reported that CD146 is expressed on human MSCs capable of reconstituting the 
murine HSC niche and are located perivascularly in the bone marrow (Sacchetti et 
al, 2007). CD146+ cells has not been reported on murine MSCs but is widely 
expressed on endothelial cells which are considered a component of the HSC niche 
(Schrage et al, 2008). Therefore, CD146 was examined in IL-7Cre tissue sections. 
CD146+ cells were detected sporadically in the central bone marrow (Figure 3.8 
A-C). Consistent with reports in human bone marrow  that CD146 is infrequently 
detected in cells lining the bone (Tormin et al, 2011), immunostaining presented 
here also demonstrate CD146 to be localised away from the endosteal region and 
not detected at the joint interface (Figure 3.8 C). No YFP+ cells were stained with 
CD146 and although CD146 was initially detected in femoral sections, subsequent 
staining of additional sections failed to identify any further staining. Further work 
would be required to confirm the presence of CD146 in bone marrow. 
 
Chapter 3. Fate tracing of IL-7 expressing cells 
 
101 
 
Vascular cell adhesion molecule 1 (VCAM-1) may be found on bone marrow stromal 
and endothelial cells as well as B cells and macrophages. VCAM-1 has been shown 
to be expressed on murine nestin+ MSCs and is important in HSC maintenance 
(Mendez-Ferrer et al, 2010). Staining of IL-7 bone sections detected VCAM-1+ cells 
throughout the bone marrow, predominantly in the central marrow with fewer cells 
towards the diaphysis. VCAM-1+ was not expressed in chondrocytes. An average of 
56% of the central marrow YFP+ cells also expressed VCAM-1 (Figure 3.9, n=4). 
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Figure 3.6 YFP expressing cells are in close proximity to CD169+ cells 
Lymph node (A) sections show expected CD169 distribution as a positive staining control. 
Inset image is antibody control.  
Representative images of 10 µm sections of snap frozen femur show CD169+ cells (red) 
close to YFP expressing cells (green) in the bone marrow (B-C) but not at the growth plate 
(D).   
CD169 CD169 and YFP merge 
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Figure 3.7 YFP expressing cells are close to CD169+ cells in the adult sternum 
CD169+ cells (red) were detected close to YFP expressing cells (green) in the bone marrow 
(A, C) but not at the growth plate or cartilage (A, B) in adult sternum sections. bm, bone 
marrow. 
 
CD169 and YFP merge CD169 
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Figure 3.8 CD146+ cells do not co-localise with YFP expressing cells 
CD146+ cells (red) were detected within the bone marrow of adult mouse femurs (A-C) but 
not at the joints (D). No co-localisation of CD146 with YFP expressing cells was detected.   
 
 
 
CD146 and YFP merge  CD146  
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Figure 3.9 VCAM-1 detection on YFP expressing cells 
YFP expressing cells (green) within the bone marrow also express VCAM-1 (blue, arrows). 
VCAM-1 was detected in the bone marrow (B-D) but not in areas of cartilage (A) or bone 
(B). bm, bone marrow. 
  
DAPI and YFP merge DAPI only 
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3.3.3 Localisation of nestin 
The distribution of YFP+ cells observed in this study is strikingly similar to that of 
differentiated cells derived from nestin+ MSCs described by Mendez-Ferrer et al. 
(2010). They identified nestin+ MSCs to be essential haematopoietic stem cell niche 
constituents in the bone marrow. Nestin+ MSCs were located near to HSCs in vivo 
and their depletion led to a reduction in number and activity of HSCs in the bone 
marrow. Due to the Cre recombinase YFP mechanism in the IL-7 mice, it is possible 
that the cells expressing YFP in our mouse model are doing so because they are 
descended from a common progenitor that expressed IL-7 and that these original 
IL-7+ cells are MSCs. If so, they may represent the same population of MSCs 
identified by nestin expression or a discrete MSC sub-population. Therefore, nestin 
staining was performed on IL-7Cre Rosa26-eYFP sections to determine if a subset of 
YFP cells would also express nestin. Nestin was in fact only found in one set of 
sections from one mouse and staining did not co-localise with YFP. Nestin 
expression was found in femoral and calvarial sections (Figure 3.10 D and B). Nestin 
was not detected in regions of cartilage or those densely populated with 
chondrocytes. No other mice (n=4) showed nestin expression in the bone marrow. 
Mouse brain was used as a positive control and nestin staining was detected (Figure 
3.10 A). Whilst nestin may be a marker for MSCs and could be detected in IL-7 
mouse tissue it was not detected at a similar frequency to that reported in the 
literature or in a distribution pattern that may be expected of bone marrow MSCs. 
This may be due to the sensitivity of methods of detection in comparing 
immunostaining to a reporter mouse line where GFP expression was under the 
regulatory elements of the nestin promoter.  
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Figure 3.10 Nestin expression in adult mouse tissue 
Nestin (red) expression was detected in adult mouse brain sections (A) and sporadically in 
bone marrow of calvaria (B) femurs (D). Co-localisation with YFP expressing cells (green) 
and detection in cartilaginous areas (C) was not detected. 
  
Nestin only Nestin, DAPI, YFP merge 
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3.3.4 Isolation of YFP expressing cells 
There is still a lack of clarity about the location of the HSC niche. Controversy 
surrounds the distinction of endosteal and vascular sites as separate niches but 
immunohistology has located HSCs in both regions (Kiel et al, 2005). In accordance 
with this, the supportive cellular components of the niche are presumed to be in 
close physical contact with the HSCs. Analyses of serial bone marrow flushes and 
enyzymatically digested bone have supported the suggestion of an endosteal niche, 
as HSCs with higher differentiation potential have been identified nearest the bone 
(Haylock et al, 2007). Human studies have also reported an improved extraction of 
MSCs using collagenase digestion of femoral heads (Jones et al, 2010). In order to 
assess the distribution and potential of YFP positive cells in the long bones, cells 
flushed from the bone marrow were compared to cells isolated from crushed and 
digested bones that have already been flushed of their bone marrow. In order to 
compare the populations, cells were sorted on the basis of YFP expression by MACS 
flow cytometry. Cells were also sorted for YFP expression either immediately after 
extraction or after a period of in vitro culture.  
 
FACS data for CD45 and YFP expression was gated based on forward scatter and 
side scatter properties to select for live cells. There were clear populations that 
were CD45 positive, and those that were CD45 negative could be segregated into 
YFP positive and negative samples that were subsequently collected. There were a 
small proportion of cells that appeared CD45+ YFP+ but these were not collected as 
the focus was on identifying stromal cells, known to be negative for CD45 (Figure 
3.12, A).  
 
In this way, cell sorting identified YFP+ cells that represented approximately 1% of 
the CD45 negative population of bone marrow and a slightly higher (1.25%) 
proportion was found in bone digest cells harvested from the same mice. YFP+ cells 
were not detected in control mice (Figure 3.11). The actual number of YFP+ resident 
cells may be higher, as some could be lost through the process of extraction, 
especially of the bone digest which requires numerous steps and effective enzyme 
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digestion. Histological analysis had identified approximately 4% of total bone 
marrow cells to be YFP positive but did not take into account CD45 expression 
(Table 3.1). Of the cells that had been cultured, for an average 13 days, before 
sorting, an average of 0.4% ± 0.44% YFP+ cells that were CD45- were recovered from 
the bone marrow (n=7 sorts). This indicates that the YFP+ cells persist in culture for 
over 4 weeks. However, the smaller proportion of YFP+ cells may indicate a loss of 
some of the YFP+ cells in culture over time and/or a preferential outgrowth of those 
that are YFP-. There was no remarkable decline seen over time between 7 different 
sorts and therefore alternative factors such as cell density, cell proliferation and 
paracrine and autocrine signalling mechanisms may play a part in regulating YFP 
expression and YFP+ cell survival in vitro. In comparison, bone digest cells that had 
been cultured yielded an average of 1.15% ± 1.49% YFP+ cells (n=5 sorts) when 
sorted which was similar to those from the fresh tissue (Figure 3.12, B). This 
suggests that the YFP+ cells from bone regions are more stable in culture than those 
from the bone marrow. Similar to the cultured cells from bone marrow, there was 
no trend in YFP expression and time spent in culture in bone digest cells (Figure 
3.12, B).  
 
The number of CD45- YFP- cells that were recovered from cells immediately sorted 
after extraction was approximately one third of the number of CD45- YFP+ cells from 
both fresh bone and bone marrow. In cultured cells, this population increased and 
was generally at least twice the number of YFP+ cells in either bone or bone marrow 
samples. YFP- cells from the bone marrow had an average (n=5 sorts) of 1.6% ± 
2.1% and in the bone the YFP- cells were 7.5% ± 10.7% of the total cell number after 
a maximum of 30 days in culture. 
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Figure 3.11 Detection of YFP+ cells by flow cytometry 
Cells were harvested from the bone marrow of IL-7Cre Rosa26-eYFP mice and the CD45+ 
population depleted by MACs. The remaining cells were then stained with biotin labelled 
CD45 and then with pacific blue conjugated streptavidin secondary antibody and analysed 
by flow cytometry for YFP expression.  
YFP+ cells could be detected in the IL-7Cre Rosa26-eYFP samples but were not found in 
control mice.  
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Figure 3.12 MoFlo sorting of YFP positive cells 
Cells were harvested from mouse bones and incubated with APC conjugated CD45 
antibody. They were then isolated using a MoFlo cell sorter and those cells that were CD45 
negative and either YFP positive (gate R6) or negative (gate R5) were collected separately. 
Gating is shown in A. R2 determines the events that were collected based on size 
properties that excluded debris. Cells were sorted fresh or alternatively after being cultured 
for up to 30 days. The graph indicates the percentage of CD45 negative cells that were YFP+ 
in each extraction. Each point represents an independent sort from an average of 7 mice 
per sort. The bone digest sorts correspond to the bone marrow at each time point (B).  
  
YFP 
C
D
4
5
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3.3.5 Characterisation of YFP expressing cells  
Cells harvested from the IL-7Cre Rosa26-eYFP bone marrow were analysed by flow 
cytometry to determine the expression of common stromal cell markers and further 
characterise the cells that expressed YFP. Cells were initially sorted to be CD45- (to 
exclude haematopoietic cells) and YFP+ expressing cells were collected. These cells 
were found to widely express VCAM-1 and gp38. CD90 and ICAM-1 were barely 
detectable and a mixed population of CD105 expressing cells were observed (Figure 
3.13). 
 
RNA was extracted from mouse bone marrow CD45- cells that had been sorted for 
YFP expression and real time PCR performed to assess the expression of nestin and 
IL-7. YFP expressing cells showed 50% greater expression of IL-7 mRNA and a 30% 
greater expression of nestin mRNA as compared to samples extracted from those 
cells that were YFP- (Figure 3.14). If IL-7 were purely a marker of a progenitor cell 
that gave rise to the mature cells in the bone marrow then it would be expected 
that the IL-7 levels would be the same between cells, regardless of their YFP 
expression. As an increased expression of IL-7 is observed, it is likely that, at the 
time of isolation, some of the YFP+ cells expressed IL-7. As the isolated cells were a 
heterogeneous population, it is also possible that a progenitor population and even 
MSCs were enriched in the YFP expressing cell set. This is supported by the 
observed increase in nestin expression, which is reportedly expressed on a range of 
stem cells, in the YFP+ cells compared to the YFP- cells.  
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Figure 3.13 Cell surface markers expressed by YFP+ cells 
Murine bone marrow cells were isolated using MACS flow cytometry and the cells were 
sorted depending on their expression of CD45 and YFP. CD45- YFP+ cells were further 
stained with stromal cell markers and analysed by flow cytometry. R3 and R4 determine 
the regions of positive marker expression compared to an unstained cell control. 
  
ICAM-1 
gp38 
CD90 
VCAM-1 
CD105 
Control 
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Figure 3.14 qRT-PCR analysis of nestin and IL-7 in bone marrow cells 
IL-7Cre Rosa26-eYFP bone marrow cells were sorted with flow cytometry (MoFlo) into 
populations that were CD45- and either YFP- or YFP+. Extracted RNA from each population 
was subsequently analysed for nestin (top) and IL-7 (bottom) gene expression and 
presented relative to murine cell line C3H10T1/2. * indicates p < 0.05 determined by t-test. 
 
  
* 
* 
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3.4 Summary 
While knockout studies have shown that IL-7 has a functional role in the regulation 
of T and B cell development in the bone marrow, little is known about the identity 
of stromal cells in the bone marrow that express IL-7. IL-7 is also involved in the 
mechanism of bone remodelling and negatively regulates bone formation, 
particularly in the context of oestrogen deficiency. Understanding the cells 
responsible for the contribution of IL-7 and their origin will therefore allow a 
greater understanding of the bone remodelling process and its interactions with T 
and B cell development. Using a transgenic mouse line (IL-7Cre Rosa26-eYFP) in 
which cells that have previously, or are currently expressing IL-7 are indelibly 
marked with YFP, the fate of IL-7 expressing cells was examined in the bone marrow 
to explore the hypothesis that IL-7 could identify MSCs. As IL-7 expression may be 
transient within stromal populations, this method of cell tracking allows the capture 
of a wider population of cells that contribute to the IL-7 expression in bone marrow. 
YFP expression was demonstrated in osteocytes within the bone, cells at the 
endosteum and cells associated with blood vessels. Whilst osteoblasts and 
perivascular cells have individually been proposed as IL-7 expressing cells in the 
literature, this study is able to consider the lineage relationship of these cells 
collectively. 
 
The results in this chapter indicate that mesenchymal cell types express YFP and 
that potentially, an IL-7-expressing common progenitor was responsible for the 
differentiation of the YFP positive cells. As MSCs are a multipotent stem cell capable 
of giving rise to each of these cell types, they are strongly implicated as this 
precursor. Importantly, not all of the cells in a given population were YFP positive, 
suggesting that if IL-7 is indeed expressed on MSCs that have subsequently 
differentiated in the bone marrow, it is only expressed on a subset of them. These 
results will be discussed in more detail in chapter 6.  
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4 An in vitro murine model of the HSC niche  
4.1 Introduction 
Haematopoietic stem cell fate is believed to be regulated by the specialised 
microenvironment or ‘niche’ in which they reside. The niche comprises cellular 
components, secreted signalling molecules and chemical gradients that promote 
the retention of the stem cells, maintains them in an undifferentiated state and 
enables their transient differentiation when required in order to preserve long term 
stem cell function (Scadden, 2006). 
 
HSCs are found in adult bone marrow and have been well characterised but the 
cells constituting their niche and their regulation of HSC fate are still not fully 
understood. The cellular fraction of the niche includes HSCs, MSCs, progenitor cells, 
osteoblasts, endothelial cells, adipocytes and CXCL12-abundant reticular (CAR) cells 
(For reviews see Lo Celso & Scadden, 2011; Mercier et al, 2012). MSCs indirectly 
control HSCs by supplying a range of mature cells that are constituents of the HSC 
niche. Nestin+ murine MSCs have been reported to have a direct effect on HSC 
function in vivo. Stromal cells expressing GFP under the control of nestin regulatory 
elements were identified in murine bone marrow. Further characterisation 
identified them as MSCs and depletion studies confirmed their requirement for 
homing and survival of HSCs (Mendez-Ferrer et al, 2010).  
 
Complex communication between each of the cell components is orchestrated via 
multiple signalling pathways that are important in the regulation of the HSC niche 
including notch, Wnt and TGFβ (Reviewed by Chotinantakul & Leeanansaksiri, 
2012). The involvement of IL-7 in this signalling network is less well understood but 
it is certainly implicated in the differentiation process of HSCs. B-lymphopoiesis 
occurs in the adult bone marrow in distinct niches depending on the differentiation 
stage of the B cells and is dependent on IL-7 (Parrish et al, 2009). IL-7 expressing 
cells are reportedly present in niches of the more proliferating stage of B cell 
development (Tokoyoda et al, 2004). Another study showed that mature 
osteoblasts that were stimulated with PTH, secreted IL-7 which led to B cell 
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differentiation of HSCs when co-cultured in vitro (Zhu et al, 2007). They also 
determined that cell contact between the osteoblasts and HSCs was required for 
initiation of lymphopoiesis and that VCAM-1 was implicated in the process, as its 
inhibition reduced the numbers of B lymphocytes produced in culture (Zhu et al, 
2007). Reports using BAC transgenic mice have described IL-7 expressing cells 
concentrated around vascular networks in the bone marrow (Mazzucchelli et al, 
2009) which was also observed in bone sections from IL-7CreRosa26-eYFP mice 
(examined in Chapter 3). Additionally, IL-7 reporter cells were located at the 
endosteum. IL-7 has an overall negative effect on bone and may therefore have a 
role in the physical modulation of the HSC niche. 
 
Studies of IL-7 and its role in B cell development in the bone marrow niches in vitro 
predominantly use 2D cultures of cells, however, cellular morphology, proliferation 
and gene expression is markedly changed in cells cultured in a 3D environment 
compared to 2D, which may be explained by the altered mechanical forces and 
greater cell contact that are imposed in a 3D structure (Birgersdotter et al, 2005). 
Bone marrow is a complex structure and as such the niche is described as a 3D 
environment, therefore, the culture of MSCs in 3D may be more representative of 
their in vivo counterparts. Numerous methods to enable 3D interactions have been 
developed to study the niche in vitro. Cellular spheroids are widely employed and 
can be formed in a number of ways: by culturing cells in rotating vessels to form 
aggregates (Frith et al, 2010); by a hanging drop method originally employed to 
study embryoid bodies (Banerjee & Bhonde, 2006) and by centrifugal force in 
plates, as well as various techniques to prevent adherence to tissue culture plastic. 
An alternative technique is to provide a biologically relevant scaffold, which allows 
the inclusion of ECM components or bone-like tissue.  
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4.2 Aims 
 
IL-7 has reported functions in lymphopoiesis and bone remodelling that occur in 
anatomically distinct regions of the proposed HSC niche. The experiments in this 
chapter are designed to build a simple cellular model of MSCs in the HSC niche that 
imitates the in vivo cellular interactions more faithfully than plastic adherent 
culture to allow the study of IL-7 and nestin in the bone marrow microenvironment.  
 
4.3 Results 
4.3.1 A simple model of the MSC niche 
C3H10T1/2 cells are a murine multipotent stromal cell line and were used as a 
model of MSCs due to their functional similarity and ready availability to generate a 
model of the niche. Using C3H10T1/2 cells allowed a single species model, as the 
primary HPCs are also isolated from mice. This provided a format to study the 
proposed murine MSC marker nestin and investigate IL-7 whose expression was 
alluded to by reporter expression in IL-7Cre transgenic mice. 
 
In order to study cellular interactions, cells were cultured in a 3D spheroid structure 
that formed spontaneously when cells were seeded in a viscous spheroid media. 
This method of spheroid production had been previously successful in producing 
consistent spheroids that were easy to manipulate (Saleh et al, 2012). Each 
spheroid was cultured individually in 96 well plates to make each one identifiable 
and accessible with the ability to control the cell number and growth conditions of 
each spheroid. 
 
C3H10T1/2 cells were initially seeded at four different densities to examine a range 
of spheroid sizes and cultured for 10 days. 2, 4, 6 and 12 x 104 cells were seeded 
and formed spheroids over 24 hours in culture. In all cases spheroid diameter 
decreased by approximately 50% by day 7 which then stabilised and was 
maintained until day 10 (Figures 4.1 and 4.2). The largest of the spheroids 
maintained a doughnut like appearance throughout the 10 days of culture, as the 
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cells were predominantly located around the periphery of the structure leaving a 
less cell dense area in the centre. In contrast, this cellular distribution was altered 
after 3 days with the smaller spheroids which appeared uniformly arranged after 
this time. 2 x 104 cell spheroids formed aggregates with orbiting cells that remained 
close to but did not join the main spheroid over the 10 days. 
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Figure 4.1  Determination of the optimal cell number for a spheroid model 
C3H10T1/2 cells were seeded into methyl-cellulose media at 2 x 104 and 4 x 104 cells per 
well in 96 well plates. Spheroids formed spontaneously after 24 hours and were cultured 
for 10 days. Scale bar 200 µm. 
Day 1 
Day 2 
Day 3 
Day 7 
Day 8 
Day 10 
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Figure 4.2 Determination of the optimal cell number for a spheroid model 
C3H10T1/2 cells were seeded into methyl-cellulose media at 6 x 104 and 12 x 104 cells per 
well in 96 well plates. Spheroids formed spontaneously after 24 hours and were cultured 
for 10 days. Scale bar 200 µm. 
Day 1 
Day 2 
Day 3 
Day 7 
Day 8 
Day 10 
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Spheroids were snap frozen in liquid nitrogen and sectioned for further analysis. 
H&E staining showed densely packed cells within the spheroid encased by an outer 
layer of cells with a more elongated appearance (Figure 4.3, left). 
Immunofluorescent staining with proliferation marker Ki67 showed an average of 
23% positive cells that were distributed throughout the spheroids at day 1. For all 
time points beyond one day, Ki67 positive cells were restricted to the outer layers 
of the spheroids and the percentage of positive cells  decreased  to fewer than 1% 
(n=3) on day 2 (Figure 4.3, centre), indicating that proliferation was dramatically 
reduced after only a short period of time in spheroid culture.  
 
As the spheroids decreased in size over time, a LIVE/DEAD assay was performed to 
determine if cells were simply dying within the spheroids leading to a reduced cell 
number and decreased spheroid size. Reconstructions of confocal image stacks 
allowed identification of the cells throughout a deeper proportion of the spheroid 
than an individual image. Spheroids harvested at days 3, 6 and 8 confirmed the 
presence of only a small number of dead cells within each size of spheroid, 
indicating that cell death could not account for the reduction in spheroid size and 
that cell survival was maintained in this method of culture. The highest proportion 
of dead cells appeared in the smallest of the spheroids: each of the 2 x 104 
spheroids over 8 days and the 4  x 104 spheroids at day 8 (Figure 4.4).  
 
To confirm the ability of C3H10T1/2 spheroids to differentiate, spheroids were 
cultured in osteogenic, adipogenic or chondrogenic spheroid media for 14 days. 
Sections of snap-frozen spheroids were stained with von Kossa, Oil Red O and type 
II collagen that indicated successful osteogenic, adipogenic and chondrogenic 
differentiation respectively (Figure 4.5). Mineralisation, as determined by von Kossa 
staining, appeared localised to the central region of the spheroid and was most 
prominent at day 14. Oil Red O-positive lipid vesicles were distributed throughout 
the spheroid and showed a large proportion of cells within the spheroid staining 
positive at day 7 with larger, merged lipid vesicles consistent with more mature 
adipocytes at day 14. Immunohistochemical staining detected type II collagen at the 
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periphery of the spheroids at day 7 but expression was more uniformly detected 
throughout the spheroid at day 14. Little or no staining was detected in spheroids 
cultured in control medium for each condition indicating a lack of any spontaneous 
differentiation of MSCs when cultured in 3D.  
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Figure 4.3 Cell proliferation within spheroids 
C3H10T1/2 spheroids were snap frozen, sectioned and stained with haematoxylin and 
eosin (H&E) to visualise morphology (Left). Sections were stained with proliferation marker 
Ki67 (green, middle) and counter stained with DAPI (blue, right). Scale bars 200 µm. 
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Figure 4.4 Viability of cells within spheroids 
C3H10T1/2 spheroids were stained on days 3, 6 and 8 with calcein AM and ethidium 
homodimer-1 to identify live (green) and dead (red) cells, respectively. Hydrogen peroxide 
was used to kill cells within the spheroid and confirm specificity of the staining. Whole 
spheroids were imaged on an LSM 510 confocal microscope (Carl Zeiss). Projections of 
z-stack images are shown. Scale bar 200 µm.  
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Figure 4.5 Differentiation of C3H10T1/2 spheroids 
Spheroids were cultured in methyl-cellulose media containing osteogenic, adipogenic or 
chondrogenic factors. At days 7 and 14, spheroids were sectioned and stained with von 
Kossa for mineralisation (brown/black) of osteogenic spheroids, Oil Red O to detect lipid 
vesicles (red) or type II collagen (dark brown) to confirm chondrogenic differentiation. Scale 
bars 50 µm.  
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IL-7 gene expression was determined by real time PCR in spheroids that were 
differentiated for 7 and 14 days and compared to the respective day 0 control 
(Figure 4.6). In both osteogenic and adipogenic spheroids, IL-7 was significantly 
decreased upon differentiation. The reduction was evident at day 7 and was 
maintained at day 14. 2D monolayers of C3H10T1/2 cells were also induced for 
adipogenic differentiation and these followed the same pattern of decreased gene 
and therefore no statistical difference could be detected in IL-7 expression in 2D or 
3D adipogenic differentiation. When compared to monolayer cultures at day 0, the 
spheroid sample had an approximately 30% decrease in IL-7 expression (p= 0.04), 
indicating differences in gene expression between the two methods of culture.  
 
Chondrogenic differentiation in spheroids resulted in an increase in IL-7 at day 7 but 
was not determined at day 14 due to low quality of sample RNA. This would require 
repeating to determine the expression at day 14. Chondrogenic differentiation is 
carried out in serum-free medium, which may be responsible for some of the 
differences. Large cell pellets rather than monolayer cultures are routinely used for 
chondrogenic differentiation and were formed here with 5 times the number of 
cells in each spheroid. Subtle differences between pellet and spheroid culture 
include formation, as pellets are generated by centrifugal force and maintained in 
culture medium rather than the viscous spheroid medium that allows spontaneous 
cell aggregation into spheroids. The increase in IL-7 expression at day 7 in pellets 
was statistically significant compared to day 7 spheroids and to the day 0 control 
pellet. At day 14, the IL-7 expression level in the pellets was drastically reduced 
from the level observed at day 7 to below that even of the day 0 pellet.  
 
4.3.2 Addition of HPCs to the niche model 
Selecting a spheroid size of 4 x 104 cells for further study due to their consistent 
aggregation, stromal cells were cultured with the addition of 10-100% HPCs. HPCs 
were combined at the initial seeding stage and contributed to the total cell number, 
which remained at 4 x 104, to include both stromal cells and HPCs. For example, a 
spheroid with 50% HPCs would contain 2 x 104 C3H10T1/2 cells were used with 2 x 
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104 HPCs. HPCs alone were unable to form spheroids.  As HSCs and progenitors are 
a rare population in the bone marrow they would not necessarily come into contact 
with each other in vivo and may therefore lack the adhesion molecules or integrins 
required to interact and so to form spheroids. 
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Figure 4.6 Expression of IL-7 during differentiation in 3D 
Spheroids and monolayers were induced with osteogenic, adipogenic or chondrogenic 
media for 14 days. Spheroids were enzymatically digested and RNA extracted to analyse by 
real time PCR. Expression of IL-7 is shown relative to the appropriate day 0 control. 
Independent t-test determined statistical significances * p= <0.05. ** p=<0.01. nd, not 
determined. 
  
nd 
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Figure 4.7 Addition of HPCs to the model 
Spheroids  with a total cell number of  4 x 104 were formed with between 10-100% of the 
total number composed of HPCs (as indicated) mixed with the C3H10T1/2 cells at seeding. 
Brightfield images are shown from days 1, 3 and 4. 
Scale bar 50 µm. 
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Figure 4.8 Addition of HPCs to the model 
Spheroids with a total cell number of 4 x 104 cells were formed with between 10-100% 
HPCs (as indicated) mixed with the C3H10T1/2 cells at seeding. Brightfield images from 
days 7, 8 and 10 show an increasing outgrowth of cells from those spheroids containing 
HPCs. HPCs do not form spheroids on their own (bottom images). Scale bar 50 µm. 
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Owing to the smaller size of the HPCs, the co-culture spheroids were smaller than 
their stromal-only counterparts, which potentially could alter the 
microenvironment due to alterations in physical forces and diffusion of factors into 
the spheroids (Figures 4.7 and 4.8). After spheroid co-culture for 3-5 days, cells 
began to appear as an outgrowth encircling the main compact spheroid. Although 
the spheroids did not decrease in size after 7 days of culture, the cells surrounding 
the spheroids increased in number indicating the proliferation of this population of 
cells (Figure 4.8). These outgrowth cells were further examined by immunostaining 
and flow cytometry. After the spheroid was removed from the well, the cells 
remained adhered to the plastic (Figure 4.9 A) and could be harvested separately by 
trypsinisation. The cells were cytospun onto slides and stained with H&E which 
showed a cellular appearance typical of macrophages with bulky vacuolated 
cytoplasm, attributed to their phagocytic cell type (Figure 4.9 B). The majority of 
cells also stained positive for the trans-membrane protein F4/80, a marker of 
mature macrophages (Figure 4.9 C) and for common cell surface markers CD45 and 
CD11b when assessed by flow cytometry (Figure 4.9 D). Macrophages did not 
appear around the spheroids containing only stromal cells but were particular to 
those containing HPCs. Macrophages could have been introduced as a contaminant 
from the HPC population or, alternatively, differentiated from the HPCs once in 
spheroid culture. Subsequently, they migrated out of the spheroids and readily 
proliferated and preferentially adhered to the plate despite the untreated surface 
and the presence of spheroid media.   
 
The use of CellTracker labelling also suggested that some HPCs exit the spheroids by 
day 6 after originally being contained within the spheroids (Figure 4.10). HPCs 
labelled by CellTracker Green were found throughout the C3H10T1/2 spheroid at 
day 3. A proportion of CellTracker labelled green cells were detected outside of the 
spheroid at day 6 and were located even further from the main spheroid body by 
day 8 whilst some still remained in the spheroid. As the C3H10T1/2 cells had 
originally been labelled with CellTracker Red, some red cells were also found 
external to the spheroid and were in the periphery of the well and associated with 
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the HPCs. Both cell types were observed to combine and remain as an intact 
spheroid after 24 hours, which suggests that the stromal cells and the HPCs exited 
the spheroid. Exit of the HPCs occurred concurrently with the stromal component 
of the spheroid. CellTracker Green is inherited in daughter cells; however, the 
extent of green cells detected in these spheroids does not account for the number 
of outgrowth macrophages observed surrounding the spheroid. This indicates that 
the label may be lost over time in highly proliferative macrophages. It also remains 
to be seen the extent to which the HPCs were able to re-enter the spheroid or 
whether the movement was unidirectional to determine how mobile these HPCs 
were in spheroid culture. HPCs are detected in adult peripheral blood and it is 
therefore plausible that entering and exiting a stromal niche would be achievable 
for these cells in vitro.  
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Figure 4.9 Characterisation of outgrowth cells 
Co-culturing of C3H10T1/2 cells with HPCs leads to an outgrowth of cells that remain in the 
well once the spheroid is removed at day 8 (Brightfield images, A). These cells were 
collected and cytospun and stained with H&E (B) and the common macrophage marker 
F4-80 (pink, C) counterstained with DAPI (blue). Inset image represents antibody control. 
Expression of macrophage markers CD45 and CD11b was determined by flow cytometric 
analysis (D). Red line represents antibody stained, blue line is the isotype control. 
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Figure 4.10 HPC detection within co-culture spheroids 
HPCs and C3H10T1/2 cells were labelled with CellTracker red and green respectively and 
combined into spheroids. Confocal imaging detected HPCs within the spheroids at days 3, 6 
and 8. Scale bar 200 µm. 
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Figure 4.11 Formation of spheroids with primary stromal cells 
Bone marrow cells were sorted by flow cytometry to be CD45 negative and either YFP 
positive or negative from IL-7CreRosa26eYFP transgenic mice. Both YFP+ and YFP- stromal 
cells were able to form spheroids that were maintained in culture for 6 days. Due to the 
small number of cells sorted, only 2.6 x 104 cells were used for each spheroid. Scale bar 250 
µm. 
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As demonstrated in Chapter 3, IL-7Cre Rosa26eYFP transgenic mice are a novel 
reporter of IL-7 and YFP+ cells were found to be a variety of mesenchymal cells 
located in the bone and bone marrow. Flow cytometric sorting of 
non-haematopoietic (CD45-) cells isolated a small percentage (approximately 1%) of 
cells that were YFP+. Both YFP positive and negative populations were successfully 
able to form spheroids that were maintained in culture for a week (Figure 4.11). 
Monolayer culture of these cells was not successful as after some initial adherence, 
the cells detached and were non-viable. These primary cells therefore appeared to 
prefer the 3D culture method, possibly due to the cross-talk that would be 
facilitated by the close interaction of cells.  
 
in vivo, murine nestin+ MSCs have been shown to support the HSC niche. Whilst 
co-culture of the C3H10T1/2 cells and HPCs has been determined to provide a 
physical model of such a niche, the next aim was to assess the ability of the stromal 
cells to maintain the HPCs functionality in culture. A sample of HPCs used in 
co-culture studies was cultured for 9 days in MethoCult, a semisolid media 
containing cytokines (rm SCF, rm IL-3, rhIL-6, rh Epo) to induce progenitor cells to 
proliferate and differentiate to produce colonies of cells (Figure 4.12). An expected 
number and range of myeloid and erythroid lineage colonies were produced by the 
foetal liver HPCs (Figure 4.12).  
 
HPCs were analysed for cell surface markers after spheroid co-culture for 8 days.   
AFT024 cells are also widely used to support HSC cultures in vitro and were used 
alongside the C3H10T1/2 cells as alternative stromal cell line. The spheroids were 
disaggregated by enzyme digestion and examined by flow cytometry for expression 
of HSC markers: lineage markers (as a cocktail containing CD3, CD45R (B220), 
CD11b, Gr-1 (Ly-6G/C), 7-4, and Ter-119), c-kit and sca-1. The results showed that 
HPC cells predicted as having the profile lin- sca-1+ c-kit+ could be detected as a 
small population within the disaggregated spheroids, suggesting their maintenance 
by each of the stromal cell lines (Figure 4.13, D and F). Expression of sca-1 was 
found in both the AFT024 and C3H10T1/2 stromal lines (Figure 4.13, C and E). From 
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the AFT024 co-culture spheroids there was a 1% population of live lin- cells that 
were also sca-1+ ckit+. 2.6% of the lin- cells were positive for c-kit but did not express 
sca-1. A similar pattern of expression was observed with C3H10T1/2 co-culture 
spheroids, with a slightly larger proportion (2.7%) of cells expressing both sca-1 and 
c-kit. 
 
HPCs could be detected by flow cytometry after spheroid co-culture but when put 
into MethoCult colony assays, did not form haematopoietic colonies (data not 
shown). This was possibly due to the overgrowth of stromal cells and their 
consumption of growth factors as no sorting was done to separate HPCs from the 
stromal cells before colony assay. So, whilst HPCs could be detected in the 
spheroids after 8 days, their ability to form colonies was not demonstrated. 
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Figure 4.12 Colony forming cell assay 
HPCs were cultured in Methocult and resulting colonies were identified microscopically 
(top images) and counted (presented in graph) on day 9. Scale bar 250 µm. CFU- Colony 
Forming Unit, -GEMM; granulocyte erythrocyte monocyte megakaryocyte, -GM; 
granulocyte, monocyte, -G; granulocyte, -E;erythroid, -M;monocyte. Error bars indicate 
standard deviation of the mean, n=3 technical replicates. 
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Figure 4.13 Expression of LSK markers in HPCs after spheroid culture 
HPCs and stromal cells were cultured in spheroids for 8 days before disaggregation and 
flow cytometric analysis of cell surface markers of lineage (CD5, CD45R (B220), CD11b, Gr-1 
(Ly-6G/C), 7-4, and Ter-119), c-kit and sca-1. Cells were gated to be lineage negative and 
numbers shown are percentage of population that are lin-ckit+sca-1+. HPCs alone were 
assessed pre-spheroid culture (A) and after 8 days (B), C3H10T1/2 (C) and C3H10T1/2 with 
HPCs (D), AFT024 cells (E) and AF024 with HPCs (F) were assessed after spheroid culture.  
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4.4 Summary 
The bone marrow microenvironment is a complicated tissue, therefore it is 
important to generate a 3D in vitro model in order to more accurately study stem 
cell proliferation, self-renewal and differentiation. The results of this chapter will be 
discussed in chapter 6. Briefly, C3H10T1/2 cells were able to spontaneously form 
spheroids in methyl-cellulose media and could differentiate efficiently when 
induced down osteogenic, adipogenic and chondrogenic lineages. Owing to the 
consistent spheroid shape, 4 x 104 cells was the number selected from a range of 
spheroid sizes to be further characterised. C3H10T1/2 cells organised into a dense 
network of cells in the spheroid which was surrounded by an outer layer of cells 
that arranged in spindle-shaped appearance to encase the spheroid. Only small 
numbers of cells in the peripheral layer of the spheroids were positive for 
proliferative marker Ki67, demonstrating that the cells adopt a quiescent state in 
the spheroids. Primary YFP+ murine stromal cells are able to form spheroids and can 
be maintained in culture more successfully than in 2D, demonstrating the 
importance of a 3D environment to cells cultured in vitro. However, detection of 
LSK cells after 8 days of co-culture with C3H10T1/2 cells was not successful; 
indicating that C3H10T1/2 cells were ineffective at maintaining HPCs in this 
spheroid culture system and therefore, that further development of the model is 
required. 
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5 Characterisation of IL-7 and nestin in human MSCs 
5.1 Introduction 
Human MSCs are commonly distinguished in vitro by a panel of cell surface markers 
including CD90, CD105, CD73 and CD106 as well as Stro-1 (Simmons & Torok-Storb, 
1991), although these may differ between investigating groups. As MSCs are 
routinely isolated and examined in vitro, culture dependent changes and the 
probability of examining a heterogeneous cell population contributes to the 
difficulty in isolating and characterising a single cell type. Currently, a number of 
markers such as CD271 and CD146 (human) and nestin (mouse) have been 
proposed to prospectively isolate MSCs with a high degree of purification (Jones et 
al, 2002; Mendez-Ferrer et al, 2010; Sacchetti et al, 2007). However, these proteins 
are also expressed on a population of differentiated cells and cannot account for 
the entire MSC ability of the bone marrow. This suggests subsets of MSCs exist with 
distinct profiles that are yet to be identified.  
 
Nestin is recognised as a marker of stem and progenitor cells in an increasing 
number of human tissues and studies in mouse models report nestin+ MSCs to be 
critical in HSC survival in the bone marrow (Mendez-Ferrer et al, 2010). These MSCs 
expressed higher levels of IL-7 mRNA than nestin- cells in the bone marrow. IL-7 is 
known to be expressed in human bone marrow cells but their relationship in the 
regulation of the HSC niche has not been determined.  
Much of the work that has defined stem cell niche biology has been carried out in 
invertebrates and mouse studies and the systems involved are highly conserved. 
Therefore, results from the previous chapters together with these published 
reports suggest that IL-7 and nestin could be applicable to identifying human MSCs 
and as such the experiments in this chapter aim to determine IL-7 and nestin 
expression in human MSCs and examine their potential functional role. 
 
5.2 Aims 
 To determine expression of IL-7 and nestin in human MSCs 
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 To identify IL-7 and nestin expression patterns during human MSC 
differentiation 
 To identify whether IL-7 has a functional role in MSCs 
 
5.3 Results 
5.3.1 Characterisation of human MSCs 
MSCs obtained from patient femoral head samples were purified using a density 
gradient and centrifugation protocol. Additionally, MSCs were isolated from knee 
bone by simply placing the bone chip into a tissue culture dish with media. Cells 
which were adherent on tissue culture plastic could then be selected for further 
analysis. Cells were examined by flow cytometry for the expression of markers 
commonly used to identify MSCs (Figure 5.1). Cells were examined between 
passages 2-4 to allow sufficient proliferation from their original isolation and the 
loss of any contaminating haematopoietic cells. All donors (refers to K6, FH441, 
FH450 and FH181) were found to be negative for haematopoietic markers CD45 
and CD34 and macrophage marker CD11b. Cells were positive for CD105, CD166, 
CD29, CD90, CD73 and CD44. CD271 was not detected. Donors from knee and hip 
sources showed an identical profile for these markers and were consistent with the 
expected expression on MSCs.  
To confirm their differentiation capacity, each MSC donor was induced for 21 days. 
Adipogenic differentiation was detected by Oil Red O staining. By day 7, a large 
proportion of cells had visible lipid vesicles within the cytoplasm. The number of 
cells containing lipid vesicles increased over time and the individual vesicles became 
larger and merged together in mature adipocytes by day 21 (Figure 5.2). At day 21, 
one or two cells stained positive in the control samples indicating infrequent 
spontaneous differentiation events. Early osteogenic differentiation was 
determined at day 7 by staining for alkaline phosphatase (ALP) activity, which 
appeared as diffuse pink staining. ALP activity remained widespread and could also 
be detected at days 14 and 21. Mineralisation was detected by von Kossa staining 
and showed brown staining, which was most prominent at day 21 (Figure 5.3).   
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Figure 5.1 Expression of MSC cell surface markers 
Overlay histograms of flow cytometry results show the expression of negative (CD34, CD45, 
CD11b) and positive (CD105, CD166, CD29, CD90, CD73, CD44) surface markers used to 
identify MSCs. CD271 was not detected on the MSCs. Donor FH441 shown as 
representative of those analysed: K6, FH181, FH450. Red lines indicate isotype control. 
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Figure 5.2 Adipogenic differentiation of MSCs 
MSCs were cultured in normal basal media or media containing adipogenic factors for 21 
days.  At days 7, 14 and 21 samples were stained with Oil Red O (red) to determine the 
presence of lipid vesicles. Scale bar 50 µm. Donor K6 is shown. 
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Figure 5.3 Osteogenic differentiation of MSCs 
MSCs were cultured in basal or osteogenic media for 21 days. Samples were stained at 
weekly intervals for alkaline phosphatase activity (pink) and von Kossa staining 
(brown/black) to show mineralisation. Scale bar 50 µm. Donor FH450 is shown. 
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Similar to the adipogenic controls, the osteogenic control samples showed little or 
no staining. Each donor was found capable of multipotent differentiation. 
Quantitative real time PCR (qPCR) was used to examine gene expression in MSCs 
during differentiation. Genes indicative of osteogenic, adipogenic and chondrogenic 
lineage commitment were analysed as well as the two genes of interest; IL-7 and 
nestin. All genes were normalised to the housekeeping gene RPS27a and expression 
was compared to the appropriate day 0 control.  
 
Adipogenic differentiation of MSCs led to the progressive increase in expression of 
fatty acid binding protein 4 (FABP4, Figure 5.4) and peroxisome 
proliferator-activated receptor gamma (PPARγ, Figure 5.5) in all donors. Donor 
FH441 varied slightly in that the expression of each marker was similar on day 7 and 
14 before increasing to a maximum on day 21. Control samples at each time point 
had low or no expression in comparison. 
 
Gene expression was more varied between donors during osteogenic 
differentiation. ALP was increased at day 7 and then further increased at day 21 in 
K6 and FH441 cells but the increase at day 7 in donor FH181 cells was followed by a 
reduction at later time points (Figure 5.6). Runx2 expression in FH181 cells was 
upregulated at day 7 which was maintained at day 14 before decreasing at day 21. 
The other three donors, particularly K6 cells, had similar expression of Runx2 in 
both the control and osteogenic cells (Figure 5.7). FH441 and FH450 only showed 
an increase in Runx2 expression compared to the control at day 21. Despite these 
variations in gene expression, all donors were similarly differentiated as determined 
by histology staining.  
All donors examined for chondrogenesis had the greatest increase in collagen II 
expression at day 14, which was seen to decrease at day 21 in FH181 (Figure 5.8). 
Whilst Sox9 expression was increased compared to day 0 in donors FH441 and 
FH450, it was not distinctly different to the control at each time point apart from 
day 14 in FH450 cells (Figure 5.9). Sox9 expression even appeared reduced in FH181 
cells. 
Chapter 5. Characterisation of IL-7 and nestin in human MSCs 
 
148 
 
 
Figure 5.4 qRT-PCR analysis of adipogenic marker FABP4 
RNA samples were extracted from monolayers undergoing adipogenic differentiation and 
examined for FABP4 expression. Error bars indicate sd.  
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Figure 5.5 qRT-PCR analysis of adipogenic marker PPARγ 
RNA samples were extracted from monolayers undergoing adipogenic differentiation and 
examined for PPAR expression. Error bars indicate sd.  
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Figure 5.6 qRT-PCR analysis of osteogenic marker alkaline phosphatase (ALP) 
RNA samples were extracted from monolayers undergoing osteogenic differentiation and 
examined for ALP expression. Error bars indicate sd.  
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Figure 5.7 qRT-PCR analysis of osteogenic marker Runx2 
RNA samples were extracted from monolayers undergoing osteogenic differentiation and 
examined for Runx2 expression by real time PCR. Error bars indicate sd.  
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Figure 5.8 qRT-PCR analysis of collagen II during chondrogenic differentiation 
RNA samples were extracted from cell pellets undergoing chondrogenic differentiation and 
examined for collagen II expression. Error bars indicate sd. 
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Figure 5.9 qRT-PCR analysis of Sox9 during chondrogenic differentiation 
RNA samples were extracted from cell pellets undergoing chondrogenic differentiation and 
examined for Sox9 expression. Error bars indicate sd. 
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5.3.2 Expression of IL-7 and nestin during MSC differentiation  
Nestin expression is reportedly downregulated in differentiated cells. Therefore, 
mRNA levels were analysed to detect if this expression profile of nestin was 
apparent in bone marrow MSCs as they differentiated down tri-lineage pathways. 
IL-7 expression was also analysed in these samples and would be expected to follow 
a similar pattern to that of nestin if IL-7 were a stem cell marker of MSCs. In chapter 
3, bone marrow cells in transgenic mice expressed IL-7 reporter YFP and therefore, 
differentiated MSCs may potentially express IL-7. qPCR of samples collected at days 
7, 14 and 21 during differentiation induction was used to determine IL-7 and nestin 
expression. IL-7 expression was primarily increased under both control and 
differentiation conditions in monolayer cultures over 21 days. With only a couple of 
exceptions in donor FH441, IL-7 expression was highest in the control samples 
compared to those that were differentiated at each time point (Figure 5.11). Nestin 
expression was also predominantly highest in control cells followed by osteogenic 
and adipogenic cells and was also usually lower in day 7, 14 and 21 when compared 
to day 0 (Figure 5.13).  
 
Osteogenically differentiated cells generally showed a progressive increase in IL-7 
expression although in FH181 cells; this decreased a little after day 14. Donor FH181 
showed the least variation in expression from the day 0 control and control and 
osteogenic samples were quite similar throughout as noted by less than half of the 
osteogenic samples being statistically significant from their respective controls 
(Figure 5.11). Nestin expression increased in FH441 cells at days 7 (p=0.006) and 14 
(p=0.002) compared to the control sample. The other 3 donors showed more 
variability but nestin was essentially expressed at day 7 slightly above the control 
level and then in day 14 and 21 osteogenic samples, nestin had decreased below 
the individual and day 0 controls (Figure 5.13).  
 
IL-7 expression during adipogenic differentiation generally remained at a consistent 
level at all time points in each donor. In FH181 cells it was noticeably lower on days 
7, 14 and 21 in comparison to the day 0 control and whilst in the other donors the 
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expression level was higher in each condition compared to day 0, IL-7 in the 
differentiated samples remained lower than the control at each time point (Figure 
5.11). This was also the case with nestin expression; at each time point the level 
was statistically lower in adipogenic samples than the control apart from donors 
FH441 and FH181 at day 14. In an opposite effect to IL-7, rather than an increase 
compared to the day 0 control, nestin expression decreased and remained lower 
than this control in each of the adipogenic samples (Figure 5.13). 
 
Cells were formed into pellets rather than monolayer culture for chondrogenic 
differentiation studies. IL-7 expression increased in control and chondrogenic 
samples over time with negligible difference between them at day 7. IL-7 was 
generally increased in chondrogenic samples compared to the control at the same 
timepoint although FH441 cells at day 14 showed a decrease in expression 
(p=0.004) (Figure 5.10). Conversely, nestin expression in cell pellets decreased 
compared to day 0 levels in both control and differentiated samples in FH181 cells 
and did not increase more than 2-fold in other donors. Compared to the respective 
day control sample, statistical significance was not detected between control and 
chondrogenic samples (Figure 5.13). 
 
Cells cultured in 3D rather than 2D have been shown to have differences in their 
behaviour and gene expression. IL-7 was expressed at a higher level in the pellet 
samples compared to monolayer cultures in all 3 donors although, the difference 
between control and chondrogenic samples in donor FH441 was not considered 
statistically significant (Figure 5.10). However, nestin expression was significantly 
lower in day 0 monolayer cultures compared to day 0 cell pellets in donors FH181 
and FH441, with no significance detected in donor FH450, indicating a general 
difference between the two culture methods (Figure 5.12). 
 
5.3.3 Nestin is detected in human MSCS 
After confirming the presence of nestin mRNA by qPCR and alterations in its 
expression during differentiation, MSCs were seeded onto coverslips and stained to 
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detect the presence of nestin protein (see section 2.6.6). NTERA2/D1 cells are 
derived from a human embryonal carcinoma and were used as a positive control as 
they are known to express nestin and showed strong cytoplasmic staining. 
Unexpectedly, K6 cells showed weak nuclear staining with some diffuse cytoplasmic 
staining. This was similar after 24 hours and 7 days (Figure 5.14). Conversely, two 
other donors showed initial nuclear staining which was replaced by more distinct 
cytoplasmic staining at day 7 (Figure 5.15). When differentiated for 7 days, K6 cells 
retained the nestin staining, perhaps a little weaker, which agreed with the mRNA 
expression detected. Ki67 staining showed similar low level proliferation events in 
osteogenic and adipogenic samples (Figure 5.16). 
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Figure 5.10 qRT-PCR analysis of IL-7 expression during chondrogenesis 
RNA samples were extracted from cell pellets undergoing chondrogenic differentiation and 
examined for IL-7 expression. Error bars indicate sd. 
p ≤ 0.05 not significant (ns), p < 0.05 *, p < 0.01 **, p < 0.001 *** represents statistical 
significance determined by t-test. 
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Figure 5.11 qRT-PCR analysis of IL-7 expression during differentiation 
RNA samples were extracted from cells undergoing adipogenic or osteogenic 
differentiation and examined for IL-7 expression. Error bars indicate sd. 
p ≤ 0.05 not significant (ns), p < 0.05 *, p < 0.01 **, p < 0.001 *** represents statistical 
significance determined by t-test. 
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Figure 5.12 qRT-PCR analysis of nestin expression during chondrogenesis 
RNA samples were extracted from cell pellets undergoing chondrogenic differentiation and 
examined for nestin expression. Error bars indicate sd. 
p ≤ 0.05 not significant (ns), p < 0.05 *, p < 0.01 **, p < 0.001 *** represents statistical 
significance determined by t-test. 
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Figure 5.13 qRT-PCR analysis of nestin expression during differentiation 
RNA samples were extracted from cells undergoing adipogenic or osteogenic 
differentiation and examined for nestin expression. Error bars indicate sd. 
p ≤ 0.05 not significant (ns), p < 0.05 *, p < 0.01 **, p < 0.001 *** represents statistical 
significance determined by t-test. 
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Figure 5.14 Immunofluorescent detection of nestin expression in MSCs (FH496 and 
FH492) 
Cells were seeded onto coverslips at 2 x 104 cells/cm2 and staining performed 24 hours and 
7 days later. Nestin (red) could be detected in the nucleus of FH492 (top panels) and FH496 
(bottom panels) MSCs. After 7 days, nuclear nestin staining was weaker whilst cytoplasmic 
staining increased. Cells were counterstained with Dapi (blue). Scale bar 100 µm. 
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Figure 5.15 Immunofluorescent detection of nestin expression in MSCs (K6) 
Cells were seeded onto coverslips at 2 x 104 cells/cm2. 24 hours or 7 days later nestin (red) 
could be detected in the nucleus of K6 MSCs. NTERA2/D1 cells are known to express nestin 
and were used as a positive control. Rabbit IgG was used as an antibody control. Cells were 
counterstained with Dapi (blue).  Scale bar 100 µm. 
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Figure 5.16 Nestin expression and proliferation in differentiated MSCs (K6) 
Cells were seeded onto coverslips at 2 x 104 cells/cm2. MSCs were differentiated for 7 days 
in osteogenic (top) or adipogenic (bottom) induction medium. Nestin (red) could be 
detected in the nucleus of K6 MSCs. Ki67 staining indicated a small proportion of 
proliferating cells in each sample. Cells were counterstained with Dapi (blue).  Scale bar 100 
µm. 
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5.3.4 IL-7 has no effect on MSC differentiation 
To determine the effect of IL-7 addition on differentiating MSCS, cells were seeded 
into 96 well plates for adipogenic or osteogenic differentiation using 6 wells for 
each condition. Media was supplemented on day 0 with 20 pg or 20 ng/ml 
recombinant human IL-7, which was also replenished at each media change. Plates 
were stained on days 0, 7, 14 and 21 with alizarin red to detect mineralisation or Oil 
Red O to highlight lipid vesicles. Each of the stains could be eluted and quantified 
on a microplate reader (Dynex technologies) at 570 nm or 490 nm respectively.  
IL-7 had no effect on the ability of cells to undergo adipogenesis (Figure 5.17). A 
large proportion of cells with lipid vesicles were detected in all wells cultured in 
adipogenic medium, with no visible difference between the conditions with IL-7 
treatment (Figure 5.17, A) This was confirmed by quantifying the Oil Red O stain 
(Figure 5.17, B). Results shown are representative of 3 donors.  
IL-7 also had no effect on the ability of cells to undergo osteogenesis (Figures 5.18 
and 5.19). Alizarin red staining was detected in all osteogenic samples from day 7, 
which increased over time (Figure 5.18, A). No clear difference could be detected 
between those osteogenic samples with or without the addition of IL-7, which was 
confirmed with the measurement of the eluted stain (Figure 5.18, B and Figure 
5.19). Control samples did not stain positive for alizarin red or Oil Red O at the same 
time points. No positive stain was detected in control samples that had been 
cultured with the addition of IL-7 (results not shown). To control for the lack of an 
effect, the recombinant IL-7 protein (same batch) was subsequently used in T cell 
survival assays (data not shown) to confirm that the IL-7 was bioactive.   
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Figure 5.17 Effect of IL-7 on adipogenesis (K6) 
MSCs were cultured in 96 well plates for 21 days in control media or adipogenic media. 6 
wells were used for each condition. Adipogenic media was supplemented with 20 pg/ml or 
20 ng/ml IL-7. Plates were then stained with Oil Red O (red) to detect lipid vesicles (A). 
Stain was eluted in 100% isopropanol and read on a plate reader at 490 nm (B). The 
addition of IL-7 had no effect on adipogenesis. 
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Figure 5.18 Effect of IL-7 on osteogenesis (K6) 
Cells were cultured in 96 well plates for 21 days in control media or osteogenic media. 6 
wells were used for each condition. Osteogenic media was supplemented with 20 pg/ml or 
20 ng/ml IL-7. Plates were then stained with alizarin red (red) to detect mineralisation (A). 
Stain was eluted in 10% CPC and read on a plate reader at 570 nm (B). The addition of IL-7 
had no effect on osteogenesis. Scale bar 500 µm. 
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Figure 5.19 Effect of IL-7 on osteogenesis 
MSCs (FH450, top and FH441, bottom) were cultured in 96 well plates for 14 days in control 
media or osteogenic medium. 6 wells were used for each condition. Osteogenic medium 
was supplemented with 20 pg/ml or 20 ng/ml IL-7. Plates were then stained with alizarin 
red to detect mineralisation, which was eluted and the absorbance measured at 570 nm. 
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Figure 5.20 Expression of IL-7 signalling components  
RT-PCR confirmed the presence of components of the JAK/STAT signalling pathway in 
MSCs. Human T cells were used as a positive control.  
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5.3.5 IL-7 signalling in MSCs 
IL-7 is known to signal through the JAK/STAT pathway in B and T cells. Initially, IL-7 
is bound by its receptor IL-7Rα, recruiting a second receptor subunit, the common γ 
chain (IL2Rγ) which is a binding subunit shared by many other cytokines. Initiation 
through JAK1 and JAK3 leads to the downstream phosphorylation and activation of 
STAT5. In order to assess the gene expression of these signalling molecules in MSCs, 
RNA was extracted from monolayers of MSCs seeded out 24 hours previously at 2 x 
104 cells/cm2. ADSCs were also included in the analysis to represent MSCs derived 
from an alternative source. RT-PCR confirmed the presence of some of the 
components of this signalling pathway; JAK1 and STAT5B were detected in human 
MSCs but IL2Rγ was only detected in human T cells. JAK3 was present in donors 
FH441, FH181 and K6 but it was not detected human ADSCs or donor FH450 (Figure 
5.20). Knee and femoral head derived MSCs as well as ADSCs showed almost 
identical expression of each of the signalling components.  
 
As the initial step in IL-7 signalling is the binding of IL-7 to its receptor, MSCs were 
then assessed for their ability to bind to IL-7. An assay was carried out using 
biotinylated IL-7 followed by incubation with FITC conjugated avidin that allowed 
the detection of bound protein by flow cytometry (see section 2.7.6). T cells are 
known to bind IL-7 and were used as a positive control. Donors FH441 and K6 were 
also able to bind IL-7 (Figure 5.21, green lines).  Controls including a negative 
control biotinylated protein and a sample incubated with the addition of an 
anti-IL-7 blocking antibody did not show any positive FITC detection, indicating the 
specificity of the assay (Figure 5.21).  
 
In order to address some of the reported downstream effects of IL-7, several 
experiments were carried out to look at altered gene expression. IL-7 is reported to 
have an impact on the inflammatory cytokine IL-6. An increase of IL-6 was detected 
by real time PCR after 3 hours and decreased again at 24 hours to levels observed 
before the addition of IL-7. This pattern of expression was identical in both control 
and treated samples (Figure 5.22, A). A possible explanation is the method of IL-7 
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addition to the MSCs. The culture medium was replaced at the beginning of the 
timecourse with fresh medium containing the IL-7; therefore, the increase may be 
the effect of fresh serum in the medium and not a true IL-7 mediated effect. 
 
IL-7Rα was not detected by flow cytometry in bone marrow derived MSCs from four 
donors in control conditions or following treatment with 20 ng/ml or 20 pg/ml IL-7 
for 24 hours (Figure 5.22, B). Additional concentrations of 0.1 and 10 ng/ml IL-7 
were also used to treat MSCs for 24 hours and RNA was collected and examined by 
real time PCR for the expression of IL-7Rα, IL-7 and nestin. Compared to cells that 
received no IL-7 treatment, 20 pg/ml IL-7 reduced the expression of IL-7Rα 
(p=0.002) but higher concentrations of IL-7 did not alter the expression of the 
receptor. Conversely, the two highest concentrations of IL-7 (10 and 20 ng/ml) led 
to an increase in relative IL-7 expression. Nestin expression was not affected in an 
IL-7 dose dependent manner as 20 pg/ml slightly decreased nestin expression 
(p=0.001), 10 ng/ml decreased it further (p=0.003) but 20 ng/ml increased the 
expression (p= 0.012) compared to the control (Figure 5.23). 
 
 
 
 
 
Chapter 5. Characterisation of IL-7 and nestin in human MSCs 
 
171 
 
 
Figure 5.21 IL-7 binding assay 
MSCs were incubated with IL-7 (green line), a negative protein control (blue line) or no 
protein control (turquoise line) followed by FITC-conjugated avidin. Bound protein could 
then be measured by flow cytometry. To test the specificity of the assay, some cells were 
also incubated with anti-IL-7 antibodies (orange line) which reduced the binding to control 
levels (red line). 
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Figure 5.22 Effect of IL-7 on IL-6 and IL-7Rα expression 
qRT-PCR was used to determine the expression of IL-6 after IL-7 treatment for 3 hours and 
24 hours on MSC monolayers (A). The expression of IL-7Rα was determined by flow 
cytometry after 24 hour treatment with IL-7 (B). No expression was found in any donor (K6 
shown) or after IL-7 treatment. Red line, cells only; blue line, IgG control; orange line, 20 
pg/ml IL-7; green line, 20 ng/ml IL-7. PE-conjugated anti IL-7Rα was used. 
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Figure 5.23 Effect of IL-7 on IL-7 and nestin expression in MSCs (K6) 
Media was supplemented with IL-7 for 24 hours before RNA collection and qRT-PCR 
analysis for nestin (top graph) and IL-7 (bottom graph) mRNA expression. 
p ≤ 0.05 not significant (ns), p < 0.05 *, p < 0.01 **, p < 0.001 *** represents statistical 
significance determined by t-test.  
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5.3.6 IL-7 has no effect on MSC proliferation 
IL-7 is known to enhance T and B cell proliferation. To examine if it has a similar 
impact on MSCs, cells were grown for 7 days in the presence of IL-7 and their 
proliferation assessed by a CCK-8 kit (Dojindo) on days 3, 5, and 7. This kit uses a 
colourimetric assay based on cellular dehydrogenase reduction of a tetrazolium salt 
to give an indication of the number of viable cells present. The amount of formazan 
produced is directly proportional to the number of living cells. An increase in 
absorbance was detected over 7 days in K6 cells and reached a stable level in FH441 
cells by day 3 indicating that the cells had proliferated over 7 days. No increase was 
detected with the presence of IL-7 in either donor examined (Figure 5.24). 
 
In experiments presented earlier in this chapter, IL-7 mRNA expression has been 
seen to increase in MSC cultures at day 7 and beyond, whilst nestin generally 
decreases upon culture and differentiation. In order to assess how quickly these 
changes in gene expression take place in control culture conditions, RNA samples 
were collected daily for 7 days and analysed for nestin and IL-7.  
 
In donor FH450, nestin expression decreased on day 1 to 20% that of the day 0 
sample and maintained a low expression level throughout the 7 days rising slightly 
to 40% on days 6 and 7 (Figure 5.25). IL-7 expression was determined in cells that 
had been seeded out at 2 initial plating densities. All cells had increased IL-7 
expression compared to day 0. Those cells seeded out at the low density generally 
had higher IL-7 expression than their counterparts seeded at a higher density. In a 
repeat of the experiment, K6 cells were seeded out at a range of cell densities. 
Mitomycin C was added for 1 hour on day 0 to a series of cells seeded at 2 x 104 
cells/well to arrest cell proliferation. Nestin was decreased as before to 
approximately 50% that of the day 0 level, which was maintained at days 5 and 7 in 
cells seeded out at 2 x104/well and higher. Those cells seeded lower saw an 
increase in nestin expression over 7 days compared to their day 0 controls. 
Mitomycin C treatment also increased nestin expression at each time point. 
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IL-7 expression increased in the 2 highest seeding densities over 7 days with a peak 
on day 3 followed by a subsequent decrease. Cells seeded at lower densities 
showed a progressive increase in IL-7 over 7 days of culture. Mitomycin C treated 
cells had approximately half the level of IL-7 expression than those cells seeded out 
at the same density, which may indicate a role for IL-7 in proliferating MSCs.  
  
Chapter 5. Characterisation of IL-7 and nestin in human MSCs 
 
176 
 
 
 
 
 
 
Figure 5.24 IL-7 treatment does not affect MSC proliferation 
Cells were seeded into 96 well plates and cultured for 7 days with control media or media 
supplemented with IL-7, which was replenished with media changes. A colourimetric assay 
to measure cell proliferation (CCK-8) was carried out and the resulting absorbance, 
measured at 450 nm, was proportional to the number of viable cells.  
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Figure 5.25 Nestin and IL-7 expression over 7 day culture (FH450) 
MSCs were seeded out at high or low density and RNA collected over 7 days and examined 
by qRT-PCR for nestin (top) and IL-7 (bottom).  
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Figure 5.26 Effect of seeding density on Nestin and IL-7 (K6) 
MSCs were plated at different densities and RNA collected over 7 days to examine nestin 
(A) and IL-7 (B) expression by qRT-PCR. Cells treated with mitomycin C were seeded at 2 x 
104/cm2. Brightfield images show cells on day 0 (C).  
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5.3.7 Generation and analysis of MSC clones 
By the nature of their isolation, MSC cultures are a heterogeneous population that 
may contain cells at various stages of commitment and varying levels of 
differentiation potential. In order to address the expression of IL-7 and nestin in 
cells derived from an individual progenitor, clonal lines were generated. MSCs were 
originally described by their ability to generate colony-forming units and this 
character was exploited to isolate clusters of cells that arose from an individual 
MSC.  
 
MSCs seeded out at clonal density (10 cells/cm2) led to the establishment of CFUs, 
which were harvested and expanded in culture. Many donors (n=6) were set up at 
different passages and into either dishes or wells of a 6-well plate. In several cases 
(62/142 plates), the colonies that were produced were not suitable for harvest due 
to close proximity to other cells or colonies which could lead to isolation of cells 
from multiple progenitors. Higher passage cells (5+) tended to produce an even 
outgrowth of cells in monolayer that did not form defined clusters of cells. In some 
cases, those colonies that were harvested did not: adhere when re-seeded into 
individual wells, expand in culture sufficiently or produce a large enough sample of 
clonal lines.  
 
Two donors, K6 and FH408, yielded 19 and 17 clones respectively that could be 
expanded to sufficient number to extract RNA. K6 colonies had a 100% success rate 
of colony formation to cell expansion, while 59% of FH408 colonies harvested from 
one batch survived and proliferated enough to analyse further. Cells were cultured 
for 4 weeks after colony harvest and seeded into 6-well plates at 5 x 104 cells/well 
and RNA extracted 24 hours later. Real time PCR identified differences in gene 
expression amongst the clones. K6 clones were compared to RNA extracted from 
the parent line of the same passage and showed a range of expression of both 
nestin (Figure 5.27, A) and IL-7 (Figure 5.27, B). The pattern of expression was not 
the same for each gene and in some cases was opposite. Clone 19 showed the 
highest relative expression of IL-7 and high nestin expression whilst clone 3 had 
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highest level of IL-7 and barely detectable level of nestin and clone 13 had much 
higher levels of nestin than IL-7.  
 
Cell numbers were counted as they were harvested to move to increasingly larger 
plates and flasks. The clones that proliferated most and produced the highest final 
cell number were 5, 16 and 19 (Figure 5.27, C). Clones 5 and 16 showed moderate 
expression of IL-7 and nestin and, as mentioned, clone 19 had high levels of both. 
Clones 1, 3, 7, 11, 12 and 15 were used solely for gene analysis as they had 
expanded to sufficient numbers for RNA extraction, but not for further 
differentiation culture. All other clones were also put into osteogenic 
differentiation studies in 96 well plates. Clones 5, 9 and 16 were seeded into 6 wells 
per condition of control or osteogenic media. Owing to the small number of cells, 
the remaining clones had between 1 and 4 wells per condition, so these results give 
an indication of their ability to differentiate but the comparisons are made mindful 
of the small sample number.  
 
Alizarin red staining showed that all clones were capable of osteogenic 
differentiation. Clones 4, 5, 8 and 10 had the highest degree of staining after 21 
days. Each of these clones had a similar, moderate expression of nestin (12 ± 1.9) 
and differed in their IL-7 expression. IL-7 was undetectable in clone 4, and negligible 
in clone 10 but comparable to the parental line in clones 5 and 8. The lowest level 
of staining was in clone 13, which had the second highest expression level of nestin 
and almost undetectable IL-7.  
 
Additionally, 4 clones were analysed for adipogenic potential. Oil Red O staining of 
clones that had been cultured in adipogenic conditions showed that of the 4 clones 
that were analysed, clone 5 did not produce any visible lipid vesicles whilst clone 19 
had many more cells staining positive (Figure 5.30, B). Quantification of the eluted 
stain did not show this clearly; perhaps due to the small amount of stain to be 
measured making small differences indeterminate (Figure 5.30, C). Cells were 
seeded to confluence in 96 well plates and cultured with chondrogenic media for 14 
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days, all of which stained faintly with alcian blue. Clone 16 cells detached from the 
bottom of the well and formed aggregates. Chondrogenesis would normally be 
measured in pellet culture but as not enough cells were available, monolayer 
culture was hoped to give an indication of differentiation. Alcian blue staining was 
weak but apparent in each of the wells with chondrogenic factors and not in control 
wells. An extended period of culture may have increased the differentiation but 
would certainly benefit from traditional pellet culture differentiation. 
 
FH408 clones also showed a range of expression levels for nestin and IL-7 when 
analysed (Figure 5.31). Generally, the clones had low IL-7 expression levels and 
higher nestin levels. Fourteen clones were induced with osteogenic media and were 
all able to differentiate (Figure 5.32, A). Weaker alizarin red staining was observed 
in induced clones 4 and 9 indicating less differentiation (Figure 5.32, B). Clone 4 had 
the highest expression of nestin with a moderate IL-7 level but clone 9 showed a 
similar pattern to the expression levels of other clones. Again, this variation may 
simply be due to the small sample number. Analysis of more clones would allow 
greater prediction of outcome based on gene expression. Only 3 FH408 clones had 
sufficient cells to determine adipogenic differentiation. Clones 1, 4 and 6 all showed 
cells with lipid vesicles with clone 1 generating a greater number of 
positively-stained cells than clones 4 and 6 (Figure 5.32, C).  
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Donor Passage Dishes/wells Colonies 
harvested 
K6 1 10 9 
 3 17 0 
 4 17 19 
 5 3 6 
 6 12 0 
 7 12 0 
FH408 3 8 29 
 4 9 13 
FH441 1 5 20 
 2 3 0 
 3 5 0 
FH496 3 18 0 
FH492 1 3 0 
 2 3 5 
K61 0 17 8 
Table 5.1 CFU-F assays 
MSCs were seeded at clonal density (10 cells per cm2) and cultured for 14 days before 
discrete colonies were harvested using cloning cylinders and trypsinisation. A large number 
were discounted due to apparent cell migration between colonies or close proximity to 
other colonies that could not be distinguished using the cloning cylinders. 
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Figure 5.27 qRT-PCR analysis of K6 clonal lines 
RNA was extracted from 19 clones and examined for expression of nestin (A) and IL-7 (B) 
mRNA. Cell numbers are represented as the total accumulated over 27 days culture after 
initial colony harvest (C). 
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Figure 5.28 Osteogenic differentiation of K6 clones 
Cells were cultured in 96 well plates for 21 days in control media or osteogenic media. Up 
to 6 wells were used for each condition. Plates were then stained with alizarin red (red) to 
detect mineralisation (A). Stain was eluted in 10% CPC and read on a plate reader at 570 
nm (B). 12/19 clones were assayed for osteogenic ability. 
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Figure 5.29 Osteogenic differentiation of K6 clones 
Relationship between IL-7 and nestin gene expression and osteogenic differentiation 
performance of K6 clones. 
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Figure 5.30 Adipogenic and chondrogenic differentiation of K6 clones 
Cells were cultured in 96 well plates for 14 days in control media or chondrogenic or 
adipogenic media. Up to 6 wells were used for each condition. Plates were then stained 
with alcian blue (A) to detect chondrogenic differentiation or Oil Red O (red) to detect lipid 
vesicles (B). Oil Red O stain was eluted in 100% isopropanol and read on a plate reader at 
490 nm (C).  
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Figure 5.31 qRT-PCR analysis of FH408 clonal lines 
RNA was extracted from 19 clones and examined for expression of nestin (top) and IL-7 
(bottom) mRNA. Expression is represented relative to clone 1. 
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Figure 5.32 Differentiation of FH508 clones 
Cells were cultured in 96 well plates for 21 days in control media or osteogenic media. 
Plates were then stained with alizarin red (red) to detect mineralisation (A). Stain was 
eluted in 10% CPC and read on a plate reader at 570 nm (B). 14/17 clones were assayed for 
osteogenic ability. 3/17 clones were assayed for adipogenic ability and stained with Oil Red 
O at day 14 to examine the presence of lipid vesicles (C).  
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5.4 Summary 
The characterisation and understanding of HSCs was significantly improved by the 
discovery of a panel of SLAM receptors that could distinguish between stem cells 
and progenitors. It is hoped that the same can be achieved in MSC biology by the 
identification of markers that can be used to prospectively isolate MSCs. There is a 
lack of coherence in the field about which markers are best suited to assess MSCs 
as well as evidence to suggest that a number of different subsets of MSCs exist. 
Results presented in this study have identified murine mesenchymal cells that are 
potentially derived from an IL-7-expressing MSC and that these cells are able to 
form 3D spheroids in culture. Therefore, the experiments in this chapter were 
undertaken to explore the potential of IL-7 expression in human MSCs. Bone 
marrow derived MSCs could be differentiated in the presence of induction medium 
containing osteogenic, adipogenic and chondrogenic factors. During differentiation, 
levels of IL-7 were generally increased in comparison with day 0 controls, whereas 
nestin expression was decreased, which is in agreement with data reported for its 
downregulation in neuronal cells when differentiating from neural crest stem cells 
and indicative of it being used as a stem cell marker.  However, IL-7 had no effect 
on osteogenic or adipogenic differentiation of MSCs in vitro and therefore MSCs 
may express IL-7 but not respond themselves to IL-7. 
 
MSC isolation strategies give rise to heterogeneous populations of cells in culture 
that have varying differentiation potentials. This has been demonstrated by the 
analysis of clonal lines and was confirmed by the generation of MSC clones in this 
study. In order to determine the association between IL-7 and nestin expression 
and the efficiency of differentiation, clonally derived cells were differentiated in 
vitro.  The hypothesis was that the MSC clones expressing the highest levels of each 
gene would represent true stem cells and be the most effective at tri-lineage 
differentiation.  Owing to the small sample size, little can be drawn from the 
differentiation studies, although tentatively it was clear that high mRNA expression 
of IL-7 and nestin did not bestow a dramatic advantage in differentiation capacity. 
 
  Chapter 6. General discussion 
190 
 
6 General Discussion 
 
This thesis has examined two proteins: nestin and IL-7, as potential markers for 
bone marrow derived MSCs in the context of MSCs providing a niche in the bone 
marrow for HSCs. Despite the existence of MSCs being demonstrated nearly 50 
years ago, the accurate description of their in vivo location and prospective 
isolation has remained elusive. MSCs are able to extensively differentiate into fat, 
cartilage and bone and are an essential component in forming a niche for HSC 
maintenance in the bone marrow. Whilst nestin has already been described as a 
potential stem cell marker in a wide range of tissues and is detected on MSCs that 
have potentially been derived from the neural crest, the functional role of nestin in 
stem cells is yet to be determined. IL-7, on the other hand, is known to be 
expressed by stromal cells in the bone marrow and has a critical role in B cell 
development but the exact nature of the cells that express it is not fully 
understood. Therefore, studying the characteristics of MSCs, IL-7 and nestin could 
provide new insights into the regulatory mechanisms involved in the stem cell 
niche. 
 
Using a novel mouse model in which Cre recombinase, under the control of IL-7 
regulatory elements, drives YFP expression, IL-7-reporter expression was identified 
in mesenchymal-lineage cells in the bone and bone marrow. Immunodetection to 
enhance the signal determined YFP expression in bone lining cells, in central bone 
marrow cells and in cells closely associated with vasculature consistent with the 
location and morphology of cells expected to derive from mesenchymal 
progenitors.  Interestingly, YFP was not detected in every cell of the same type at 
identical locations, for example only approximately 20% of osteocytes in the bone 
were YFP+ (Table 3.1). It was therefore predicted that IL-7 had been expressed in a 
common progenitor that had given rise to the mature cells and that IL-7 could be 
used to identify a specific subset of MSCs in the bone marrow. This supports 
observations of another study using an alternative transgenic model of IL-7 where 
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GFP is knocked into the IL-7 locus and therefore IL-7 expressing cells also express 
GFP. A high proportion of VCAM-1 staining was observed on GFP positive cells and 
an endosteal location of the cells was suggestive of a mesenchymal cell 
identification (Hara et al, 2012). A large proportion of GFP positive cells were also 
identified as PDGFR+ Sca-1+, markers which have previously been used as part of a 
panel to identify mMSCs that were found to be quiescent and located in a 
perivascular region (Morikawa et al, 2009a). If the GFP positive cells were MSCs, 
they would be ideally located to provide HSCs in a perivascular niche with IL-7 to 
promote lymphopoiesis while the GFP positive cells at the endosteum could be 
osteoblastic cells that exert a regulatory effect on osteoclastic activity. 
 
Two mechanisms of bone formation known as intramembranous and endochondral 
ossification are employed in the developing skeleton, therefore bones formed by 
each process were examined to determine if IL-7 reporter expression was located in 
the same regions. In each case, MSCs initially form condensations during 
development that then either directly differentiate to form bone in the case of 
intramembranous ossification, or create an intermediary cartilage template before 
bone mineralisation occurs (endochondral). Little is known about this initial 
aggregation of MSCs and the subsequent initiation of bone modelling. If the MSCs 
were to express IL-7 at this point, it would follow that all of the bone and cartilage 
tissue would express YFP. In chapter 3, examination of embryonic tissue found only 
a small proportion to be YFP positive cells in the femur (formed by endochondral 
ossification), indicating that IL-7 is not expressed until the cartilage template is 
complete. Interestingly, YFP cells were not detected in the embryonic sternum 
(formed by intramembranous ossification) that was at the same developmental 
stage as the femur, indicating anatomical differences in the onset of IL-7 expression 
in bones and between bones that are formed by different processes.  
 
Analysis of the adult sternum showed a distinct expression pattern of YFP in the 
hypertrophic chondrocytes next to the cartilage costal regions. At the knee joint 
surface, IL-7 reporter was expressed in the layer of articular chondrocytes and, less 
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extensively in the hypertrophic chondrocytes compared to the sternum. These 
findings suggest further anatomical variation in IL-7 expression by chondrocytes in 
the adult. IL-7 has been reported to be increased in chondrocytes with age, which 
may explain some of the YFP expression in the adult mice. Chondrocytes also play 
an important role in the progression of RA and are therefore of interest to 
determine the interaction of IL-7 in this, and other, inflammatory conditions. As the 
long bones develop, the primary ossification centre initiates bone formation in a 
collar that extends from the centre to the ends of the bone. The chondrocytes are 
replaced with bone, apart from at each distal end of the bones where articular 
cartilage is not calcified and remains covering the joint surface. Secondary sites of 
ossification appear within the ends of the bone where chondrocytes also remain in 
the growth plate to increase bone length into adulthood. Therefore, traditional 
concepts of bone formation are challenged and either bone formation can be 
initiated by a mixed population of MSCs, or IL-7 expression may be restricted to 
more committed progenitors and mature cells.  
 
As a gene associated with haematopoietic support, IL-7 transcript expression was 
found to be high in CD271+ MSCs isolated from bone marrow aspirates of healthy 
individuals. A non-significant decrease in its expression was detected in cultured 
MSCs (Churchman et al, 2012) . This is consistent with the role of MSCs being 
intrinsic to haematopoietic function and importantly shows the expression of IL-7 in 
freshly isolated MSCs. IL-7 production from MSCs has also been reported in MSCs 
derived from the human periodontal ligament (PDL) (Trubiani et al, 2008) which 
were able to support in vitro haematopoietic progenitors in long-term culture 
initiating cell assays. IL-7 was detected by ELISA in the supernatants of cultured 
MSCs at concentrations of approximately 10 pg/ml, which were higher than reports 
of IL-7 in cultures of bone marrow MSCs (Isgro et al, 2005). The level of IL-7 
detected increased to 20 pg/ml and 120 pg/ml after several weeks of osteogenic 
and adipogenic differentiation, respectively (Trubiani et al, 2008). This differential 
expression is the opposite to this study, which has shown at the transcript level 
where adipogenesis induced a decrease in IL-7 mRNA in some donors and suggests 
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that MSCs from different sources have different characteristics and distinct 
functional attributes. It is suggested that IL-7 expression from PDL-MSCs may 
contribute to tooth development or regeneration but has yet to be explicitly 
determined and highlights the requirement for fully investigating cell potential and 
defining key cell surface markers for their accurate isolation with consistency 
between tissues. 
 
IL-7 expression by differentiated mesenchymal cells. 
Despite charting the fate of IL-7 expressing cells as they differentiate, the IL-7Cre 
Rosa26-eYFP mouse model cannot explicitly demonstrate the current IL-7 
expression status of cells that are YFP+. Therefore, it remains a possibility that IL-7 
may be expressed at the time of analysis by a proportion of the YFP+ cells and is 
required for the functional roles of these mature cells in the bone marrow. Based 
on the physical location of YFP positive cells and information that is reported about 
IL-7 in the bone marrow, several candidates could be proposed as the source of 
IL-7, including osteocytes, osteoblasts and endothelial cells.  
 
Under certain situations, such as PTH stimulation, osteoblasts are known to express 
IL-7 (Zhu et al, 2007). Some IL-7 reporter-expressing cells have the potential to be 
osteoblasts given their endosteal and bone lining location identified in chapter 3. In 
order to confirm the presence of YFP in osteoblastic cells, immunostaining with 
markers osteocalcin and osteopontin was performed on femoral sections from 
IL-7Cre Rosa26-eYFP mice. Unfortunately, staining was not successful and echoes 
similar problems that have been reported in staining osteoblasts for these 
molecules (Mazzucchelli et al, 2009). With so many osteoblasts present at the 
endosteum, discerning which ones make a functional contribution to the niche is a 
complicated process and has resulted in contradictory evidence regarding whether 
or not they are essential in the HSC niche. Recently, two papers have been 
published with evidence to support the theory that distinct niches exist for HSC 
progenitors as well as stem cells. CXCL12 is expressed by osteoblasts, stromal cells 
and endothelial cells. Cell-specific selective depletion was performed in a similar 
  Chapter 6. General discussion 
194 
 
mechanism of Cre mediated depletion in both studies to determine the key niche 
cells that are the essential sources of this chemokine. It was revealed that CXCL12 
expression comes predominantly from CAR cells with a minor contribution from 
mature osteoblasts and endothelial cells. Osterix Cre mediated CXCL12 depletion in 
mature osteoblasts and CAR cells which led to HSC mobilisation and a loss of B 
lymphopoiesis, indicating these cells are required for HSC retention and supportive 
function in B cell development. Osteocalcin Cre activity demonstrated no effect of 
the depletion of CXCL12 in mineralising osteoblasts.  
 
Surprisingly, when Prx-1 Cre mediated CXCL12 depletion in mesodermally derived 
cells, dramatic effects were noted in the loss of HSCs, their quiescence and common 
lymphoid progenitors. Prx-1 Cre was found to target PDGFR+Sca-1+ cells that were 
capable of high CFU-F forming efficiencies (much higher than those determined in 
nestin-GFP+ MSCs).  Perivascular cell markers: CD146, leptin receptor and nestin 
were not detected in these PDGFR+Sca-1+ cells. Common haematopoietic 
maintenance gene expression of kit ligand and ang-1 was also absent in these cells 
and could point to IL-7 being the key factor in both HPC retention and B 
lymphopoiesis mechanisms (Greenbaum et al, 2013). Similar cell types showed 
expression of CXCL12 when reported using a dsRed knock-in into the CXCL12 locus. 
Cell-specific deletion of CXCL12 in haematopoietic cells and nestin-cre expressing 
cells had little effect on HSCs or restricted progenitors, questioning the role of 
CXCL12 expression or secretion by these cells. Leptin receptor expressing cells that 
were specifically deleted for CXCL12 resulted in the mobilisation of HSCs, indicating 
their role in the retention of HSCs (Ding & Morrison, 2013). 
 
Osteocytes are derived from osteoblasts that become embedded in bone matrix 
and remain in communication with the bone-lining cells through long cytoplasmic 
processes and a network of channels called canaliculi. The mechanism for 
osteoblast conversion into osteocyte is not well understood. Osteocytes represent 
95% of all cells in the bone and approximately a fifth of osteocytes examined in 
tissue sections were found to express YFP. As it is known that osteoblasts can 
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express IL-7, so it is reasonable to accept that a proportion of these cells are 
enveloped into the bone and could account for the YFP+ osteocytes and, 
additionally, that IL-7 signalling has no functional role in these terminally 
differentiated cells. However, some similarities exist between the signalling 
mechanisms involved in osteoclastogenesis mediated by osteocytes and T cells. IL-7 
production from stromal cells has been seen to induce RANKL in T cells, resulting in 
the subsequent activation of osteoclasts and bone resorption (Weitzmann et al, 
2000). Osteocytes have also been reported to increase RANKL expression in 
response to microdamage of bone in order to initiate osteoclastogenesis in the 
process of bone remodelling (Kennedy et al, 2012). As IL-7 and its receptor mRNA 
have been reported in osteocytes, they may be able to respond to IL-7 by up-
regulating RANKL and potentially express IL-7 themselves to perpetuate the signal.  
However, IL-7 gene expression in osteocytes with activated PTH receptor was not 
altered compared to wild type mice (Calvi et al, 2012). PTH stimulates bone 
formation and increases the number of osteoblasts and osteocytes and subsequent 
IL-7 expression from osteoblasts. As IL-7 is reported to reduce bone formation and 
increase osteoclastogenesis, a threshold level may occur that initially promotes 
bone remodelling in a regulatory mechanism but that breaching a critical level 
results in sustained bone resorption and a decrease in bone mass. Osteocytes are 
worthy of further investigation as it becomes clear they are not just retired 
osteoblasts but have a pivotal role in initiating bone remodelling.  
 
YFP was detected throughout the central bone marrow and associated to vessel-like 
structures. Others have demonstrated this concentration of IL-7 reporter cells 
around vasculature in the bone marrow using a similar transgenic mouse that 
directly marked IL-7 producing cells with eCFP on account of a BAC transgene 
containing eCFP in the IL-7 locus  (Mazzucchelli et al, 2009). Homing in on the cells 
that express IL-7 in the bone marrow will lead to the refinement of the cells 
considered to be part of the HSC niche.  
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YFP was not detected in adipose tissue surrounding the leg bones in IL-7Cre 
Rosa26-eYFP mice. Mice overexpressing IL-7 have a decreased adipose tissue mass 
associated with a higher number of smaller adipocytes than controls. PCR detected 
similar levels of IL-7 mRNA in adipocytes and the stromal vascular fraction (SVF) of 
adipose tissue but higher levels of the IL-7 receptor in SVF cells (Lucas et al, 2012). 
This indicates that these cells may be able to express and respond to IL-7 signals 
and that the SVF cells are more likely to be responsive to IL-7 regulation of fat 
tissue. This fraction contains endothelial cells, macrophages and adipo-progenitors 
that are potentially stimulated by IL-7 to differentiate into adipocytes. The 
observation that adipocytes were not YFP+ suggests that they do not arise from an 
MSC that has expressed IL-7. IL-7 expressing MSCs may therefore be restricted in 
their differentiation capacity. In the differentiated cell type, it may be explained by 
the IL-7 reporter that may not be expressed in these cells due to a level of IL-7 
expression too low to initiate reporter expression, or it may be expressed 
differently in various adipose regions. Regulation of the adipogenic differentiation 
pathway is largely unknown but IL-7 clearly has an indirect role on the fate of 
adipocytes at least.  
 
Similarities between IL-7Cre expression and nestin-GFP expression 
Originally identified as a marker of central nervous system stem cells, which is then 
downregulated and replaced during their differentiation into the mature cells of the 
nervous system, nestin has been reported in stem cells and progenitors in the adult 
brain, heart and pancreas (Reviewed by Wiese et al, 2004). In an attempt to 
uniquely characterise murine MSCs, nestin was used as a marker of MSCs whose 
progeny show a remarkable similarity to the distribution of YFP+ cells in the IL-7Cre 
Rosa26-eYFP mice (Mendez-Ferrer et al, 2010). Of particular note was the feature 
that not all cells of a certain lineage expressed nestin; for example, only a fraction 
of the osteocytes were derived from nestin+ MSCs, which is comparable to the YFP 
expression in IL-7Cre Rosa26-eYFP mice demonstrated in this study. This was also 
highlighted in histological images of 4-week-old mouse femurs (Mendez-Ferrer et 
al, 2010). Hypertrophic chondrocytes were visibly distinct in origin from their 
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neighbours and in contrast to the vast majority of YFP+ articular chondrocytes that 
have been demonstrated in this study, very few articular chondrocytes appeared 
derived from nestin+ MSCs. Nestin+ cells have been detected by 
immunohistochemistry as spindle-shaped cells located at the endosteum and 
throughout the central marrow, which were increased in wild type mice treated 
with PTH but not in mice with activated PTH1R. However, not all of these 
spindle-shaped cells were positive for nestin (Calvi et al, 2012). This suggests 
another subset of MSCs distinct from nestin+ cells that are also expanded in 
response to PTH treatment. IL-7 is well placed to mark this unique subset of MSCs. 
The authors propose that the nestin positive cells that associated with trabeculae 
were potentially osteoblastic cells and their gradual decline from the bone marrow 
of transgenic mice with constitutively activated PTH1R contributed to the loss of 
bone marrow HSC support (Calvi et al, 2012).  
 
Can MSCs respond to IL-7? 
An altruistic mechanism is proposed in T cell populations that promotes the 
maximal survival of T cell numbers. It is thought that this is achieved by a 
dowregulation of IL-7Rα in response to an IL-7 signal which allows further IL-7 to be 
shared with remaining T cells (Park et al, 2004). A significant downregulation of 
IL-7Rα was observed after incubation with 20 pg/ml IL-7 for 24 hours in human 
MSCs (Figure 5.23). Higher doses of IL-7 treatment did not have any effect on the 
expression of IL-7Rα, suggesting that a negative feedback response is not initiated 
in MSCs in the presence of IL-7. A different effect may have been observed 
analysing the samples after a shorter period in culture.  
 
Results detailed in chapter 5 also indicate that addition of IL-7 to in vitro cultures 
and its continued presence throughout had no impact on the differentiation of 
MSCs. As IL-7 reportedly downregulates bone formation upon administration in 
vivo, this was unexpected. The two concentrations of 20 pg/ml and 20 ng/ml are 
above those reported in serum screens from normal patients and those with 
arthritis but may not present a high enough tissue specific dose to exert its effect, 
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or IL-7 may indirectly cause the block of bone formation and the linking cell type is 
missing from the in vitro situation. IL-7 also had no effect on the proliferation of 
MSCs. The lack of responsiveness to IL-7 is coupled with the finding that the γc 
co-receptor could not be detected by PCR. However, IL-7Rα transcript was detected 
and MSCs could efficiently bind IL-7 as demonstrated in the flow cytometric binding 
assay and although further investigation would need to assess the functional 
signalling of IL-7 by detection of phosphorylated JAK/STAT proteins, the basis of the 
signalling pathway is present in these MSCs. Potentially, IL-7 could also signal 
through Flt3 and c-kit receptors (Cosenza et al, 2002).  
 
Does IL-7 and nestin expression predict MSC function? 
Bone marrow flushes of IL-7Cre Rosa26-eYFP mice were sorted by flow cytometry 
and it was predicted that a small number of the CD45- YFP+ cells may be MSCs 
capable of multipotent differentiation. Unfortunately, attempts at osteogenic and 
adipogenic differentiation and CFU-F assays were unsuccessful. Whilst some cells 
initially adhered to the plates, further growth or proliferation was not observed. A 
combination of growth factors was added to the medium to encourage MSC 
expansion but again this was unsuccessful. It is possible that the appropriate 
growth factors that would be provided by a heterogeneous cell population from the 
bone marrow were not fully compensated for and a critical factor remained absent, 
which led to the death of the cells. Others have reported that the IL-7 reporter cells 
from bone marrow are very fragile (Mazzucchelli et al, 2009) and they may have 
been irreparably damaged during the processing. Murine MSCs are generally more 
difficult than their human counterparts to culture in vitro and variations in culture 
requirements and growth properties have been shown to be dependent on mouse 
strain and the presence of haematopoietic cells during initial expansion (Peister et 
al, 2004). As the proportion of progenitor cells in the YFP+ fraction is likely to be 
small even when plated at high density, there may not have been sufficient number 
of MSCs to support paracrine stimulation and survival. Similar to the culture 
method used for neural stem cells, nestin+ MSCs were able to form cell aggregates 
or ‘mesenspheres’ when seeded out at low densities (Mendez-Ferrer et al, 2010). 
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Although isolated YFP+ cells were not sufficiently maintained to generate cellular 
aggregates from clonal seeding methods, they did successfully form spheroids 
when cultured in methyl-cellulose media. YFP negative cells were also able to form 
spheroids, indicating an intrinsic factor was met in 3D culture that enabled murine 
stromal cell survival in vitro. 
 
Additionally, CAR cells identified by GFP expressed under the promoter of the 
CXCL12 locus have been reported to die immediately in culture when sorted from 
transgenic mice. The investigators therefore used whole bone marrow cultures in 
vitro that maintained the CAR cells in a viable state and allowed them to undergo 
differentiation. GFP+ pre-adipocytic cells and cells expressing ALP were identified 
after adipogenic and osteogenic differentiation respectively (Omatsu et al, 2010). It 
is therefore conceivable that a subset of the YFP+ cells isolated might be CAR cells 
and that their culture in vitro would be assisted by heterogeneous culture with the 
whole bone marrow. It will also be interesting to examine the CXCL12 expression 
status of YFP+ cells.  
 
CD146 is an adhesion molecule that was first identified in melanoma cells and 
recognised for its association with tumour progression (Lehmann et al, 1989). 
CD146 has since been reported in human endothelial cells in the thymus and on 
circulating endothelial progenitor cells (Duda et al, 2006). Bone marrow-derived 
CD146-expressing human subendothelial cells have been demonstrated to 
recapitulate the bone and marrow at ectopic sites when transplanted in irradiated 
mice (Sacchetti et al, 2007) but CD146 has not been reported on murine MSCs. 
Studies in mice have reported CD146 expression on endothelial cells in a range of 
tissues including kidney, spleen, heart and liver but relatively little is known about 
its function (Schrage et al, 2008). A population of natural killer (NK) cells in the bone 
marrow have also been isolated with CD146 expression (Despoix et al, 2008).  
 
Immunostaining of IL-7Cre Rosa26-eYFP bone sections revealed cells throughout 
the bone marrow that expressed CD146 which were small, round cells but did not 
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seem to be organised around vascular areas or have an expected spindle-shaped 
appearance. The CD146 positive cells detected may be NK cells or perhaps 
neutrophils but are unlikely to be other lymphocytes as murine B, T and monocytes 
reportedly do not express CD146 (Despoix et al, 2008). Further investigation would 
be required to evaluate the localisation of CD146 in the bone marrow and if these 
cells were in any way associated with IL-7 cells. CD146 is expressed by stem cells 
and progenitor cells in humans and has been reported in a variety of murine cells 
that contribute to the HSC niche such as endothelial cells. Therefore, although 
CD146 was not co-localised with YFP in the tissue examined, it remains conceivable 
that CD146 has a role to play in the bone marrow microenvironment.   
 
Examination of the YFP+ cells determined that they were in close proximity to 
CD169+ macrophages in the bone marrow. CD169+ macrophages are reported to 
support the retention of HSCs by nestin+ MSC. Macrophage depletion did not alter 
numbers of nestin+ MSCs or osteoblasts after 7 days but it decreased the gene 
expression of CXCL12, Ang-1, KitL and VCAM-1 in MSCs (Chow et al, 2011). As an 
important factor in the attraction and retention of HSCs, CXCL12 is expressed by 
osteoblasts and stromal cells. Its expression in osteoblasts was not changed upon 
macrophage deletion, adding some weight to the argument that osteoblasts are not 
essential components of the HSC niche. VCAM-1 was also detected on 
approximately half of the YFP+ cells, indicating these cells may be involved in the 
retention of HSCs in the bone marrow.  
 
Cells in vitro have altered behaviour depending on their culture environment 
including growth substrate, nutrient medium and co-culture with additional cell 
types. Therefore, considering MSCs in a 3D model will improve the understanding 
of the interactions and regulatory mechanisms of MSCs in the HSC niche. The use of 
a simple 3D cellular spheroid model bridges the gap between the in vivo 
environment and traditional 2D culture by providing greater cell-cell contact and 
additional mechanical forces in the structure created. This study has focused on a 
model of simple cellular spheroids that were reproducibly formed in static culture 
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using 4 x 104 C3H10T1/2 cells, a common murine cell model of MSCs. Cells within 
the spheroids were found to be quiescent after 48 hours and able to differentiate 
down osteo-, chondro-, and adipogenic lineages. 
 
Addition of primary murine HPCs to C3H10T1/2 cells also resulted in the 
spontaneous formation of spheroids. In work presented in this thesis, cells were 
observed leaving the main body of the spheroid after 3 days of co-culture and 
congregating and expanding around the spheroid, preferentially attaching to the 
tissue culture plastic. Further examination demonstrated that the cells were F4/80+ 
macrophages. Whilst the source of the macrophages was not determined, they 
were potentially either contaminants in the HPC fraction or were differentiated 
from them in the spheroid; they may provide a beneficial additive to the 3D model 
given the reported roles of niche macrophages. The macrophages may support the 
MSC function of HPC maintenance and further analysis would be required to 
measure the impact of their presence.  
 
Fluorescent labelling of the HPCs allowed monitoring of their location within the 
spheroids. A proportion of these cells were identified outside of the main body of 
the spheroid and further characterisation would confirm if they are HPCs and not 
differentiated cells. It remains a possibility that they were also able to re-enter the 
spheroid in a manner similar to that in vivo that allows a small proportion of HSCs 
to enter the peripheral circulation from the bone marrow and back again.  As the 
HPCs were isolated from the foetal liver, where HPCs are known to extensively 
proliferate before homing to the bone marrow, the tissue source of origin may have 
an impact on the mobilisation characteristics of these cells. Further characterisation 
is needed to assess the level of mobility that the HPCs have within the spheroid 
model and the role played by the stromal and macrophage cells in retaining HPCs. 
 
Nestin is increasingly becoming regarded as a marker of stem cells and progenitors. 
In order to address if nestin was expressed by human MSCs, gene expression 
analysis and immunohistochemistry was performed on primary MSCs. In agreement 
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with these findings, results in chapter 5 demonstrate nestin mRNA is expressed by 
bone marrow MSCs and is subsequently decreased during osteogenic and 
adipogenic differentiation. This pattern was not noted in chondrogenic cells and 
nestin was in fact increased in some cases, when compared to the control. Cellular 
spheroids are believed to enhance the in vitro stem cell environment and enable 
cells to retain a more immature phenotype compared to traditional 2D culture. 
Chondrogenic differentiation is carried out in a 3D pellet structure and may 
therefore have altered gene expression and potentially improved conditions to 
sustain primitive stem cell features. Therefore, it might be expected that nestin 
expression would be increased in this situation. Indeed, when assessed at day 0, 
two of the three donors had nestin levels at least 4-fold more than that of the 
monolayer culture. During differentiation, however, nestin levels were detected 
above that of the appropriate control at each time point, although this was not 
always statistically significant. Therefore, nestin expression was highest in 3D 
compared to 2D culture but the factors contributing to the upregulation in 3D were 
not over-ridden by the chondrogenic differentiation of the cells as might be 
expected.  
 
Nestin is reported to be re-expressed in stem cells that respond to tissue demand 
for regeneration and remodelling (El-Helou et al, 2005). MSC populations may exist 
as a reservoir of cells ready to be activated and generate bone and cartilage tissue 
and be induced to up-regulate nestin to acquire a more immature phenotype, 
rendering them more able to proliferate and differentiate into the required cells. 
The in vitro situation of osteogenesis and bone remodelling is somewhat artificial, 
whereas the chondrogenic process involves deposition of ECM from the cells 
undergoing differentiation. Additionally, cells are under different mechanical forces 
and as nestin is an intermediate filament, it may have a more functional role in the 
changes in the cytoskeleton that occur in cells cultured in 3D. A combination of 
these factors may contribute to the observed increase in nestin during 3D culture 
and differentiation. 
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Alternatively, other culture conditions such as time in culture and factors present in 
the growth medium could account for the observed differences, as described in 
studies carried out in mice. Nestin expression has been reported on 50% of murine 
MSCs isolated to study the expression of nestin as a marker of neuronal 
differentiation potential and in a population of mMSCs that were first 
immunodepleted to exclude the presence of  endothelial and haematopoietic cells 
(Baddoo et al, 2003; Tropel et al, 2006). However, it has also been reported that 
nestin expression is upregulated in a number of cell types following culture in vitro 
and therefore its expression in bone marrow MSCs may be an artefact of culture. In 
both cases mentioned above, the cells were cultured for 10-20 passages or 8 days 
respectively, before analysis, which may have allowed the expression of nestin.  
Nestin was upregulated in rat MSCs after several population doublings in vitro or 
upon neuronal differentiation which was carried out in serum-free medium (Wislet-
Gendebien et al, 2003). Serum removal also independently induced nestin 
expression in another study of bone marrow MSCs (Wautier et al, 2007). 
Chondrogenic culture is performed in serum-free medium which may be 
responsible for inducing nestin expression in this instance and suggests the 
presence of a factor in serum that inhibits the expression of nestin. 
 
MSCs – a heterogeneous population of IL-7 and nestin expressing cells 
This study generated a total of 36 clones from two patient donors, which revealed a 
varying level of nestin and IL-7 mRNA expression between MSCs. Induction of 
osteogenic, adipogenic and chondrogenic pathways also determined variation in 
the differentiation potential of clonally derived cells. Of the 26 clones that were 
assessed for osteogenic potential, all were able to show some degree of osteogenic 
differentiation with only one out of seven clones showing a distinct lack of Oil Red 
O staining to indicate the absence of adipogenic differentiation. Chondrogenic 
differentiation was not confidently determined and improved cell numbers would 
be required for further assessment. As the clones were cultured in vitro before 
analysis, a necessity to obtain enough cells to analyse, a possible explanation for 
the loss of adipogenic potential and the decreased ability to differentiate 
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osteogenically is that the multipotency which the cells had when first isolated was 
reduced or lost in culture and therefore not representative of the original cells. It is 
also possible that the cells which were able to form colonies were committed 
progenitors only capable of restricted differentiation and that the initial CFU-F 
assay selected for these cells.  
 
As nestin has been previously proposed as a marker of stem cells and bone marrow 
MSCs, it is hypothesised that cells with the highest expression levels of nestin would 
be the most immature cells and therefore have the greatest potential to perform as 
stem cells in their self-renewal and proliferation in culture and the widest 
differentiation potential. In the clones that were generated this did not appear to 
be the case. It may be that at the time of RNA extraction, the cells were not in a 
state that was representative of homeostatic nestin expression, which would 
therefore skew the subsequent results. Nestin is downregulated in the stationary 
growth phase (Zimmerman et al, 1994). Although cells were seeded at the same 
density and collected at the same time point, some cells were certainly more 
proliferative than others. This supports the theory that some clones lose their 
stemness in culture and began to ‘age’.  
 
Immunohistochemistry was carried out in order to determine the presence of 
nestin protein in MSC cultures and, as demonstrated in chapter 5, nestin expression 
has been detected in the cytoplasm of MSCs, consistent with its expected cellular 
location as an intermediate filament. However, in donor K6 cells, nestin was weakly 
expressed in the nucleus of most of the cells, suggesting its mis-localisation or an 
alternative cellular function. A similar distribution has been reported in neurogenic 
tumour lines where nuclear staining was observed in cells with a weakly staining 
cytoplasm. Nuclear nestin was determined in 3/11 tumour lines and had variable 
expression between cells and lines as detected by Immunofluorescence and cellular 
fractionation followed by Western blot analysis (Krupkova et al., 2011). However, 
within their study only 10% of cells in each line expressed nuclear nestin and these 
cells were lost during culture in favour of purely cytoplasmic expression of the 
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protein, suggesting no benefit of the nuclear expression in culture at least 
(Krupkova et al, 2011). Relatively little is known about the nuclear localisation of 
nestin and the evidence that is presented is contradictory, highlighting the need for 
further characterisation. 
 
Antisense transfected nestin clones from neuroblastoma lines reduced the 
expression of nestin approximately 1.5 fold but the level of N-myc protein was 
unchanged. This led to the reduced motility and colony-forming efficiency of the 
neuroblastoma clones compared to the parental line, suggesting the roles of 
tumour migration and cell proliferation that were previously attributed to N-Myc 
expression were in fact regulated by nestin, presumably downstream of N-Myc 
(Thomas et al, 2004). However, another study analysed over 30 paraffin embedded 
neuroblastoma samples and found no association between nestin expression and 
proliferation or tumour malignancy and only 1/7 neuroblastomas expressed nestin 
(Korja et al, 2005). As nestin cannot be transported into the nucleus by 
nucleopores, an alternative suggestion is that the ancestral gene of nestin was 
lamin-like and that other intermediate filaments arose and lost the nuclear 
localisation signal. (Dahlstrand et al, 1992; Dodemont et al, 1990). Nuclear 
interaction of nestin and DNA has been suggested (Hartig et al, 1998) but 
essentially, the functional role of nestin is still not well understood. This study has 
shown that bone marrow MSCs express nestin, which is subsequently 
downregulated upon osteogenic and adipogenic differentiation and therefore 
supports the theory that nestin is a marker of stem cells. Evidence suggesting roles 
for nestin in the proliferation and migration of cells is inconsistent and results from 
this study can only hint at an effect of nestin on proliferation due to the small 
number of clones generated. 
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6.1 Thesis conclusions 
MSCs and their progeny have been described as essential components of the HSC 
niche. The HSC niche has been proposed to be located in close proximity to the 
endosteum or alternatively near blood vessels in the bone marrow. Furthermore, 
this theory is currently being extended to include niches that exist for progenitors 
that overlap and interplay. Each niche location has a different composition of cell 
types and availability of factors such as oxygen concentration, and consequently the 
microenvironment is thought to control different aspects of HSC renewal and 
differentiation. In a logical extension, MSCs present at each location may also be 
differentially activated to regulate HSC fate. Evidence to suggest that MSCs are 
derived from distinct embryonic origins such as the neural crest (Nagoshi et al, 
2008) and the mesoderm (Vodyanik et al, 2010) supports the theory that the bone 
marrow is host to a number of different subsets of MSCs that may have variable 
expression profiles and different functional attributes. 
 
IL-7 has been examined in this study as a potential marker of bone marrow derived 
MSCs. A novel IL-7Cre BAC transgenic mouse model facilitated the identification of 
cells that appeared to arise from a subset of MSCs given the distribution of the 
mature cells in the bone marrow that were YFP (IL-7 reporter) positive.  
Understanding and acquiring information about the key components involved in 
the HSC niche will lead to more accurate representations of the microenvironment 
that can potentially be exploited to manipulate haematopoiesis in a clinical setting. 
For example, the number of HSCs is known to be a limiting factor in bone marrow 
transplantation. Therefore, the ability to expand these HSCs in culture would offer 
greater potential for therapeutic use. Maintaining the ability of stem cells to self 
renew ex vivo is difficult and the challenge now is to imitate these complex stem 
cell niches in vitro in order to better control stem cell renewal and differentiation.  
 
The generation of an in vitro spheroid model reproduced in vivo attributes of the 
stem cell niche such as cell quiescence and stromal organisation but was unable to 
sufficiently maintain HPCs in culture and requires further modification. The 
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functional roles of IL-7 and nestin in MSCs are still to be determined but the work 
presented here supports published data about nuclear expression of nestin and the 
potential of IL-7 to be expressed by MSCs to regulate a range of haematopoietic 
niches but not necessarily be affected by its expression.  Together with reported 
studies, the evidence suggests that IL-7 is expressed by osteoprogenitors that have 
perivascular locations close to the endosteum and that they support 
B-lymphopoiesis and HPC maintenance in the niche. 
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Abbreviations 
°C degrees Celsius 
2D 2 dimensional  
3D 3 dimensional 
α-MEM minimum essential medium – alpha 
β3-tub beta III tubulin 
µg microgram 
µL microlitre 
ACPA anti citrullinated peptides antibodies 
ADSC adipose derived stem cell 
AGM aorta-gonad-mesonephros 
ALP alkaline phosphatase 
Ang-1 angiopoietin 
APLNR apelin receptor  
ARC adventitial reticular cell 
ATP adenosine triphosphate 
BABB benzyl alcohol: benzyl benzoate 
BAC bacterial artificial chromosome 
Bcl2 B cell lymphoma-2 
bFGF basic fibroblastic growth factor 
BMP bone morphogenic protein 
BMPR1A bone morphogenic protein receptor 1A 
bp base pair 
BSA bovine serum albumin  
CAR cell CXCL12 abundant reticular cell 
CCK-8 cell counting kit -8  
cDNA complementary deoxyribonucleic acid 
C/EBP CCAAT-enhancer-binding protein 
CFSE carboxyfluorescein diacetate succinimidyl ester 
CFU colony forming unit 
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CFU-F colony forming unit - fibroblast 
CFU-M colony forming unit - macrophage 
CNS central nervous system 
Ct cycle threshold 
CXCL12 CXC chemokine ligand 12 
CXCR4 CXC chemokine receptor 4 
DAPI 4',6-diamidino-2-phenylindole 
dATP 2’-deoxyadenosine-5’-triphosphate 
dCTP 2’-deoxycytidine-5’-triphosphate 
dGTP 2’-deoxyguanosine-5’-triphosphate 
dH2O distilled water 
DMARD disease modifying anti-rheumatic drug 
DMEM Dulbecco’s modified Eagle’s medium 
DNA deoxyribonucleic acid 
dNTP deoxyribonucleotide triphosphate 
DTT  dithiothreitol 
dTTP 2’-deoxythymidine-5’-triphosphate 
EB embryoid body 
eCFP enhanced cyan fluorescence protein 
ECM extra cellular matrix 
EDTA ethylenediaminetetraacetic acid 
Epo erythropoietin 
ESC embryonic stem cell 
EthD-1 ethidium homodimer-1 
FABP4 fatty-acid-binding protein 4 
FACS fluorescence-activated cell sorting 
FBS foetal bovine serum 
FGF fibroblast growth factor  
FITC  fluorescein isothiocyanate 
g acceleration due to gravity 
G gauge 
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GAG glycosaminoglycan 
G-CSF granulocyte-colony stimulating factor 
GFAP glial fibrillary acidic protein 
H&E haematoxylin and eosin 
HPC haematopoietic progenitor cell 
HSC haematopoietic stem cell 
IBMX 3-isobutyl-1-methylxanthine 
ICAM-1 inter-cellular adhesion molecule 1 
IgG immunoglobulin G 
IL interleukin 
IMS industrial methylated spirit 
ISCT international society for cellular therapy  
JAK janus kinase 
kDa kilodalton 
KO knockout 
LT-HSC long term-haematopoietic stem cell 
MACS magnetic-activated cell sorting 
Mcl-1 myeloid cell leukaemia sequence 1 
M-CSF  macrophage colony stimulating factor 
MHC major histocompatibility complex 
MMP matrix metalloproteinase  
mRNA messenger ribonucleic acid 
MSC mesenchymal stem cell 
MPP multipotent progenitor 
NCSC neural crest stem cell 
NEAA non essential amino acid 
NF-L neurofilament 
ng nanogram 
nm nanometre 
NSC neural stem cell 
OC osteoclast 
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OCT optimal cutting temperature compound 
OPG  osteoprotegerin 
P/S penicillin/streptomycin 
PBS phosphate buffered saline 
PBS-T phosphate buffered solution – Triton X-100 
PCR  polymerase chain reaction 
PDGFR platelet derived growth factor receptor 
PDL periodontal ligament 
PE phycoerythrin 
PFA paraformaldehyde 
pg picogram 
pNP p-nitrophenol 
pNPP p-nitrophenyl phosphate 
PNS peripheral nervous system 
PPARγ peroxisome proliferator-activated receptor gamma 
PTH parathyroid hormone  
PVA polyvinyl acetate 
qPCR quantitative polymerase chain reaction 
RA rheumatoid arthritis 
RANKL  receptor activator of NF-κB ligand  
RNA ribonucleic acid 
rpm revolutions per minute 
RPS27a ribosomal protein S27a  
RT  reverse transcriptase 
RT-PCR  reverse-transcription polymerase chain reaction 
SCF stem cell factor 
SDF-1 stromal cell-derived factor-1 
SCID severe combined immunodeficient 
SLAM signalling lymphocytic activation molecule 
SNS sympathetic nervous system 
SOCS suppressors of cytokine signalling 
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STAT signal transducers and activators of transcription 
ST-HSC short term-haematopoietic stem cell 
SVF stromal vascular fraction 
TEC thymic epithelial cell 
TEM  transmission electron microscopy 
TRAP tartrate resistant acid phosphatase 
TSLP thymic stromal lymphopoietin  
VCAM-1 vascular cell adhesion molecule 1 
VE-cadherin vascular endothelial cadherin  
YFP yellow fluorescent protein 
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